location^key^class^originating_source^type^identifier_local^identifier_url^name^description_full^description_brief^electronic_url^doi^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2002047"^"http://purl.org/au-research/grants/nhmrc/2002047"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"ALIVE - A National Research Translation Centre to implement Mental Health Care at Scale,Special Initiative"^"ALIVE is a national research translation Centre to implement mental health care at scale. Our vision is to reduce the individual, social and economic impacts of mental illness burden and health inequities by transforming the primary care and community settings to: 1) embed novel preventive life course models; 2) implement mental-physical health tailored models of care with priority populations; 3) be informed by lived-experience models and leadership."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007001"^"http://purl.org/au-research/grants/nhmrc/2007001"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Revolution of sleep diagnostics and personalized health care based on digital diagnostics and therapeutics with health data integration,International Collaborations"^"Almost 1 billion people suffer from sleep apnoea. Unfortunately, the current diagnostic metric relates poorly to the symptoms and comorbidities of sleep apnoea merely measuring the frequency of breathing cessations. We aim to develop machine learning techniques to better estimate sleep apnoea severity. These techniques are implemented to high-end wearables developed in this project. Finally, we aim to design a digital diagnostic platform and create new standardised guidelines for sleep medicine."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007006"^"http://purl.org/au-research/grants/nhmrc/2007006"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"DigiCare4You - An intersectoral innovative solution involving DIGItal tools, empowering families and integrating community CARE services for the prevention and management of type 2 diabetes and hypertension,International Collaborations"^"The overall aim of the research is to design and implement an innovative intervention that will bring together the available community-care infrastructure, human resources and services, as well as technological advancements on digital health, for the early prevention and treatment of type 2 diabetes and hypertension. The active involvement of Australian researchers in this international collaboration ensures that this innovation and its benefits will be transferred to Australia in the future."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007014"^"http://purl.org/au-research/grants/nhmrc/2007014"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Intelligent total body scanner for early detection of melanoma,International Collaborations"^"Melanoma is the 4th most common cancer in Australia; the main screening tool is a time-consuming total body examination with a hand-held dermoscope. This project aims to develop a total body scanner using fast-refocusing lenses to take total body dermoscopy images of all skin lesions in approximately 6 minutes, integrated with a computer aided diagnostic tool providing a risk score for each lesion incorporating medical history, genotypic and phenotypic risk markers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007048"^"http://purl.org/au-research/grants/nhmrc/2007048"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"ManagemenT of chronIc cardioMetabolic diseasE and treatment diScontinuity in adult ADHD PAtieNts (TIMESPAN),International Collaborations"^"The aim of TIMESPAN is to improve the management of patients with Attention Deficit Hyperactivity Disorders (ADHD) and co-occurring cardiometabolic disease (i.e. obesity, type-2 diabetes, and cardiovascular disease). Inadequate treatment of these common conditions can lead to premature death and substantial societal costs. We will use linked electronic health records and novel research methods to improve clinical outcomes and quality of life of adults with ADHD and cardiometabolic disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007059"^"http://purl.org/au-research/grants/nhmrc/2007059"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Re-imagining Environments for Connection and Engagement: Testing Actions for Social Prescribing in Natural Spaces,International Collaborations"^"This project will evaluate whether and how nature-based social prescribing (NBSP) can address mental well-being. We will experimentally test the effectiveness of NBSP in promoting connection among populations experiencing social isolation and loneliness with socially oriented opportunities in safe, inclusive and accessible, green and blue outdoor urban spaces. The project will build the evidence base for the value of NBSP investments in improving mental health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2002381"^"http://purl.org/au-research/grants/nhmrc/2002381"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Parenting+ Improving health and service-use outcomes through health literacy training for new parents: an effectiveness-implementation hybrid trial,Partnership Projects"^"The Parenting+ project will evaluate an educational program for socio-economically and culturally diverse new parents. The study will assess the impact of the program on parents' health literacy, parent and infant health and psychosocial outcomes and health service use over one year. It additionally will identify key characteristics and reproducible steps in the successful implementation of the program in order to support wider adoption by other health services."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2002625"^"http://purl.org/au-research/grants/nhmrc/2002625"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enhancing behavioural surveillance to address gaps and disparities in Australia's HIV response in a changing HIV epidemic,Partnership Projects"^"This project will test and evaluate changes to Australia's HIV behavioural surveillance system, increasing recruitment and data collection from overseas-born, bisexual and heterosexual men who have sex with men (MSM). This is necessary because Australia's HIV epidemic is changing, with falling infections among Australian-born gay men, but rising infections in other groups, such as Asian-born MSM. The project will use technological advancements in recruitment, survey research and interviews."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2003399"^"http://purl.org/au-research/grants/nhmrc/2003399"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel strategies for improving syphilis testing and control,Partnership Projects"^"Syphilis has been resurgent in many countries including Australia. Our research will evaluate novel strategies to improve syphilis testing, surveillance, and control and ensure these new strategies are effective at targeting affected groups attending health services. The research findings will help guide better syphilis testing and control by health care providers, pathology services and health policy makers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2005191"^"http://purl.org/au-research/grants/nhmrc/2005191"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining and optimising the economic and social return on investment of telephone cancer information and support services for all Australians,Partnership Projects"^"The economic and social value of telephone cancer information and support services (CISS) for Australia is undefined thus hindering decisions about the future direction of services and levels of funding. This research will identify and compare the broad monetised, social benefits of CISS with the costs of providing the service. We will identify different strategies to deliver, promote and target services to improve cancer outcomes for all Australians and maximise the return on investment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2005403"^"http://purl.org/au-research/grants/nhmrc/2005403"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the safety and quality of emergency nursing care,Partnership Projects"^"Failure to assess, treat comprehensively and escalate emergency patient care can be catastrophic. However, there is no emergency nursing framework in use for the 29,000+ emergency nurses working in Australia. We aim to improve access, consistency, safety and quality of emergency care for the best possible patient outcomes through system wide implementation of HIRAID - the only validated framework designed to teach emergency nurses how to systematically assess and manage emergency patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2005589"^"http://purl.org/au-research/grants/nhmrc/2005589"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"I-HEART - Implementation of HEArt failure guidelines in Regional AusTralia,Partnership Projects"^"Heart failure (HF) is a common disease of the heart with a high rehospitalisation and mortality rate. Regional HF patients rarely receive the full benefits of evidence-based care simply due to inaccessibility to a HF specialist team. This translational project will implement key recommendations from clinical guidelines in regional health services and improve access to specialist services. It has the potential to keep patients out of hospital and save lives."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2005759"^"http://purl.org/au-research/grants/nhmrc/2005759"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving interpreting for dementia assessments: The MINDSET Study,Partnership Projects"^"The MINDSET Study aims to improve the quality of communication in an interpreter mediated cognitive assessment for dementia. Working with interpreters, clinicians, culturally and linguistically diverse people with dementia, and their carers we will co-design, trial, and implement national online training targeted at interpreters. This training will enable interpreters to be prepared and confident in performing their role impartially, effectively, and accurately."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2005779"^"http://purl.org/au-research/grants/nhmrc/2005779"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the management of Obstructive Sleep Apnea and Insomnia in General Practice,Partnership Projects"^"The two most common clinical sleep disorders, insomnia and obstructive sleep apnea (OSA), affect &gt;4 million Australians, costing Australia over $66 billion annually. People with sleep disorders are receiving care that is far from best practice and is potentially dangerous. This novel partnership study represents a major step towards improving management of sleep disorders in primary care (PC) using new, evidence-based, models of care for insomnia and OSA, designed specifically for PC."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2005790"^"http://purl.org/au-research/grants/nhmrc/2005790"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Partnership for Precision Prevention in CAD (PPP-CAD),Partnership Projects"^"There is an urgent need for new tools to improve risk prediction for coronary artery disease which accounts for one fifth of deaths in Australia. Polygenic risk scores that incorporate the information from millions of genetic variants have shown great promise, but need prospective evaluation. Our team of clinical, research, industry and government leaders will develop clinical pathways and implement polygenic risk scores in primary care to improve precision of preventative strategies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2005797"^"http://purl.org/au-research/grants/nhmrc/2005797"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Personalising Acute Myocardial Infarction Care to improve Outcomes (PAMICO Project),Partnership Projects"^"The modern management of heart attacks has improved survival dramatically, however, not all patients receive the best care available, leading to variation in quality and health outcomes. The PAMICO Project (Personalising Acute Myocardial Infarction Care to improve Outcomes) aims to bridge this gap using sophisticated electronic data systems and integrated care teams to produce personalised clinical management pathways so that care is patient-centered and aligned with best practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006408"^"http://purl.org/au-research/grants/nhmrc/2006408"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Steroid-Reducing Options for ReLapsING PMR (STERLING-PMR): a pragmatic, randomised trial to compare the clinical and cost-effectiveness of adding immunosuppression to steroid-tapering treatment for patients with relapsing PMR, versus steroid-tapering,International Collaborations"^"Polymyalgia rheumatica (PMR) is a common inflammatory disease of older people, treated with prednisolone (steroid tablet). About 50% will relapse and often suffer from steroid side effects (eg diabetes, bone fracture). This study will determine whether an extra treatment can reduce prednisolone use in people with relapsing PMR; and improve quality of life. The study will include participants in UK and Australia and provide a unique opportunity for further research in this under-researched area."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007142"^"http://purl.org/au-research/grants/nhmrc/2007142"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Meniscal Transplant surgery or Optimised Rehabilitation full randomised trial (MeTeOR2),International Collaborations"^"It can be hard to decide what treatment to use for people with pain and disability who have had the meniscus cartilage removed from the knee. Some surgeons try to improve pain and function by replacing the lost meniscus with a transplant from a donor who has died. The alternatives include exercises, physiotherapy, and bracing. This study will help us understand if the results for people who have the transplant are better or worse than for exercise and physiotherapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2005944"^"http://purl.org/au-research/grants/nhmrc/2005944"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"National First Nations Research Network,National Network for Aboriginal and Torres Strait Islander health researchers"^"The National First Nations Research Network will mark a transformation in First Peoples livelihoods and Health Equity. Delivered and led by Indigenous Peoples for Indigenous Peoples, guided by self-determination, this Network will nurture culturally safe environments, connect expertise, catalyse research methods, training and development. The Network will create career pathways to achieve national capability and generational growth, for sustained health and wellbeing of our communities."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006719"^"http://purl.org/au-research/grants/nhmrc/2006719"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Emerging techniques for earlier diagnosis and assessment of severity and progression of artificial stone silicosis,Targeted Call for Research"^"Stonemasons who have worked with engineered stone have been shown to develop a rapidly progressive and potentially fatal form of silicosis. This research will use data from affected workers from Victoria, Western Australia and Queensland. The research will comprise a suite of projects to investigate many uncertainties related to radiological screening methods, as well as investigating new methods to assess disease severity and identify indicators of progression to inform future practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009196"^"http://purl.org/au-research/grants/nhmrc/2009196"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"HPV-based testing and treatment for the elimination of cervical cancer in Papua New Guinea (HPVTATE),International Collaborations"^"Building on the innovative cervical screening model that we successfully designed and delivered in partnership with provincial health authorities in urban primary care settings in PNG, the overarching aim of the proposed study is to determine the reach, effectiveness, cost-effectiveness, acceptability and scalability of HPV-based testing and treatment for the elimination of cervical cancer (HPVTATE) among women in rural and remote communities in Papua New Guinea."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009206"^"http://purl.org/au-research/grants/nhmrc/2009206"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"SISTAQUIT scale-up in Indigenous populations in Australia,International Collaborations"^"SISTAQUITÂ®(Supporting Indigenous Smokers to Assist Quitting) is a research backed training program that provides free, online training in quit smoking methods to health providers. This study aims to expand the SISTAQUIT intervention to all Australian health services that cater to Indigenous women during pregnancy. This research will test numerous methods to implement SISTAQUIT to identify the most effective and economical strategy suitable for roll-out, and build Indigenous workforce capacity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009317"^"http://purl.org/au-research/grants/nhmrc/2009317"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing a scalable, woman-centred model for cervical cancer screening in vulnerable women in India,International Collaborations"^"Cervical cancer is a devastating but preventable disease and 1 in 5 cases of cervical cancer in the world occur in India. We will work with women, communities, and health services in two States of India (Tamil Nadu and Mizoram) to design a woman friendly approach to prevent cervical cancer. This project brings together international and Indian experts to overcome current barriers to cervical screening by using a newer, more effective way of screening to reach underserved women and save lives."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010271"^"http://purl.org/au-research/grants/nhmrc/2010271"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing and testing a community-informed intervention to increase VIA cervical cancer screening in Eswatini,International Collaborations"^"Eswatini has the highest rate of cervical cancer in the world. Cervical cancer screening is effective at reducing deaths from this disease. However, in Eswatini rates of cervical screening are very low, with one study estimating that only 5% of women had ever undergone screening. This project will explore barriers to cervical screening in Eswatini, and develop and test culturally appropriate strategies to improve participation in cervical screening."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000344"^"http://purl.org/au-research/grants/nhmrc/2000344"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pragmatic trial of a targeted digital intervention for youth with suicidal thoughts and behaviours attending outpatient care,Clinical Trials and Cohort Studies Grants"^"Existing programs aiming to reduce suicide ideation in youth often fail to impart lasting benefits in helping young people stay well. Our team have developed an online social media-based intervention (called Affinity) that addresses limitations of past programs by allowing 24/7 access to digital therapy, alongside therapist and peer support. This trial will aim to uncover whether Affinity is effective in reducing suicide ideation in young people, relative to a control program."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000375"^"http://purl.org/au-research/grants/nhmrc/2000375"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Phase III randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine ("Ice") dependence,Clinical Trials and Cohort Studies Grants"^"Crystalline methamphetamine ('ice') is a growing concern in Australia. There are no approved medications that can be used to treat dependence on this drug. This clinical trial will examine whether mirtazapine, a newly identified treatment agent for methamphetamine use, can be used safely and effectively in routine clinical care to manage methamphetamine dependence in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000376"^"http://purl.org/au-research/grants/nhmrc/2000376"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Breathing Control as a treatment for Non-Epileptic Seizures,Clinical Trials and Cohort Studies Grants"^"Non-epileptic Seizures (NES) are fits that look like epilepsy but are not, and are instead thought to be a psychological response to problems. Treating them psychologically is difficult, however, and doesn't usually work. We have discovered that patients' fits involve hyperventilation, like a panic attack, and can be stopped by teaching them to control their breathing in a similar way. In this study we aim to prove this, by completing a trial of breath control training in NES."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000404"^"http://purl.org/au-research/grants/nhmrc/2000404"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Providing translatable evidence to advance prevention and management of COPD: a longitudinal study from the 1st to 7th decade of life,Clinical Trials and Cohort Studies Grants"^"Chronic obstructive pulmonary disease (COPD) makes breathing difficult and reduces wellbeing. People are more likely to get COPD from the age of 60 years, but we do not know why and who. Our study will develop tools to identify early who will develop COPD by 60 years. We will also develop a tool to identify 60-year-old individuals whose lung function is declining faster than normal. These findings will help us to better prevent and manage COPD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000540"^"http://purl.org/au-research/grants/nhmrc/2000540"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"PRogrEssion of DIabetic ComplicaTions - PREDICT,Clinical Trials and Cohort Studies Grants"^"The PREDICT study will fill a very important gap in our understanding of diabetes. By studying what happens to over 3,000 people with type 2 diabetes over the next decade, it will identify improved ways of identifying which people with diabetes will develop its devastating complications. This will allow targeting of intensive treatment on those who need it the most, and will also provide an important means of identifying potential new ways of treating and supporting people with type 2 diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000711"^"http://purl.org/au-research/grants/nhmrc/2000711"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"AGITG TOP GEAR: A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer,Clinical Trials and Cohort Studies Grants"^"While surgery to remove stomach cancer has been traditionally accepted as the only way to potentially cure the disease, there have been several recent advances using chemotherapy and/or radiotherapy both before and after surgery. Doctors' opinions remain divided regarding best treatments to give and in what order. This trial will address the important question of whether combined chemotherapy plus radiotherapy is more effective than chemotherapy alone in improving cure rates for stomach cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000780"^"http://purl.org/au-research/grants/nhmrc/2000780"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine plus dihydroartemisinin-piperaquine to reduce adverse pregnancy outcomes and prevent malaria in Papua New Guinea: a randomised controlled trial,Clinical Trials and Cohort Studies Grants"^"Millions of pregnancies are complicated by malaria worldwide. Monthly sulphadoxine-pyrimethamine (SP) treatments, the current treatment strategy, no longer protects from malaria but improves birth outcomes through non-malarial effects. Dihydroartemisinin-piperaquine clears malaria but babies are smaller compared to women who received SP. A clinical trial of their combination has potential to substantially improve health outcomes for women and babies in Papua New Guinea and beyond."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000842"^"http://purl.org/au-research/grants/nhmrc/2000842"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Uncovering the hidden impacts and costs of exposure to intimate partner violence in childhood: a 20-year cohort study,Clinical Trials and Cohort Studies Grants"^"Intimate partner violence (IPV) and adverse childhood experiences are common, and cluster within families. This longitudinal study will improve understanding of intergenerational impacts and costs of IPV and provide evidence regarding strategies that may reduce the risk of poor mental health in adult life for the more than 1 in 3 Australian children growing up in households where IPV is occurring."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000989"^"http://purl.org/au-research/grants/nhmrc/2000989"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IMPLORE - Implementing an opioid stewardship intervention to reduce opioid use,Clinical Trials and Cohort Studies Grants"^"Back pain is the leading cause for opioid use globally. Guidelines actively discourage opioid use for this condition but unfortunately it commonly ends up managed with opioid medicines. Urgent efforts are needed to reduce the burden of harm associated with excessive prescribing of opioids for back pain. This trial will evaluate a clinical care model that is grounded in research, and designed to curb opioid analgesic use and achieve better health outcomes for people with back pain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2001237"^"http://purl.org/au-research/grants/nhmrc/2001237"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Low OxyGen Intervention for Cardiac Arrest injury Limitation trial (LOGICAL),Clinical Trials and Cohort Studies Grants"^"Life support with mechanical ventilation (MV) is required for most patients after cardiac arrest. Delivery of liberal oxygen therapy to patients receiving MV is standard care and exposes them to a high oxygen dose and higher blood oxygen levels. A higher amount of oxygen might be harmful after cardiac arrest, but the optimal oxygen therapy in these patients is uncertain. This study tests standard care versus a protective conservative dose of oxygen on neurological recovery after cardiac arrest."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2001264"^"http://purl.org/au-research/grants/nhmrc/2001264"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing household air pollution exposure to improve early child health and development; extending the intervention and follow-up of "Poriborton: the CHANge trial".,Clinical Trials and Cohort Studies Grants"^"Around the world each year household air pollution causes 4.3 million deaths. Mothers, babies and children, who spend the most time at home are extremely vulnerable. We will study the health of infants who have had reduced exposure in their first critical years of life and compare them to infants whose exposure was not reduced. This will provide compelling evidence for governments around the world of the need to assist families in developing settings to adopt clean energy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2001375"^"http://purl.org/au-research/grants/nhmrc/2001375"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder,Clinical Trials and Cohort Studies Grants"^"We urgently require new treatment strategies. Alcohol misuse is a leading cause of preventable death yet treatment options are limited. We will undertake the first human trial of N-acetylcysteine (NAC) for the management of alcohol use disorder (NAC-AUD). The NAC-AUD project will evaluate the efficacy and cost-efficacy of NAC to reduce alcohol consumption. The results will generate high level clinical evidence for a safe new treatment for a common life threatening disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2001391"^"http://purl.org/au-research/grants/nhmrc/2001391"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Cognitive Improvement through early Restoration of cirCADian rhythms in very preterm Infants via Environmental Modification: The CIRCA DIEM Study,Clinical Trials and Cohort Studies Grants"^"When very premature infants are born, they no longer receive important signals from their mother about whether it is daytime or night-time, and are cared for in hospital environments that are noisy and brightly lit all day. The absence of the maternal signals and the constant light and noise may interfere with normal brain development. We will determine if wearing eye masks and ear muffs at night in hospital will improve brain development and general health in premature babies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2001517"^"http://purl.org/au-research/grants/nhmrc/2001517"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reconceiving early detection of melanoma,Clinical Trials and Cohort Studies Grants"^"Treatment for skin cancer costs the Australian healthcare system &gt;$1 billion annually. Early detection and accurate diagnosis of melanoma improves survival, however a standardised approach to diagnosis does not currently exist. This study will prospectively recruit 15,000 patients to develop and validate a risk stratified image-based approach to melanoma prevention, early detection and surveillance which will incorporate cutting edge technologies to standardise diagnosis and optimise care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2001568"^"http://purl.org/au-research/grants/nhmrc/2001568"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A large-scale clinical effectiveness (health services) trial to determine whether personalised health care packages, combined with digitally-supported measurement-based care, improve functional outcomes in young people with mood disorders,Clinical Trials and Cohort Studies Grants"^"One of our greatest current health challenges is to develop highly-personalised interventions for teenagers and young adults with emerging mood disorders. This research will combine our national expertise to develop and implement care packages utilising digital technologies, personalised assessment techniques, targeted treatment choices, and long-term outcome tracking. In a clinical trial we will assess the clinical effectiveness of these innovative healthcare packages."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2001578"^"http://purl.org/au-research/grants/nhmrc/2001578"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Australasian Malignant Pleural Effusion (AMPLE)-3 trial,Clinical Trials and Cohort Studies Grants"^"Cancers can spread to the lung causing fluid build-up and requires drainages in hospital that are painful and costly. Surgery is previously seen as the definitive option to stop fluid forming, but is invasive with complications. Indwelling pleural catheter (IPC) is a novel implanted device inside the chest that allows patients to drain fluid at home. AMPLE Trial-3 is the first multicenter randomized clinical trial to compare surgery vs IPC to provide fluid control and improve quality of life."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2001751"^"http://purl.org/au-research/grants/nhmrc/2001751"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"'Azithromycin before Birth'- Single dose azithromycin shortly before birth to reduce infection in Aboriginal mothers and babies: a randomised controlled trial.,Clinical Trials and Cohort Studies Grants"^"Aboriginal mothers and babies in the Northern Territory have high rates of infection. A single dose of azithromycin given during labour (or prior to caesarean section) may reduce the rates of subsequent bacterial infection. This pragmatic clinical trial ('Azithromycin before Birth') will assess a simple intervention that has the potential to substantially improve health outcomes for women and babies at risk of new bacterial infection after birth."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2001834"^"http://purl.org/au-research/grants/nhmrc/2001834"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Scalable Insomnia Program during the Pregnancy and Postpartum Periods: An Effectiveness-Implementation Hybrid Trial,Clinical Trials and Cohort Studies Grants"^"Persistent sleep problems are common during pregnancy/postpartum periods and have significant consequences. Cognitive behavioural interventions are efficacious for improving sleep but are not currently available in perinatal care. This study examines the effectiveness, cost- effectiveness, and implementation potential of an innovative nonpharmacological intervention for better maternal sleep and wellbeing, with high potential for sustainable integration with routine perinatal care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006101"^"http://purl.org/au-research/grants/nhmrc/2006101"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Prospective Ovarian Cancer Cohort to Authenticate Stratification of Prognosis in Ovarian Tumours (POCCA-SPOT),Clinical Trials and Cohort Studies Grants"^"Ovarian cancer has poor survival, with less than 40% of women surviving 5 years. There is a wide range of survival, but very few characteristics that indicate which patients will do well or poorly. We have developed a tumour test at diagnosis, that can predict prognosis at 5 years. In newly diagnosed cases, we will test tumours to predict prognosis and then determine the accuracy and assess patient acceptability. This study will lead to clinical use of the test and improve treatment decisions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006403"^"http://purl.org/au-research/grants/nhmrc/2006403"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"INTERCEPT (Investigating Novel Therapy to target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): a multi-arm, precision-based, recursive, platform trial,Clinical Trials and Cohort Studies Grants"^"Acute myeloid leukemia is a rare and lethal blood cancer with limitless potential to evolve resistance. New technologies allow early detection of molecular 'fingerprints' of returning disease. We propose an international research team to conduct a multi-arm, precision-based platform trial aimed at increasing and extending the duration of patient response and survival using novel combination options. INTERCEPT will suppress and eradicate relapse before the patient becomes clinically unwell."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006415"^"http://purl.org/au-research/grants/nhmrc/2006415"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Anti-PD 1 Brain Collaboration + Radiotherapy Extension: The ABC-X Study,Clinical Trials and Cohort Studies Grants"^"The purpose of this research study is to determine whether administering radiotherapy to melanoma brain tumours, in combination with 2 drugs called nivolumab and ipilimumab(also known as Immunotherapy), will be more effective than treating brain tumours with immunotherapy. Patients in this trial will be randomly assigned to 1 of 2 treatment groups. Group 1 will receive radiotherapy to their melanoma brain lesion(s), combined with immunotherapy. Group 2 will receive immunotherapy treatment alone."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006451"^"http://purl.org/au-research/grants/nhmrc/2006451"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preventing infections in patients with blood cancer through evidence-based use of immunoglobulin or alternatives: The RATIONALISE trial,Clinical Trials and Cohort Studies Grants"^"Patients with blood cancers, with immune deficiency from low antibody levels and other disease or treatment factors, are at risk of life-threatening infection. Immunoglobulins (Ig) made from plasma can supplement antibody levels. Government criteria recommend stopping Ig therapy in stable patients, but with no evidence for when or how to do so. RATIONALISE will provide this evidence, to improve patient outcomes, reduce risks and costs, and make better use of blood products for the community."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006491"^"http://purl.org/au-research/grants/nhmrc/2006491"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Whole-of-population CRISPR point-of-care testing for congenital cytomegalovirus to prevent hearing and neurodevelopment disabilities through a public health approach,Clinical Trials and Cohort Studies Grants"^"Congenital cytomegalovirus infection (cCMV) is the major infective cause of deafness and brain disability, both of which are potentially reversible with early treatment. Currently, there is no screening at birth, and cCMV is diagnosed too late for treatment. Our team will test and validate CRISPR, a new and cheap technology, on 110,000+ newborns to detect cCMV. This will revolutionise how cCMV is detected, make treatment more accessible and pave way to lower rates of deafness and cerebral palsy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006529"^"http://purl.org/au-research/grants/nhmrc/2006529"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Trans20: A longitudinal cohort study to improve outcomes for transgender children and adolescents,Clinical Trials and Cohort Studies Grants"^"1% of young people now identify as transgender or gender diverse (TGD), and increasing numbers are presenting for specialist gender-affirming clinical care. This study will prospectively evaluate the health outcomes and well being of a large cohort of TGD children and adolescents who received such care. By doing so, this research will address critical knowledge gaps in this important and emerging area of health care so as to maximise health outcomes and minimise harm for this vulnerable group."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006611"^"http://purl.org/au-research/grants/nhmrc/2006611"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Clinical trial to determine the effects of statins on cognition: STAREE-Mind,Clinical Trials and Cohort Studies Grants"^"Statins may improve brain health in older individuals but there is need for a large randomised trial to directly address this important question. This study of 10,000 community dwelling older individuals aged 70 years and over will provide crucial, high quality evidence on the effects of statins on cognitive function and dementia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006658"^"http://purl.org/au-research/grants/nhmrc/2006658"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Food allergy in the first 15 year of life: wave 5 of the HealthNuts longitudinal study,Clinical Trials and Cohort Studies Grants"^"Understanding why some food allergy persists into adolescence is critical because adolescents are at highest risk of life-threatening allergic reactions. Food allergy also has lifelong impacts on children's health. HealthNuts is a longitudinal study of 5300 children that measured allergic diseases from infancy. At the age 15 follow-up, we will identify predictors of food allergy persistence and severity, and the consequences of infant food allergy on later respiratory health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006773"^"http://purl.org/au-research/grants/nhmrc/2006773"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The effect of high SPF sunscreen application on vitamin D,Clinical Trials and Cohort Studies Grants"^"Sunscreen prevents sunburn and skin cancer, and current guidelines are that it should be routinely used when the maximum UV index is forecast to reach at least 3. However, applying sunscreen in laboratory experiments reduces vitamin D production, and there is concern that regular application of high SPF sunscreens might increase the risk of vitamin D deficiency. We propose a randomised controlled trial to determine if adhering to the current guidelines decreases vitamin D."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006867"^"http://purl.org/au-research/grants/nhmrc/2006867"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"ACTIVE STRIDES-CP: Randomised trial of Intensive Rehabilitation (Combined Intensive Gait and Cycling Training) for children with moderate to severe bilateral cerebral palsy,Clinical Trials and Cohort Studies Grants"^"In Australia, 35,000 people have cerebral palsy, and 40% experience moderate to severe difficulties with movement and reduced participation in physical activity. There are currently no effective interventions for children with moderate to severe CP to improve their ability to move, perform daily life tasks and engage in physically active leisure. We have promising data about a new intervention, called Active Strides-CP, which we will test in 150 children with CP and compare to usual care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006883"^"http://purl.org/au-research/grants/nhmrc/2006883"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Predicting Renal, Ophthalmic and Heart Events in the Aboriginal Community: The PROPHECY Diabetes Multi-Omics Cohort Study,Clinical Trials and Cohort Studies Grants"^"Diabetes is at epidemic levels in Indigenous Australians, impairing quality of life, and contributing to poor health. This is a result of rapid development of kidney, heart and eye complications. We have established a large long-term population study among Aboriginal communities within South Australia and will explore the burden, natural history and the social, psychological, environmental, clinical and genomic predictors of diabetes and its complications."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006893"^"http://purl.org/au-research/grants/nhmrc/2006893"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A randomised trial of the effects of SGLT2 inhibition versus metformin on decline in renal function when used as first line therapy in type 2 diabetes,Clinical Trials and Cohort Studies Grants"^"Type 2 diabetes affects 5 in 100 Australians with many going on to develop serious heart and kidney complications. Sodium glucose co-transporter 2 (SGLT2) inhibitors are a new type of medicine that may provide benefit when used early in diabetes, but that are currently only used once complications have developed. This study will test the value of SGLT2 inhibitor treatment for kidney protection in Australians with newly diagnosed type 2 diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006514"^"http://purl.org/au-research/grants/nhmrc/2006514"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Centre for Research Excellence to Transform Outcomes of Critically Ill Patients in ICU (CRE-ICU),Centres of Research Excellence"^"Patients who are admitted to intensive care (ICU) and require mechanical ventilation for life support account for 63,000 ICU admissions and 8,190 deaths each year in Australia, higher than the national road toll. CRE-ICU will transform outcomes for these patients by using data within registries and electronic medical records to perform high-impact, low cost clinical trials, generating new knowledge to inform national guidelines and policies and training the next generation of researchers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006523"^"http://purl.org/au-research/grants/nhmrc/2006523"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre of Research Excellence in Stillbirth,Centres of Research Excellence"^"In Australia, over 2000 families suffer the tragedy of stillbirth each year. By building on our achievements of the first Stillbirth CRE rapidly translating new research into maternity care, we will reduce stillbirth rates by 20%, and reduce inequities in stillbirth rates by Australia by 2025. We also anticipate a reduction in adverse neonatal outcomes. When stillbirth or neonatal death does occur, our research aims to ensure that all women and families receive optimal care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006545"^"http://purl.org/au-research/grants/nhmrc/2006545"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Wiser healthcare: better value care for all Australians,Centres of Research Excellence"^"This CRE develops a new solutions-based approach to overuse of unnecessary, ineffective healthcare. Overuse causes harm and diverts resources from areas of need. We will produce new solutions to address four drivers of overuse. We will: build health literacy in patients, communities and health professionals; respond to changing screening and diagnostic technology; address financial drivers; and change clinical practices, to minimise harm and waste, achieving more sustainable healthcare for all."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006551"^"http://purl.org/au-research/grants/nhmrc/2006551"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Skin Imaging and Precision Diagnosis,Centres of Research Excellence"^"Skin cancers, including melanoma, present a significant health, social and economic burden in Australia. Despite the rising incidence of melanoma, the most deadly form of skin cancer, there is currently no national or population-based screening program available. The aim of this CRE is to identify how novel skin imaging technologies can be integrated into the pathway to improve early detection, and ultimately reduce the health and economic burden caused by melanoma skin cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006579"^"http://purl.org/au-research/grants/nhmrc/2006579"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"CRE for Better Outcomes in Inflammatory Arthritis,Centres of Research Excellence"^"We aim to find the right treatment for children and adults with inflammatory arthritis to give the best path to symptom relief with least risk of side effects. We will build on our national data-base and biospecimens bank (A3BC-ARAD) to collect a broad range of patient-reported, biological, environmental and health information to unlock the answers using big-data analysis. We will build a resource and workforce to continue to look for cures to deliver the best outcomes for patients and society."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006595"^"http://purl.org/au-research/grants/nhmrc/2006595"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"BREATHE - mitigating airborne threats to health,Centres of Research Excellence"^"The COVID-19 pandemic has highlighted the risk of closed, indoor settings due to accumulation of aerosols generated from breathing, speaking, coughing or sneezing. Any airborne threat, whether an infectious virus or a chemical agent, will create a higher exposure in indoor settings. To mitigate this risk, using inter-disciplinary expertise, this research will improve preparedness, reduce health impacts of airborne threats, inform worker and occupant safety, building design and healthy futures."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006620"^"http://purl.org/au-research/grants/nhmrc/2006620"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Healthy Food, Healthy Planet, Healthy People,Centres of Research Excellence"^"Food is the biggest issue for health on the planet. High levels of obesity and related illnesses such as heart disease, diabetes, and cancer highlight the need for consumers to have better access to meaningful nutrition information across more food choice contexts. The substantial contribution of the food system to climate change means consumers, industry, and governments need information about which products are better or worse for the environment. This Centre will provide this information."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006765"^"http://purl.org/au-research/grants/nhmrc/2006765"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Vascular Contributions to Dementia (VCD-CRE) - a transformative approach to reducing the burden of cognitive disorders,Centres of Research Excellence"^"The total contribution of vascular pathology to dementia is estimated to be as high as 50-70%. The Vascular Contributions to Dementia CRE brings together leading researchers in cerebrovascular disease and dementia to address the most important issues relating to the epidemiology of Vascular Dementia, its robust biomarkers and its treatment and prevention, so as to reduce its overall health burden, and meet the promise of vascular dementia as a truly 'preventable dementia''."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006797"^"http://purl.org/au-research/grants/nhmrc/2006797"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"On TRACK (Teaching, Research And Community Knowledges) : CRE promoting brain health with older Aboriginal and Torres Strait Islander peoples.,Centres of Research Excellence"^"Aboriginal and Torres Strait Islander peoples experience high rates of dementia at younger ages of onset, having far reaching consequences for the person, their family and their communities. The OnTRACK (Teaching, Research and Community Knowledges) Centre for Research Excellence will generate knowledge about culturally safe approaches to optimise the well being and quality of life of Aboriginal and Torres Strait Islander peoples at risk of or living with dementia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006841"^"http://purl.org/au-research/grants/nhmrc/2006841"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre for Research Excellence in Developmental and Epileptic Encephalopathies,Centres of Research Excellence"^"We will study the clinical, genetic and psychological aspects of patients with the most severe group of epilepsies, the Developmental and Epileptic Encephalopathies (DEEs). We will define the clinical spectrum of each genetic DEE, improve health outcomes through understanding the natural history of these diseases, build an integrated model of care, produce family resources and assess health economic impacts. This program will ensure Australia is poised for emerging Precision Medicine trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006899"^"http://purl.org/au-research/grants/nhmrc/2006899"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre of Research Excellence in Precision Public Health Approaches to Breast Cancer Screening, Early Detection and Mortality Reduction,Centres of Research Excellence"^"The ultimate aim of the CRE is to make it possible to further reduce mortality from breast cancer, and in a more effective way, by identifying women at vastly different levels of risk at younger ages, determining which screening modalities are likely to be more effective, and helping radiologists to better detect cancers. Given that digital mammography is the contemporary standard, and the incidence of breast cancer is increasing across the world, this CRE has global relevance."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006999"^"http://purl.org/au-research/grants/nhmrc/2006999"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre of Research Excellence in the Early Prevention of Obesity in Childhood -Translate (EPOCH-Translate),Centres of Research Excellence"^"Overweight &amp; obesity affect 1:4 Australian children by the time they start school. The Centre of Research Excellence in the Early Prevention of Obesity in Childhood: Translate (EPOCH-translate) brings together researchers from across Australia and New Zealand to work out how best to prevent obesity in children aged 0-5 years. We will look at what works in the long-term, what is the best value for money, and what works for parents as well as health professionals."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007007"^"http://purl.org/au-research/grants/nhmrc/2007007"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal, persONalised Dosing (RESPOND),Centres of Research Excellence"^"Each year more than 17 million people die from infectious diseases. Many of these deaths are due to the poor use of antimicrobial drugs and an increase in infections caused by antimicrobial-resistant 'superbugs'. CRE RESPOND will enable an optimal treatment of infection by empowering clinicians with an evidence-based, patient-centred approach to guide antimicrobial dosing. We will generate new knowledge, educate healthcare workers, and build research capacity through our network of collaborators"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007026"^"http://purl.org/au-research/grants/nhmrc/2007026"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT),Centres of Research Excellence"^"CRE-PACT will partner with patients to generate and translate new high-priority evidence to improve outcomes that are important to people living with chronic kidney disease (CKD). We will address the topics and questions most important to patients. We will build the next generation of research leaders and a community of research-ready patient-partners. There will be an integrated pathway for evidence translation and implementation at a global scale to improve patient-centred outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007037"^"http://purl.org/au-research/grants/nhmrc/2007037"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre of Research Excellence in Enhanced Dementia Diagnosis (CREEDD),Centres of Research Excellence"^"The diagnosis of dementia is often difficult, especially in its early stages. The current delays and uncertainties in diagnosing dementia cause anxiety in patients and limit treatment options. A number of new technologies have demonstrated their value in clinical dementia research, but have not been adopted into clinical practice. The Centre of Research Excellence in Enhanced Dementia Diagnosis will provide a pathway to implement new technologies to transform dementia diagnosis in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007049"^"http://purl.org/au-research/grants/nhmrc/2007049"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre of Research Excellence in Alcohol and Other Drug sector capacity building for outcome focused, evidence based and cost effective care (CRE in AOD -CB),Centres of Research Excellence"^"AOD use is the number one risk factor for the most death and disability combined in all age groups in Australia. This CRE's mission is to reduce the burden and cost of primary and complex comorbid AOD problems in Australia, by using MBC to increase the capacity of the AOD sector to deliver evidence based, efficient and cost effective care to clients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007062"^"http://purl.org/au-research/grants/nhmrc/2007062"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre of Research Excellence - Better Health Outcomes for Compensable Injury,Centres of Research Excellence"^"Many people do not recover after a road traffic injury but develop chronic pain, disability and poor mental health. Health outcomes are worse for people who lodge a claim for injury compensation and/or engage a lawyer. The CRE will extend research and implementation beyond health services to the compensation and legal systems. Results will improve health outcomes advancing knowledge of system processes mediating recovery and implementing interventions that promote not hinder recovery."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008140"^"http://purl.org/au-research/grants/nhmrc/2008140"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reverse or Anatomical (replacement) for Painful Shoulder Osteoarthritis: Differences between Interventions -Aus,International Collaborations"^"Shoulder osteoarthritis is common in older adults, causing severe pain and making daily life difficult. Shoulder replacement is an effective treatment - it replaces the damaged joint with metal and plastic implants. Two types of shoulder replacement exist, but the best option is uncertain as they have not been compared in randomised trials. We will produce evidence about the benefits, harms and cost-effectiveness of each shoulder surgery to enable patients to receive the best type of surgery."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006089"^"http://purl.org/au-research/grants/nhmrc/2006089"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Working it Out Together! Aboriginal and Torres Strait Islander led co-design for a strong and deadly health workforce,Partnership Projects"^"High primary health care (PHC) workforce turnover and few Aboriginal and Torres Strait Islander staff in rural/remote areas affects community trust and cultural safety. This impacts health care quality and costs. This Indigenous-led project sees local communities in four rural/remote areas driving new workforce plans with PHC services and partners. Implementation with continuous evaluation and adaption will increase workforce stability, trust, engagement and health improvements."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006138"^"http://purl.org/au-research/grants/nhmrc/2006138"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"BALANCE: Promoting wellBeing in AdoLescent and young Adult caNCEr survivors,Partnership Projects"^"Almost 5000 adolescents and young adults (AYAs) in Australia were diagnosed with cancer in the last 5 years, and many will survive well into adulthood. Survival does not mean AYAs return to their former state of health. They need support to manage the detrimental effects of their cancer experience - support that is scarce in this country. This project tests a lifestyle program to address this issue. We aim to ensure young people who survive cancer have the same quality of life as their peers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006240"^"http://purl.org/au-research/grants/nhmrc/2006240"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing a model of Preventative Healthcare for People with Intellectual Disability,Partnership Projects"^"People with intellectual disability face stark health inequalities, die prematurely from potentially avoidable causes and experience poor access to preventative health care. Access to preventative health care is one of the key pillars of Australia's long-term national health plan. This project will find out why there are gaps in preventative health care for people with intellectual disability, determine how these gaps affect people and develop a new model of health care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006282"^"http://purl.org/au-research/grants/nhmrc/2006282"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enhancing hepatitis C testing and treatment among people who inject drugs in drug treatment settings: the ETHOS III Study,Partnership Projects"^"Progress towards hepatitis C elimination has been slowed. Given that most people with hepatitis C have a history of injecting drug use, reducing hepatitis C burden requires scale-up of enhanced testing and treatment for people who inject drugs. This Partnership project will evaluate an intervention to enhance hepatitis C testing and treatment in drug treatment clinics and develop a translational framework to scale-up hepatitis C care in this setting nationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006306"^"http://purl.org/au-research/grants/nhmrc/2006306"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Be Healthy: Implementing culturally secure programs for obesity and chronic disease prevention with remote Aboriginal communities and families,Partnership Projects"^"Environments cultivated in recent decades encouraging physical inactivity and poor diet have disproportionately affected Aboriginal people. Appropriate lifestyle modification programs substantially improves outcomes. We have co-designed, piloted and refined the 'Be Healthy' program with Derby Aboriginal people. This project aims to show how this program can be scaled up and transferred to other Aboriginal communities, leading to reduced rates of obesity, and improved health and quality of life."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006448"^"http://purl.org/au-research/grants/nhmrc/2006448"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Implementation research to guide the elimination of HIV transmission in NSW,Partnership Projects"^"The implementation of new biomedical forms of HIV prevention since 2015 has been accompanied by a 40% reduction in HIV diagnoses in gay and bisexual men in New South Wales (NSW). Reductions in HIV have been much smaller in the overseas-born, the young, and in those living outside of inner Sydney. We propose a 5-year program of implementation research, integrated with the NSW HIV Strategy 2021-25, which will see NSW become the first jurisdiction globally to virtually eliminate HIV."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006486"^"http://purl.org/au-research/grants/nhmrc/2006486"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A digital sexual health hub: Co-design, development and evaluation of an online sexual health clinic,Partnership Projects"^"Sexually transmitted infection rates have increased dramatically in recent years in Australia, with major health consequences - congenital syphilis is killing babies, chlamydia in females is causing pelvic inflammatory disease, increasing the risk of infertility, and drug-resistant gonorrhoea is an urgent global threat. Our specialist sexual health services are at capacity. We will develop an innovative online sexual health hub providing online testing and treatment for STIs and HIV."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006528"^"http://purl.org/au-research/grants/nhmrc/2006528"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Prostate Cancer Survivorship Essentials for Men with Prostate Cancer on Androgen Deprivation Therapy: Transforming Care to Improve Outcomes,Partnership Projects"^"Up to half of all men diagnosed with prostate cancer will undergo androgen deprivation therapy (ADT) as part of their treatment at some point. Although ADT is effective in treating prostate cancer, many men will experience considerable side effects that negatively impact their quality of life. This research study will identify if a nurse-led survivorship care intervention, delivered by phone or video-call, improves the quality of life for men with prostate cancer who are receiving ADT."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006628"^"http://purl.org/au-research/grants/nhmrc/2006628"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for hip osteoarthritis: program evaluation of HipHealth, an evidence-based telehealth exercise and weight loss program,Partnership Projects"^"Hip osteoarthritis is a common problem leading to chronic pain and disability and high rates of joint replacement surgery. This project aims to improve the health and well-being of Australians with hip osteoarthritis (OA) by implementing and evaluating an education, exercise and weight loss program (HipHealth) delivered remotely by physiotherapists and dietitians. The program will be tested in the private health insurance setting with view to future scale-up in this and other settings."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006751"^"http://purl.org/au-research/grants/nhmrc/2006751"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Talk stroke: Developing Australia's first National tele stroke framework and communications platform,Partnership Projects"^"Patients with a stroke in the regional areas are twice as likely to suffer significant disability compared to patients living in inner city regions. We propose to develop technology to close this gap, and guide its implementation with a national tele stroke policy framework. The technology we develop with our partner organisations will facilitate tele medicine to close the gaps in critical patient care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006755"^"http://purl.org/au-research/grants/nhmrc/2006755"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Establishing a digital health foundation for outcomes-based diagnostic excellence, safety and value,Partnership Projects"^"Our partnership proposal will lead to the development of a digital infrastructure (involving big data resources and sophisticated decision support systems) as a foundation for outcomes-based research, optimised clinical care processes and translation into policy and practice. The partnership will encompass key research areas involving the quality, safety and value of care in musculoskeletal care, infectious diseases, diabetes care and emergency/intensive care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006950"^"http://purl.org/au-research/grants/nhmrc/2006950"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving physical activity and screen time in Outside School Hours Care through evidence-based guidelines: an effectiveness-implementation hybrid trial,Partnership Projects"^"This study aims to lift the standards of physical activity and screen time offerings in Out of School Hours Care services throughout Australia, by implementing and evaluating newly developed Australian OSHC physical activity and screen time guidelines. The guidelines will be evaluated in a rigorous trial in OSHC services in SA, NSW and WA, prior to national release and evaluation Australia-wide."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006957"^"http://purl.org/au-research/grants/nhmrc/2006957"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A National Aged Care Medication Roundtable - Translating aged care data into action to improve quality of care through collaboration and co-design,Partnership Projects"^"Older Australians with the most complex health needs live in residential care. Greater than 80% of residents are on five or more medications daily, and 40% are taking 10 or more. Poor medication management is the greatest source of complaint to the Aged Care Quality &amp; Safety Commission. This project will provide timely information to a group of providers and consumers about the medicines residents receive, identify problem areas and trial innovative interventions to address these issues."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006969"^"http://purl.org/au-research/grants/nhmrc/2006969"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Control of neglected tropical diseases in the Pacific: integration of programs to increase their impact,Partnership Projects"^"Our goal is to improve programs to control neglected tropical diseases, diseases of poverty common in Australia's neighbours: Papua New Guinea, Solomon Islands and Vanuatu. Our partners are supporting the Ministries of Health in these countries to implement integrated programs to better control these diseases. Our multidisciplinary research will use improved diagnostics, spatial mapping, health systems, social science and health economics to evaluate this integrated approach to disease control."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006970"^"http://purl.org/au-research/grants/nhmrc/2006970"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Implementation of Negative Pressure for Acute Paediatric Burns,Partnership Projects"^"Over 4000 children present to our burns services every year. Contemporary burn care aims to speed up a patients time to healing which directly avoids the child's risk of developing a scar. We know that applying negative pressure wound therapy (NPWT) to a child's burn within 72 hours post injury will improve a child's time to healing, decreasing the risk of scarring &amp; cost of care. Co-developing a NPWT Pathway and implementation strategies will improve outcomes for childhood burns nationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006987"^"http://purl.org/au-research/grants/nhmrc/2006987"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Integration and expansion of a sentinel surveillance system to improve infectious disease outcomes for Indigenous Australians; the ATLAS network,Partnership Projects"^"Infectious diseases remain a significant health issue for Indigenous Australians. Our proposal is to extend a sentinel surveillance network operating in 32 Aboriginal primary care services, with a focus on sexually transmissible infections and blood borne virsuses. By expanding, we will increase the number of sites, and add vaccine preventable diseases to the network. In doing this, we move from a surveillance system to a research network that can inform health service strategies and practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006061"^"http://purl.org/au-research/grants/nhmrc/2006061"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A randomised trial of a Carer End of Life Planning Intervention (CELPI) in people dying with dementia,Targeted Call for Research"^"Dementia is the second highest cause of death in Australia. Although palliative care helps individuals avoid suffering and futile interventions at the end of life, only 6% of people that die of dementia receive such care. Many older people with dementia attend an ED in their final year of life. In CELPI we will trial using that opportunity of an ED visit as the trigger to implement a triad of carer education, access to palliative care and a formal planning process for participants."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006121"^"http://purl.org/au-research/grants/nhmrc/2006121"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IMPART - IMproving PAlliative care in Residential aged care using Telehealth,Targeted Call for Research"^"Sixty-thousand Australians die every year in residential aged care facilities but the quality of their end-of-life care varies. The IMPART program aims to improve palliative care in residential aged care using telehealth. We provide training and palliative-geriatric support to aged care staff and general practitioners to enable timely end-of-life discussions, improve documentation of care preferences, reduce avoidable hospitalisation and improve residents' quality of care at the end of life."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006170"^"http://purl.org/au-research/grants/nhmrc/2006170"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the wellbeing of people with advanced cancer and their family carers: An effectiveness-implementation trial of an Australian dyadic digital health intervention (FOCUSau),Targeted Call for Research"^"The end-of-life-wishes for many Australians are not upheld which has a negative impact on their quality of life as well as their family carers. However, patient and carer wellbeing is improved when they are supported together. Our research will adapt and then examine the clinical and health economic benefits of an internet-based strategy (developed in the USA) which aims to improve the quality of life of patients with advanced cancer and their family carers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2006283"^"http://purl.org/au-research/grants/nhmrc/2006283"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Enhanced Advance care planning and life Review Longitudinal Intervention (EARLI) study: Increasing proactive care planning in Australian community aged care settings,Targeted Call for Research"^"The Enhanced Advance care planning and life Review Longitudinal Intervention (EARLI) project will proactively screen older adults at high-risk of health decline and provide assistance to discuss and document preferences for future care. The intervention is implemented in the community aged care setting, through partnerships with home care providers. Expected benefits include increased rates of advance care planning, higher quality documents and improved wellbeing among older adults and carers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007718"^"http://purl.org/au-research/grants/nhmrc/2007718"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Post-stroke depression: vulnerability, mechanisms and novel treatment targets,Investigator Grants"^"People with post-stroke depression have poor rehabilitation outcomes and reduced quality of life. Acute treatment has done very little to shift the burden of disability, which is largely due to the fact that brain-based mechanisms that lead to these problems are poorly understood. This project will combine neuroimaging and computational neuroscience approaches to identify vulnerability states, reveal underlying mechanisms, and propose promising new treatment targets for post-stroke depression."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007722"^"http://purl.org/au-research/grants/nhmrc/2007722"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the health status and reducing the mortality gap for vulnerable young Australians,Investigator Grants"^"Disadvantage and inequality in health status emerge during adolescence and young adulthood, with profound consequences for later life, including premature death. My program of research will for the first-time characterise mortality and access to health care among 700,000 young Australians who have sought homeless services in the past decade. This work will inform policy regarding vulnerable adolescents and young adults as well as guide a range of services including health care and housing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007725"^"http://purl.org/au-research/grants/nhmrc/2007725"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Priority driven childhood respiratory research,Investigator Grants"^"My research program will focus on childrenâs lung health. I will measure how tissues in the nose fight viruses. These results will help develop new prevention methods and vaccines. Children with cystic fibrosis (CF), a genetic lung disease, often have difficult-to-treat lung infections. I will use friendly viruses to kill antibiotic-resistant bacteria causing these infections. We will investigate whether wearable devices can detect health changes so children with CF can receive treatment early."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007726"^"http://purl.org/au-research/grants/nhmrc/2007726"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Applied research to tackle the Australian poisoning epidemic,Investigator Grants"^"Poisoning is a large and increasing cause of deaths and hospitalisation in Australia. The research will use poisons centre calls, medical and coronial records, and prescribing data to identify agents with higher toxicity. Restrictions or tighter regulation could reduce the risks from such poisoning. This research will also evaluate the effect of recent policies, clinical guidelines, and service enhancements that aim to reduce the harms from poisoning."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007731"^"http://purl.org/au-research/grants/nhmrc/2007731"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Prevention is better than cure: Development and implementation of an effective multi-strategy approach for youth suicide prevention,Investigator Grants"^"Suicide is a leading cause of death in young Australians, and young people are consistently identified as a group requiring specific attention in suicide prevention policy. By leading an innovative program of research which focuses on solving how to sustainably embed proven effective prevention practices into key settings of young people, at scale, this Fellowship will enable me to address grand challenges in youth suicide prevention both in Australia and internationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007732"^"http://purl.org/au-research/grants/nhmrc/2007732"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Engineering T cells to promote peripheral immunity,Investigator Grants"^"Tissue-resident memory T cells (TRM) are key for immune protection against diseases. This has led to much interest in understanding how TRM develop, although elucidation of molecules that regulate TRM formation are still scarce. This project aims to identify genetic regulators of TRM in peripheral organs. Expected outcomes are to identify molecules shaping TRM development and modulate genetic regulators to enhance immune protection against infections and cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007734"^"http://purl.org/au-research/grants/nhmrc/2007734"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Generating an effective T-cell based influenza vaccine,Investigator Grants"^"Influenza is a highly contagious, rapidly spreading respiratory pathogen that causes profound morbidity and mortality. Current influenza vaccines are suboptimal, they need to be updated and administered annually, and provide no protection in the event of a pandemic influenza outbreak. This research program will see the development of a novel universal 'one-shotâ influenza vaccine that provides long term protection against both seasonal and newly emerging pandemic influenza strains."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007739"^"http://purl.org/au-research/grants/nhmrc/2007739"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Control of cellular homeostasis in health and disease,Investigator Grants"^"This research program will explore the roles of an essential cellular process called ubiquitination in influencing human health and disease. Abnormal ubiquitination is associated with many human ailments including cancer, inflammatory diseases, cardiovascular diseases and chronic kidney disease. Our research will uncover new mechanisms involved in these common diseases, thus generating new knowledge to better understand, prevent and help develop new therapeutic tools for their treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007741"^"http://purl.org/au-research/grants/nhmrc/2007741"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Less pain in the back: how new approaches can improve care for low back pain,Investigator Grants"^"Low back pain causes more disability than any other health condition. Low back pain directly impacts a personâs ability to perform simple daily activities, such as lifting objects, bending and even working. Many treatments currently offered to patients with low back pain may be causing more harm than benefit. The project will improve access to high quality LBP care and will provide knowledge on the safety and efficacy of LBP treatments such as surgery."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007747"^"http://purl.org/au-research/grants/nhmrc/2007747"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advancing Indigenous Australian oral health through clinical trials, cohort studies and surveillance,Investigator Grants"^"There are gaps between what optimises Indigenous Australian oral health and what is experienced in everyday practice. In partnership with Indigenous stakeholders, this proposal will facilitate best practice oral care models for Indigenous Australians and result in: (1) improved Indigenous oral health outcomes; (2) raised standards of oral clinical care for Indigenous Australians through cultural competency workshops and; (3) capacity building of Indigenous oral health workforce."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007765"^"http://purl.org/au-research/grants/nhmrc/2007765"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building a culture of safety in Australian residential aged care facilities,Investigator Grants"^"In Australia, the aged care sector has been challenged by issues of quality and safety, including toxic cultures neglect and poor respect for residents. This research program will identify how the culture of residential aged care facilities affects the safety and quality of care provided to residents and put into action strategies to improve culture and thereby residentsâ outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007769"^"http://purl.org/au-research/grants/nhmrc/2007769"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The missing genetics of rare diseases,Investigator Grants"^"to find the genetic causes of rare, often severely debilitating, disease and recurrent miscarriage. These diseases result in a significant burden to the affected individuals and their families and also on Australiaâs health care system. A genetic diagnosis provides families with answers, allows family planning, such that couples do not have another affected pregnancy or child, enables appropriate clinical management and gives researchers targets for development of new therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007778"^"http://purl.org/au-research/grants/nhmrc/2007778"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Rapid evolution of a genome editing tool,Investigator Grants"^"CRISPRâCas9 is a powerful DNA targeting tool for genome editing and gene therapy. While the tool already shows promising results, its accuracy is not good enough for use in treatment of patients. I aim to develop a novel, high-throughput directed-evolution tool to improve the accuracy and specificity of Cas9 enzymes. The Cas9 with improved specificity will allow the wider and more reliable use of CRISPR technology in medical applications."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007800"^"http://purl.org/au-research/grants/nhmrc/2007800"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preterm birth and neurodevelopment: improving long-term outcomes,Investigator Grants"^"Globally, more than one in ten babies is born preterm (early). While most preterm babies survive, many face life-long health consequences, including impaired development. My program will focus on three important treatments (magnesium sulphate; omega-3 fatty acids; donor breast milk) for mothers and preterm babies. I will assess the effects of the treatments on preterm birth and long-term development of preterm babies, in order to improve and maximise their use and impact in Australia and beyond."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007812"^"http://purl.org/au-research/grants/nhmrc/2007812"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting T cell Interactions for Tailored Immunity,Investigator Grants"^"Dynamic immune cell interactions determine the way our body responds to infection and cancer. My laboratory has developed imaging methods that allow us to observe and track immune cell interactions in real time. We will use this information to catalyse the development of precision immunotherapies that either eliminate chronic infection and cancer, or to prevent current and emerging infectious diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007839"^"http://purl.org/au-research/grants/nhmrc/2007839"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards Zero Deaths from Melanoma: Innovative Clinical Trials with Multi-omics Analyses,Investigator Grants"^"Australia has the highest incidence of melanoma in the world. Survival in advanced-stage disease has risen from &lt;10% to &gt;50% at 5 yrs in a decade due to the unprecedented success of immunotherapy. But 30% of melanoma patients have had no change in survival due to drug resistance. This research proposal will rapidly develop novel drug therapies using innovative clinical trial designs, collecting unique high-value tumour, blood &amp; stool samples to understand the causes, and conquer drug resistance."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007884"^"http://purl.org/au-research/grants/nhmrc/2007884"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Discovery of novel inborn errors of immunity that underlie Common Variable Immunodeficiency,Investigator Grants"^"My research will study the underlying causes of Common Variable Immunodeficiency (CVID), the most common type of inherited immunodeficiency. It is caused by mutations in genes that are important for normal immune function. However, diagnosis is complex as many different gene mutations cause CVID, and most are still unknown. This research will identify new gene mutations and determine how they cause disease. The findings will support future gene-based diagnoses and guide targeted therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007887"^"http://purl.org/au-research/grants/nhmrc/2007887"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the control of cell death and the functions of the tumour suppressor p53 to develop improved therapies for cancer,Investigator Grants"^"Cancer is a leading cause of morbidity and mortality in Australia and worldwide, imposing a substantial burden on affected families and the health care system. I will build on my previous success of delivering a highly successful new anti-cancer drug (venetoclax) to market by determining the mechanisms that control the killing of cancer cells and the suppression of tumour development. My aim is to kick-start translational programs to develop new anti-cancer drugs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007896"^"http://purl.org/au-research/grants/nhmrc/2007896"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards a Mechanistic Understanding of the Causes of Congenital Heart Disease and Associated Extra-Cardiac Anomalies,Investigator Grants"^"Birth defects are common, devastating and costly. Heart defects are the most common type affecting about 9 per 1,000 babies. In most cases the cause of the birth defect is not known. This research seeks to identify the gene mutations and other factors, that cause birth defects and uses experimental models to understand why babies do not develop normally. This research will help families understand why birth defects occur and will help to prevent some cases in the future."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007901"^"http://purl.org/au-research/grants/nhmrc/2007901"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovative technologies to improve sexual and reproductive health among women in high-burden, low-resource settings,Investigator Grants"^"I will evaluate novel, newly-available point-of-care technologies to improve sexual and reproductive health outcomes among women living in high-burden, low-resource settings. My vision is to improve the health of women and infants by reducing adverse birth outcomes due to undiagnosed and untreated sexually transmitted infections in pregnancy; and to prevent premature deaths due to cervical cancer by establishing and scaling-up robust clinical screening algorithms."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007904"^"http://purl.org/au-research/grants/nhmrc/2007904"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using translational neuroscience to optimise treatment for older adults with anxiety disorders,Investigator Grants"^"The best way to treat anxiety disorders in older adults remains a critical question. Despite significant advances in our understanding of how we can most effectively reduce fears in younger adults based on experimental neuroscience research, this has not been extended to older adults where age-related changes in cognition may alter the efficacy. This research program will bridge this gap to examine whether treatment for late-life anxiety can be improved by targeting the underlying mechanisms."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007908"^"http://purl.org/au-research/grants/nhmrc/2007908"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A curative approach for chronic myeloid leukaemia,Investigator Grants"^"Patients with chronic myeloid leukaemia (CML) still have adverse outcomes in 2021 with the majority requiring ongoing toxic therapy to control their disease. My program will focus on improving outcomes by determining the key genetic events driving drug resistance and disease progression, further developing the new, highly targeted drug asciminib which promises to revolutionise CML therapy, and remove the current barriers to treatment free remission, the ultimate goal of CML therapy today."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007912"^"http://purl.org/au-research/grants/nhmrc/2007912"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Precise medication use in people with Alzheimer's disease,Investigator Grants"^"New evidence suggests that Alzheimerâs disease (AD) not only affects the brain, but also impacts on how our body handles medicines. That is to say, if one has AD, he/she will have a much higher chance to experience undesirable effects from medication(s). This project aims to develop a dose calculator specifically designed for people with AD, so that they can be given with the right dose of medication for better treatment outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007919"^"http://purl.org/au-research/grants/nhmrc/2007919"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pandemic-proofing our future,Investigator Grants"^"We urgently need to generate better diagnostics and treatments for the next viral pandemic. Here, I will develop novel diagnostics and therapies for both severe influenza virus and coronavirus infections â two viruses of significant pandemic potential. The aim is to bring these treatments and diagnostics to clinical development now, so that we will have a ready stockpile of validated therapeutics and diagnostics to treat infected individuals at the inevitable outset of the next viral pandemic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007920"^"http://purl.org/au-research/grants/nhmrc/2007920"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New directions in global tuberculosis control,Investigator Grants"^"Tuberculosis (TB) is the greatest infectious killer in history, and still affects 10 million people each year. One third of cases are never diagnosed, and few of the 2 billion people with dormant infection ever receive treatment. This research programme addresses the major gaps in prevention, detection and treatment of TB. A series of trials will help to reduce the spread of infection and improve treatment outcomes globally and in Australia. Findings will underpin new global TB control policies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007929"^"http://purl.org/au-research/grants/nhmrc/2007929"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing immunity for optimal SARS-CoV-2 and influenza vaccines,Investigator Grants"^"Vaccines are our most important public health measure to combat infection, however the optimal vaccine format and dosing, or duration of immunity towards influenza virus and SARS-CoV-2 is poorly understood. We need to pre-arm our immune system against antigenic drift and future outbreak strains. This proposal will determine the protective potential of broadly-reactive immune responses by current vaccines, recovered patients, and experimental vaccines for influenza viruses and SARS-CoV-2."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007944"^"http://purl.org/au-research/grants/nhmrc/2007944"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing T follicular regulatory cell products and knowledge from monogenic models to improve treatment for autoimmune disorders,Investigator Grants"^"B cells of our immune system that have the potential to destroy our own tissues are normally kept in check by quality controls. If these controls fail, rogue B cells produce harmful antibodies that cause autoimmune diseases like lupus and allergies. We have discovered that a protein previously only known to function in the brain called âneuritinâ keeps B cells in check. Understanding how neuritin acts, may uncover a completely novel and non-toxic treatment for autoimmune diseases and allergies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007946"^"http://purl.org/au-research/grants/nhmrc/2007946"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Modernising cardiac rehabilitation and secondary prevention of heart disease,Investigator Grants"^"Heart disease causes nearly 20% of deaths around the world. Unfortunately, the ongoing care people receive after they leave hospital has not kept up with medical advances. To fix this, I will lead a team of researchers and clinicians who will unite and join with people with heart disease to change care so it becomes more effective and efficient. I will set up and test tracking and monitoring systems, develop new ways to reach and support more people and improve clinician and researcher training."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007957"^"http://purl.org/au-research/grants/nhmrc/2007957"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving maternal metabolic health prior to pregnancy to prevent metabolic disease in the offspring,Investigator Grants"^"The incidence of obesity in Australia is increasing most rapidly in young women of reproductive age. Currently around 1 in 5 Australian women enter pregnancy with obesity. This places both mother and baby at serious risk of complications during the pregnancy. It leaves the baby prone to metabolic diseases, such as obesity, which may present even before school-age. My program of research aims to prevent metabolic disease in children by addressing the health of women before and during pregnancy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007970"^"http://purl.org/au-research/grants/nhmrc/2007970"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Implementing and scaling an evidence-informed model for hip fracture management: harnessing implementation science for complex adaptive healthcare systems,Investigator Grants"^"This project aims to improve the care provided in Australian hospitals for people with hip fractures. Approximately 50,000 Australians are hospitalised with hip fractures every year. Supporting health professionals to deliver care according to recommended guidelines will assist in reducing wait times for surgery, ensure more Australians with hip fractures get back on their feet after surgery, and help alleviate pain and suffering."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007991"^"http://purl.org/au-research/grants/nhmrc/2007991"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving translational pathways in kidney injury: from discovery to clinical practice,Investigator Grants"^"Acute kidney injury is a common cause of death in hospitalized patients, with multiple negative long-term health implications in survivors. It greatly increases the cost of healthcare. No effective treatments exist. New targets for pharmaceutical intervention are desperately needed to improve the clinical outcomes of patients with this devastating disease. This proposal using cutting-edge technology, bioinformatics, drug repurposing and molecular biology to develop potential treatment options."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007996"^"http://purl.org/au-research/grants/nhmrc/2007996"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unifying epigenetics with long-read sequencing to reveal hidden mechanisms of health and disease,Investigator Grants"^"Superimposed on the genetic sequence, the "epigenetic state" dictates how genes are expressed and silenced. Disrupted epigenetics are common to many diseases, but we lack a thorough understanding of epigenetics even in health. This project will develop a new and broadly applicable epigenetic toolkit to investigate epigenetic phenomena in patients and mouse models, including an incurable muscular dystrophy. The new insights into epigenetic mechanisms will drive the development of treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008000"^"http://purl.org/au-research/grants/nhmrc/2008000"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing Genetic Testing Tools for Optimising Pharmacotherapy and Enabling a Precision Mental Health Care,Investigator Grants"^"On average, 30-60% of patients with mental illness receiving medication do not show adequate response to treatment. Novel tools are needed to augment the current âtrial and errorâ approach to treatment selection. Over the next five years, I will apply advanced data science techniques on internationally collected datasets to develop genetic testing tools for optimising the treatment of patients with mental illness. Better prediction of treatment outcomes will reduce the burden of mental illness."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008001"^"http://purl.org/au-research/grants/nhmrc/2008001"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating sleep biomarkers of cognitive impairment and improving cognitive outcomes through targeted sleep interventions in adults at risk for dementia,Investigator Grants"^"Sleep disturbance accelerates age-related memory decline and increases dementia risk. Monitoring the brain during sleep to understand how sleep disturbance underpins memory problems and contribute to dementia risk is of critical importance. This work will use innovative technology to identify abnormal brain waves that predict memory deficits and evaluate novel treatments that could enhance sleep and improve memory."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008017"^"http://purl.org/au-research/grants/nhmrc/2008017"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Better care for HFpEF patients through integrated basic, clinical and translational research,Investigator Grants"^"Heart failure (HF) is a very common, life-limiting cardiovascular condition in which patients have a poor quality of life and require frequent hospitalization. As the population ages, the burden of HF is increasing and the patterns of HF are changing; 'HFpEF', in particular, is now the commonest cause of HF and the are no effective treatments. My program of research will address this challenge by comprehensively studying the cause of HFpEF and developing effective treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008018"^"http://purl.org/au-research/grants/nhmrc/2008018"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transformation of the implant paradigm in breast rehabilitation,Investigator Grants"^"Breast reconstruction via silicone implants require in 10-25% of cancer patients 5-10years post-surgery implant removal and/or additional surgery. Scaffold guided breast tissue engineering rooted in convergence of 3D printing, reconstructive surgery, drug delivery, &amp; liposuction processed adipose tissue grafts redefines rehabilitation for the breast cancer patient by providing a holistic therapy that addresses limitations realized with all other contemporary reconstructive surgery procedures."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008019"^"http://purl.org/au-research/grants/nhmrc/2008019"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying and addressing preventable causes of asthma over the lifespan,Investigator Grants"^"Asthma is the most common chronic non-communicable disease in children affecting more than 300 million children and adults worldwide. Little is known about what causes asthma so there are few preventive measures and resources are aimed at treating established disease. I aim to discover potential causes of asthma by investigating specific types of asthma (phenotypes) and to translate findings clinical practice and public health guidelines."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008020"^"http://purl.org/au-research/grants/nhmrc/2008020"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Maximising quality of life in frontotemporal dementia,Investigator Grants"^"An early diagnosis is essential for the appropriate management of care of individuals with dementia. This is often missed in frontotemporal dementia, because of the variable symptoms and confusion with psychiatric disorders. Over the next 5 years, the objectives of this research program are to improve diagnosis and understanding of disease progression in frontotemporal dementia, and develop relevant therapeutic interventions that will maximise the quality of life of patients and their families."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008024"^"http://purl.org/au-research/grants/nhmrc/2008024"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Phage Therapy - a novel solution for difficult-to-treat infections in children,Investigator Grants"^"Phages are viruses that kill bacteria and offer a novel solution to treat infections, including antibiotic-resistant ones. This research aims to develop phage therapy as a treatment option for difficult-to-treat infections in children. It will combine the latest advances in bacterial genomics, rapid phage-bacteria matching and clinical trial methods to assess the value of phage therapy to treat serious infections in children with cystic fibrosis and other chronic debilitating infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008064"^"http://purl.org/au-research/grants/nhmrc/2008064"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving dementia outcomes with new targets, trials and national standards,Investigator Grants"^"While there is no cure for dementia, we know that almost half the risk for dementia is due to factors that can be tackled from midlife. My work aims to a) improve understanding of how new emerging risk factors, namely sleep disturbance contribute to dementia onset and progression b) generate robust evidence for new treatments targeting modifiable risks and c) change practices in our health services to develop national standards, timely diagnoses and provision of appropriate treatments and care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008066"^"http://purl.org/au-research/grants/nhmrc/2008066"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Molecular innovations for imaging microglial contributions to brain disorders,Investigator Grants"^"Microglia are the main defender cells in our brains. When injury or disease strikes, they rush to the affected area and perform a host of critical jobs to repair the damage caused, although the fine details of how they do this are unknown. I plan to develop molecules that can 1) track microglia when carrying out specific jobs and 2) be detected using a PET scanner to unravel some of these mysteries. This research could lead to better diagnostics and effective treatments for Alzheimerâs disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008071"^"http://purl.org/au-research/grants/nhmrc/2008071"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Implementing point-of-care tools and precision medicine approaches for antibiotic allergy to improve prescribing and medication safety in health services,Investigator Grants"^"Antibiotic allergies impact 1 in 4 hospitalised patients and range from low-risk allergies which can be removed by a test dose (e.g., childhood penicillin allergy) to high-risk allergies associated with 25% mortality (e.g., Stevens-Johnson Syndrome). This program will translate piloted allergy tools into easy-to-use bedside tests, that are able to prevent, diagnose and remove antibiotic allergies to improve safe and appropriate antibiotic prescribing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008073"^"http://purl.org/au-research/grants/nhmrc/2008073"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing self-harm, suicide and early mortality in marginalised young people.,Investigator Grants"^"Rates of mental disorders, self-harm, and suicide are all increasing, yet not enough is currently known to develop effective prevention strategies. My research will generate evidence on which we can base decisions regarding the best treatment options and the young people who will most benefit from them, including vulnerable populations at increased risk â such as young people in contact with the criminal justice system and those presenting to emergency departments following self-harm."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008079"^"http://purl.org/au-research/grants/nhmrc/2008079"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the Impact and Efficiency of Perioperative Clinical Trials,Investigator Grants"^"More than 2 million Australians undergo surgery each year. A high proportion are elderly and many have chronic medical conditions that increase the risk of serious complications, ongoing disability, and death. My research aims to improve the design and usefulness of large clinical trials in perioperative medicine and surgery. Simpler designs that allow faster recruitment and completion at much lower cost, and better value because the trial outcomes are focussed on what matters to the patient."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008090"^"http://purl.org/au-research/grants/nhmrc/2008090"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Circadian control of innate immunity: strategies for treatment of chronic diseases,Investigator Grants"^"Living organisms adapt to lightâdark rhythms using internal clocks. This body clock not only regulates our sleep and feeding behaviour but also our immune system. Disruption of the body clock can increase the risk of developing cancer, diabetes and asthma. We will discover how our body clock regulates our immune cells to allow future development of therapeutic targets to control these diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008092"^"http://purl.org/au-research/grants/nhmrc/2008092"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Serological Correlates of Protection and Pathogenesis in Infectious and Autoimmune Disease,Investigator Grants"^"Antibodies are a vital component of the immune response required for protection and control of infectious diseases. Conversely, in rare circumstances, the body can produce antibodies that mistakenly target a personâs own organs, damaging the body. Applying "Systems serology," a novel technology developed by Dr Chung, these studies will dissect how antibodies contribute to protection or pathogenesis of disease, in order to develop improved antibody-based vaccines, therapies and diagnostic tools."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008096"^"http://purl.org/au-research/grants/nhmrc/2008096"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing cryo-electron microscopy to study the engineering of microtubule networks in cancer and neurogenesis,Investigator Grants"^"Just as our skeletons provide structure to our body and facilitate movement, our cells have internal structures which form a dynamic scaffold. This scaffold is composed of long filaments called microtubules. Microtubules are needed for healthy cell division and growth, but mutations can cause cells to divide too rapidly, resulting in cancer. This research program will focus on elucidating how the microtubule scaffold is constructed and maintained in healthy cells and how mutations cause disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008097"^"http://purl.org/au-research/grants/nhmrc/2008097"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving cancer outcomes for Aboriginal and Torres Strait Islander women diagnosed with gynaecological cancers,Investigator Grants"^"Aboriginal and Torres Strait Islander women carry a higher burden of gynaecological cancers relative to other Australian women. Reducing this disparity will require mixed-methods evidence-based action across the cancer care continuum. Guided by an Indigenist research approach, this research program will improve outcomes for Aboriginal and Torres Strait Islander women diagnosed with gynaecological cancers through cancer prevention and improved the quality of treatment and survivorship care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008099"^"http://purl.org/au-research/grants/nhmrc/2008099"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Public health interventions to control sexually transmitted infections,Investigator Grants"^"Each year there are &gt;600 million new cases of sexually transmissible infections (STIs) which can lead to infertility, neonatal death and cancers. My vision for the next 5 years is to develop and trial more effective interventions which will move Australia and the Asia-Pacific Region substantially closer to the goal of controlling STIs in high-risk populations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008104"^"http://purl.org/au-research/grants/nhmrc/2008104"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Leading the way in mesothelioma â a program of immunotherapy translational research nested within novel clinical trials,Investigator Grants"^"Mesothelioma is a devastating cancer which is almost always fatal. My research is focused on clinical trials in mesothelioma and on understanding, from patient tumour samples and blood samples, why some people respond to treatment and others do not. This research will use cutting edge laboratory techniques to study samples from people participating in a 480-patient clinical trial of chemo-immunotherapy in mesothelioma, in addition to working with animal models of mesothelioma and immunotherapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008119"^"http://purl.org/au-research/grants/nhmrc/2008119"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Precision Medicine and Cancer Immunotherapy: A Multifactorial Paradigm,Investigator Grants"^"Big data from clinical trials and routine care will be pooled with novel laboratory information generated in collaboration with industry partners to identify biomarkers defining who will and will not respond to immune checkpoint inhibitors in advanced lung cancer. State-of-the-art machine learning and systems biology methodologies will unlock translational world leading insights that enable better treatment decisions and patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008129"^"http://purl.org/au-research/grants/nhmrc/2008129"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Cardiovascular Disease Prevention in Cancer Survivors by Recognition and Treatment of Subclinical Disease,Investigator Grants"^"This research program seeks to develop a cardiovascular diseases (CVD) screening program and subsequent risk-based CVD prevention program to reduce the development of CVD in cancer survivors. This is important because survivors are at risk of CVD, both because of their cancer therapy and because the risk factors for cancer are shared with CVD. Early detection of CVD by screening will enable targeted prevention efforts to reduce incident CVD in cancer survivors."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008157"^"http://purl.org/au-research/grants/nhmrc/2008157"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A deadly duo: Defining the link between Obstructive Sleep Apnoea and Cardiovascular Disease,Investigator Grants"^"Obstructive Sleep Apnoea (OSA) is a very common breathing disorder during sleep that causes low oxygen levels and disturbed sleep. This causes individuals to feel tired, increasing the risk of injury and reducing quality of life. OSA directly affects the heart and increases the risk of high blood pressure, heart attack, heart rhythm disorders, and stroke. This project aims to better understand this connection and to determine whether effective treatment of OSA improves heart health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008166"^"http://purl.org/au-research/grants/nhmrc/2008166"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Gene2Care: a comprehensive program of research to revolutionise care for children with rare genetic conditions,Investigator Grants"^"There are at least 1.3 million Australians with a rare genetic disease. 1 in 2 patients with rare genetic diseases are children. 6 out of 10 deaths in childhood are attributed to rare disease. Gene2Care will explore how to improve the patient journey for children with rare genetic diseases and their families. We will find out how to get genetic diagnoses for more children, more quickly. We will show how to move from a diagnosis to the best possible lifelong support and care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008170"^"http://purl.org/au-research/grants/nhmrc/2008170"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Men in Mind: Training clinicians to engage men in mental health treatment,Investigator Grants"^"While more men than ever are seeking help for their mental health, the male suicide rate is high and rising. The onus needs to move away from the male client adapting to treatment, and onto the systems and services designed to help them. This project focuses on training clinicians who work with men, to ensure they have evidence-based education to better understand and respond to their male clients' distress and suicidality."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008190"^"http://purl.org/au-research/grants/nhmrc/2008190"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advanced graph genome analytics for clinical and public health genomics,Investigator Grants"^"By analysing the DNA of infectious microbes, public health officials can determine whether patients are part of the same or different outbreaks, and even determine the source of the outbreak. This has become common practice for many diseases, but genome data is rich and could be used to do much more. The proposed work enhances public health by providing advanced data analytics that will increase the precision of existing analyses and extends them to outbreaks of antibiotic resistance genes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008193"^"http://purl.org/au-research/grants/nhmrc/2008193"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming outcomes by investigating integrated treatments for methamphetamine use and trauma,Investigator Grants"^"Methamphetamine use disorder is associated with a $5 billion burden annually in Australia, in part due to untreated co-occurring mental health problems. This program of research will address a gap in the treatment of methamphetamine use, by firstly quantifying the prevalence and impact of trauma and post-traumatic stress disorder in people who use methamphetamine; and secondly, by testing two new targeted approaches for trauma and methamphetamine use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008197"^"http://purl.org/au-research/grants/nhmrc/2008197"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating body clock dysfunction in mood disorders using wearable sensors,Investigator Grants"^"We don't yet understand what causes depression and bipolar disorder or why some people don't get better after treatment. This Investigator Fellowship will allow me to explore whether dysfunction of âbiological clocksââwhich control the timing of most of our behaviours and bodily functionsâare responsible for a number of problems that young people with mood disorders face, including fatigue, depressed mood, sleep/wake cycle irregularities, and bodily symptoms like upset stomach and muscle pain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008212"^"http://purl.org/au-research/grants/nhmrc/2008212"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving preterm respiratory outcomes from birth,Investigator Grants"^"Rates of preterm birth are increasing, and survivors are now entering adulthood with chronic respiratory problems. My program addresses the clear need to re-define how we manage the fragile lung of preterm infants from their very first breaths, before the injury events leading to life long problems occur. My program uses world-leading lung imaging and molecular tools and large trials to understand the preterm lung and then develop new therapies that meaningfully impact infants and families."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008255"^"http://purl.org/au-research/grants/nhmrc/2008255"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Interstitial lung disease: Improving patient outcomes through risk prediction and disease burden management,Investigator Grants"^"Interstitial lung diseases (ILD) are complex incurable lung scarring conditions, which cause distressing breathlessness, fatigue, and poor quality of life. It is the second most common cause of death due to chronic lung disease in Australia. My program will allow us to predict how the disease worsens over time, to understand how sleep and drug complexity affect health outcomes, and to better treat debilitating shortness of breath and low oxygen levels in people with ILD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008276"^"http://purl.org/au-research/grants/nhmrc/2008276"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving health outcomes for people who inject drugs: hepatitis C and drug dependence,Investigator Grants"^"People who inject drugs are a vulnerable population within society. Recent advances in treatment of hepatitis C have provided optimism for improved health outcomes for people who inject drugs. Addressing other areas, particularly management of drug dependency, is essential to improving the lives of people who inject drugs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008287"^"http://purl.org/au-research/grants/nhmrc/2008287"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Immunotherapy to prevent and cure autoimmune disease,Investigator Grants"^"Autoimmune diseases such as rheumatoid arthritis (RA) are incurable, inflammatory diseases, causing disability and early death. Building on early phase immunotherapy trials, my program develops ground-breaking immunotherapy research and technology to deliver: 1) tools to identify people at risk; and 2) preventive immunotherapy and lifestyle interventions to halt disease progression. My program will build pipeline drug development and delivery opportunities with industry to transform healthcare."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008300"^"http://purl.org/au-research/grants/nhmrc/2008300"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Maximising health and wellbeing for children with serious illness in countries with the most, through to the least, resources.,Investigator Grants"^"More than 10% of all children have a serious/chronic illness. My research aims to maximise their health and wellbeing by rolling out interventions to support families of seriously ill children across Australia. My new interventions will improve mental health in families undergoing paediatric precision medicine and improve quality of life, resilience, physical activity and diet in child cancer survivors. The program will also expand to low resource settings to reach those with the greatest need."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008313"^"http://purl.org/au-research/grants/nhmrc/2008313"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"PLACE (Prioritising Location-based Analysis and Consumer Engagement) for Change,Investigator Grants"^"Location plays a key role in Australiaâs health inequities, yet is usually ignored or aggregated to large regions. This hinders identifying appropriate, localised solutions. This fellowship uniquely incorporates both complex spatial analyses and lived consumer experience to identify priority areas and propose actionable solutions to help reduce health inequities for cancer, diabetes and injuries."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008317"^"http://purl.org/au-research/grants/nhmrc/2008317"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving survival in lung cancer using novel minimally invasive bronchoscopic techniques,Investigator Grants"^"I will develop novel techniques to achieve tumour destruction via bronchoscopy for non-surgical cure of early stage lung cancer. I will explore the immune system response to tumour destruction, and determine the efficacy of combining tumour ablation (to enhance immune system recognition of tumour cells) with immunotherapy in patients with metastatic lung cancer to increase the proportion of patients who respond to immunotherapy, and increase the duration that responses are maintained."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008339"^"http://purl.org/au-research/grants/nhmrc/2008339"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining pathogenic mechanisms to improve diagnosis and treatment of antibody-associated neurological disorders,Investigator Grants"^"Autoimmune neurological disorders have recently been identified, and can result in severe disability including blindness, paralysis, and seizures. If diagnosed early and treated with specific immune therapy, brain injury can be reversed and patients can have a normal life. My program will identify how frequent these disorders are, increase our understanding of underlying disease processes to identify new treatment targets, and develop diagnostic and therapeutic guidelines to improve outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008341"^"http://purl.org/au-research/grants/nhmrc/2008341"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A personalised pharmacogenomic approach to inform autosomal dominant hypocalcaemia treatment,Investigator Grants"^"Autosomal dominant hypocalcemia (ADH) is a rare disorder caused by genetic mutations that disrupt the bodyâs ability to retain calcium. There is no treatment for ADH. Developing new therapies has been difficult as potential drugs behave differently depending on the underlying mutation. My research is characterising how mutations in ADH can change drug behaviour. I am using this information to design new therapies resistant to these effects, providing treatment options for ADH sufferers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008344"^"http://purl.org/au-research/grants/nhmrc/2008344"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Sex differences in alcohol use disorders: harnessing reverse translation for target discovery,Investigator Grants"^"Alcohol use disorders are a major socioeconomic burden on society and treatment options are inadequate. One of the major hurdles in treatment development is translation from preclinical to clinical models, which in part is underpinned by a lack of appropriate examination in both male and female research subjects. My research will identify and characterise new targets for the treatment of alcohol use disorder in both men and women."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008347"^"http://purl.org/au-research/grants/nhmrc/2008347"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing novel therapeutic approaches by using innate lymphoid cells in chronic kidney disease,Investigator Grants"^"Chronic kidney disease is a major cause of death and morbidity in Australia. Current strategies that delay progression of kidney disease are limited. Innate lymphoid cells (ILC) are a newly identified family of immune cells and include two protective subsets of ILC: regulatory ILC (ILCreg) and type 2 ILC (ILC2), which have been shown to suppress inflammation and promote tissue repair. The project will explore therapeutic potential of ILCreg and ILC2 in kidney disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008356"^"http://purl.org/au-research/grants/nhmrc/2008356"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Germinal centres, antibodies and immunological disease,Investigator Grants"^"Antibodies that latch strongly onto foreign pathogens provide us with immunological protection. They are produced by lymphocytes called B cells participating in the germinal centre phase of the immune response. Autoantibodies that attack the bodyâs own tissues are an unwanted by-product of the germinal centre. The aim of this study is to identify the processes by which B cells producing desirable protective antibodies versus autoantibodies are identified and controlled in the germinal centre."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008359"^"http://purl.org/au-research/grants/nhmrc/2008359"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating new targets and treatments for Alzheimerâs disease: from biochemistry through to clinical trial,Investigator Grants"^"Alzheimerâs disease is a major disease of the elderly that causes profound impairment to cognition. This disease has proven difficult to diagnose and treat. Over the next 5 years I will take advantage of our new laboratory research to test new drugs and diagnostics for Alzheimerâs disease. I will test in a clinical trial of Alzheimerâs patients whether a drug candidate slows disease progression, and test whether new technologies can be used to diagnose Alzheimerâs disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008375"^"http://purl.org/au-research/grants/nhmrc/2008375"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Co-designed Critical Care Recovery,Investigator Grants"^"This research aims to improve patient and family outcomes following critical illness by developing and evaluating a novel and promising intervention - peer support delivered virtually, where survivors can support each other to recover. The outcomes from this research will include two co-designed peer support interventions that can be delivered virtually. This will reduce inequities in access to recovery programs following critical illness in Australia, and will have global impact."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008376"^"http://purl.org/au-research/grants/nhmrc/2008376"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing the regenerative potential of the newborn heart.,Investigator Grants"^"Heart failure is a massive and growing public health problem affecting over 25 million people worldwide. In contrast to the extremely limited regenerative capacity of the adult heart, we have discovered that the newborn mammalian heart retains a robust capacity for regeneration for a short period after birth. This Investigator Grant seeks to unlock the regenerative potential of the newborn heart for cardiac repair in children and adults with heart failure."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008379"^"http://purl.org/au-research/grants/nhmrc/2008379"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising the uptake of effective underused evidence-based non-drug interventions in primary care,Investigator Grants"^"Non-drug treatments, such as exercise for low back pain or behavioural therapy for depression, can be equally or more effective than drugs - with fewer side effects. Despite cliniciansâ and patientsâ growing interest in non-drug treatments, they are less known and used. My research program will develop evidence-based guides for effective non-drug treatments and provide world-first evidence on the best way to improve the uptake of non-drug treatments by clinicians and patients in primary care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008382"^"http://purl.org/au-research/grants/nhmrc/2008382"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preventing Irreversible Vision Loss from Age-Related Macular Degeneration,Investigator Grants"^"Age-related macular degeneration (AMD) is the leading cause of irreversible central vison loss in people over 50 years old. No treatments are available to slow or prevent degeneration of the tissue responsible for vision from the more common âdryâ form of AMD. This project will use state-of-the-art imaging, vision testing and artificial intelligence to substantially improve our assessment of new treatments, and to gain critical insights into disease mechanisms, needed for treatment discovery."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008392"^"http://purl.org/au-research/grants/nhmrc/2008392"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building evidence for strategies to prevent healthcare acquired infections,Investigator Grants"^"Despite being common and affecting 160,000 Australians a year, strategies to prevent infection acquired healthcare are underpinned by low quality evidence. The proposed research program consists of three discrete, inter-related projects. The work will provide evidence for practical measures to reduce common infections â urinary tract infection, pneumonia as well as improving cleaning in healthcare."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008408"^"http://purl.org/au-research/grants/nhmrc/2008408"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding how DC-T cell interactions regulate human disease,Investigator Grants"^"My research has played a significant role in understanding how certain immune cells instruct the body to eliminate infections. Building on this expertise, my team and I will address fundamental question of immune cell function that will be vital for understanding immunity and to develop better therapies against virus infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008426"^"http://purl.org/au-research/grants/nhmrc/2008426"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A new systems approach to discharge and follow up care models for chronic conditions in Aboriginal and Torres Strait Islander children.,Investigator Grants"^"A program providing culturally safe discharge planning for Aboriginal children with a burn injury will be trailed in Darwin and Townsville. It includes a component âBuilding Cultural Capabilitiesâ an educational program for health workers to develop cultural capacity improving healthcare for Aboriginal and Torres Strait Islander patients. This project will improve the quality and safety of healthcare for Aboriginal children in Darwin and Townsville and will improving burn injury outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008436"^"http://purl.org/au-research/grants/nhmrc/2008436"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing the burden of chronic obstructive pulmonary disease (COPD): novel phenotypes, risk factors and biomarkers,Investigator Grants"^"Chronic Obstructive Pulmonary Disease (COPD) is a major public health issue around the world. At present, the only known way to prevent COPD and lessen its severity is tobacco smoking avoidance. However, not everyone who gets COPD smokes and patients with COPD often have different forms of the disease. I will determine the different types and causes of COPD and develop tools to identify who is most at risk. My research will help develop interventions to prevent and better treat COPD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008447"^"http://purl.org/au-research/grants/nhmrc/2008447"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Healthcare resource utilisation and long term outcomes following critical illness,Investigator Grants"^"Patients admitted to intensive care units (ICU) are the sickest patients in hospital but little is known about what happens to these patients after they are discharged. This project will evaluate long-term outcomes such as disability, quality of life, anxiety and depression after ICU, along with ongoing healthcare use (including readmission to hospital). It will also conduct health economic analyses to determine which interventions provide the greatest value for money."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008450"^"http://purl.org/au-research/grants/nhmrc/2008450"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Next-generation therapeutics inspired by parasitic helminths,Investigator Grants"^"Billions of people in developing countries are infected with parasitic worms, but they have been eradicated from industrialised nations. Humans co-evolved with worms, so their recent removal has deprived us of signals required to keep inflammation in check. My research focuses on worm molecules that can be used as: (1) vaccines and diagnostics to combat parasitic infections in developing countries, and (2) a novel platform of anti-inflammatory therapeutics for use in industrialised nations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008454"^"http://purl.org/au-research/grants/nhmrc/2008454"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Tailored approaches to improve prevention and early detection of melanoma and other skin cancers,Investigator Grants"^"This proposal will evaluate ways to tailor melanoma and skin cancer prevention and early detection strategies to a personâs individual risk. It will help us understand the overall benefits and harms of different approaches, how to implement good national strategies, and measure the value for money for the health system. This research will improve skin cancer outcomes for the community and patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008460"^"http://purl.org/au-research/grants/nhmrc/2008460"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using social media to reduce suicide and self-harm in young people,Investigator Grants"^"This program will address the role of social media on youth suicide and self-harm. It will lead to increased understanding of the harms and benefits of online communication from the perspective of young people, parents, professionals and the social media industry. Outputs include evidence-based guidance plus co-designed social media campaign targeting young people. If effective, this work will directly translate into increased online safety for at-risk young people in Australia and overseas."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008462"^"http://purl.org/au-research/grants/nhmrc/2008462"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing more accurate cardiovascular disease detection with a cellular-resolution imaging catheter,Investigator Grants"^"Most heart attacks are caused by high-risk plaques. The holy grail in cardiology would be to reliably detect high-risk plaques before they are life-threatening. This research program will deliver a clinically applicable device to detect high-risk plaques, helping cardiologists determine the most efficient treatment on an individual basis. The imaging device will be the first-of-its-kind worldwide, holding great hope of significantly reducing cost and complications in cardiovascular diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008488"^"http://purl.org/au-research/grants/nhmrc/2008488"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising outcomes from child concussion from sidelines to recovery: improving diagnostic precision, effective treatment and community knowledge,Investigator Grants"^"In the context of wide media attention, child concussion is of increasing community concern, despite limited empirical evidence regarding its real consequences. My research will identify mechanisms underlying persistent symptoms and link these predictive markers to individual recovery profiles and to treatment responses to optimise outcomes for children with concussion."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008501"^"http://purl.org/au-research/grants/nhmrc/2008501"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Interventions to eliminate Plasmodium vivax malaria,Investigator Grants"^"Malaria affects more 230 million people each year. In Asia, the Americas and the Horn of Africa malaria due to Plasmodium vivax accounts for more than half of these cases. I will work with partners in malaria endemic countries to develop better, safer and more effective treatment strategies and design better surveillance to identify populations at greatest risk of infection. The ultimate aim of my program is to change policy, impact on health outcomes and eliminate vivax malaria globally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008523"^"http://purl.org/au-research/grants/nhmrc/2008523"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing the burden of knee osteoarthritis in young adults,Investigator Grants"^"In young people (&lt;40 years), arthritis commonly occurs after knee injury, forcing them to live with old knees and reducing their quality of life. This program of research leverages established resources to address the urgent need to prevent arthritis in young adults by: i) understanding why some people are more likely to get knee arthritis; ii) enhancing the care of knee injuries to prevent arthritis; and iii) uniting international efforts with a world-first database of early arthritis outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008535"^"http://purl.org/au-research/grants/nhmrc/2008535"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enhancing policy implementation for healthy food environments,Investigator Grants"^"This Investigator Grant aims to enhance the implementation of policies for creating healthy food environments. It is expected that the research program will provide new evidence to support effective policy action, and powerful mechanisms for holding governments and the food industry to account for their roles in improving population diets and preventing obesity. In so doing, the research will improve the policy response to the leading contributors to poor health in Australia and globally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008542"^"http://purl.org/au-research/grants/nhmrc/2008542"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing immune cell programs to drive immune protection,Investigator Grants"^"Immunity is essential for life. Harnessing the immune system to drive increased protection against disease has never been more urgent than now. Achieving this requires understanding the cues that regulate the activation of immune cells and the wiring needed for them to function efficiently and defeat pathogens. My work aims to unravel this complex network to harness the immune switches that will facilitate the future development of therapeutics and vaccines to treat world disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008546"^"http://purl.org/au-research/grants/nhmrc/2008546"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel oxygen sensing pathways in hypoxic disease,Investigator Grants"^"Oxygen (O2) is a vital biological resource and sufficient concentrations are needed for normal metabolism. Reductions in O2 (hypoxia) can cause significant stress that subverts life and is a key feature of disorders such as cancer and cardiovascular disease. By understanding how cells respond to changes in O2 we can develop effective methods to treat these detrimental conditions. This project aims to increase knowledge of a new O2 sensing system to combat hypoxic cancers such as glioblastoma."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008565"^"http://purl.org/au-research/grants/nhmrc/2008565"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"From dreams to delirium and dementia: Cognitive fluctuations as a window into novel biomarkers and therapeutic targets for neurodegeneration,Investigator Grants"^"Lewy body dementias are characterized by marked swings in attention and arousal known as cognitive fluctuations. We aim to show that disturbances in the biology maintaining the normal balance between wakefulness and sleep underlie this core symptom and use this to identify new disease biomarkers and novel therapeutic targets of Lewy body disease. We apply this to recruit the first prodromal cohort of delirium-onset Lewy body dementia and to improve prediction and treatment of delirium generally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008572"^"http://purl.org/au-research/grants/nhmrc/2008572"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Phosphatases in the pathogenesis of obesity and cancer,Investigator Grants"^"Obesity has reached epidemic proportions and is major driver of chronic human diseases, including type 2 diabetes, cardiovascular disease, fatty liver disease and cancer. This proposal will define key molecular mechanisms contributing to the development of obesity and its co-morbidities, especially liver disease and cancer. We will thereon seek to develop novel therapeutic approaches for combating obesity and these insidious and recalcitrant diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008574"^"http://purl.org/au-research/grants/nhmrc/2008574"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining effective health actions for adolescents globally,Investigator Grants"^"The world is now home to 1.8 billion adolescents, the largest population in human history. My earlier work has described the unmet health needs of these adolescents- the task now is to define how to best respond. Working in partnership with adolescents across Indigenous communities, Papua New Guinea and Myanmar, I will define the actions required to improve their health. I will define a package of actions that is informed by adolescents and can be implemented across health and education sectors."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008600"^"http://purl.org/au-research/grants/nhmrc/2008600"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Measuring unmet menstrual health needs and their impacts on health and education,Investigator Grants"^"Each day, over 300 million females are menstruating. Their menstrual health matters for gender equality, health, and education. My work will transform the way we measure womenâs and girlsâ menstrual health needs in low- and middle-income countries and advance evidence-based action in Southeast Asia and the Pacific. I will grow our understanding of how adolescent girlsâ needs change over time and quantify the impacts of menstrual health on broader health and education outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008612"^"http://purl.org/au-research/grants/nhmrc/2008612"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Generative models of brain disorders,Investigator Grants"^"The management of many neurological and psychiatric disorders remains underwhelming, due in part to of our limited understanding of how the brain works. Consequently, clinical practice remains rooted in trial-and-error and expert opinion. To make progress, we need to improve our knowledge of the brain using tools that embrace its complexity. I will use advanced mathematical modelling to understand the rules that govern neural circuits in health and as they fail in common brain disorders."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008616"^"http://purl.org/au-research/grants/nhmrc/2008616"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Immunity mediated by MHC class I-related protein (MR1),Investigator Grants"^"Immune T cells react to molecular changes in cells during infection revealed by antigen-presenting molecules that constantly sample molecular patterns. MR1 is a newly discovered Ag presentation molecule involved in microbial immunity, but new evidence indicates that MR1 can present unique molecules from cancer cells driving T cell immunity. This proposal seeks to understand this process to harness a new arm of immunity amenable to development of novel anti-tumour vaccines and immunotherapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008625"^"http://purl.org/au-research/grants/nhmrc/2008625"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Achieving precision care in chronic lung disease,Investigator Grants"^"Current treatment guidelines poorly manage up to 30% of all patients with a chronic lung disease (CLD). In order to improve this, we need to identify useful disease markers that inform treatment response. Using stored samples and data from thousands of CLD patients, I will meticulously measure markers of disease and identify patient characteristics that inform treatment response. This research will improve guidelines for the large number of patients with poor disease control."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008631"^"http://purl.org/au-research/grants/nhmrc/2008631"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for patients with homologous recombination deficient cancer,Investigator Grants"^"Some cancers, including ovarian and breast, have faulty DNA repair, which makes them respond to powerful cancer drugs called PARP inhibitors. Unfortunately, many cancers eventually develop resistance to these drugs. I will use genomic technologies to study the portraits of cancers with faulty DNA repair. I will look at how we can prevent resistance to PARP inhibitors and to treat each cancer most effectively. This important work aims to improve the cancer survival rates."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008632"^"http://purl.org/au-research/grants/nhmrc/2008632"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving antimicrobial use and reducing harms in children,Investigator Grants"^"Antibiotics are often given to children in hospital incorrectly or for longer than needed. My program makes use of routinely collected Australian data, and introduces improved systems for managing antibiotics in hospital, including guidelines and policy. The program will improve the reporting of how antibiotics are used in Australian hospitals, improve management of those antibiotics in children, and lead to better outcomes for children and families, with less time spent in hospital."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008640"^"http://purl.org/au-research/grants/nhmrc/2008640"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing Bioinformatics Capability to Diagnose Infectious Diseases using Clinical Metagenomics,Investigator Grants"^"Current methods to identify infectious pathogens are time-consuming, inaccurate, and unable to detect novel pathogens. This research will develop the bioinformatics and clinical tools needed to implement unbiased metagenomic sequencing as an improvement to current practice in pathogen diagnostics. This new approach can be implemented in remote and regional healthcare settings and will have enormous global impact on the worldâs expanding tropical population, who have limited access to healthcare."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008645"^"http://purl.org/au-research/grants/nhmrc/2008645"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Bringing artificial intelligence into the real world of healthcare - the implementation challenge,Investigator Grants"^"This research program focuses on three foundational challenges to bringing artificial intelligence (AI) into the clinical world. To ensure AI is safe, the 1st challenge, the program will research optimal mechanisms for surveillance and governance of AI safety. The 2nd challenge addressed is the lack of genuine independent testing of claims for the benefits of AI. The 3rd challenge for clinical AI is that good performance in one setting may not be repeated in even closely related settings."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008648"^"http://purl.org/au-research/grants/nhmrc/2008648"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding natural and vaccine-induced immunity to malaria,Investigator Grants"^"Malaria is responsible for the deaths of &gt;400,000 individuals per year. Eradication of malaria will require a safe and effective vaccine. Vaccine development requires an understanding of the immune responses to malaria parasites and vaccines. The work here aims to understand the necessary components for a successful vaccine and to understand why our immune system struggles to make effective responses to malaria."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008649"^"http://purl.org/au-research/grants/nhmrc/2008649"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming Young Aboriginal and Torres Strait Islander Mental Health through New Knowledge and Co-designed Healings,Investigator Grants"^"Young Indigenous Australians have one of the highest rates of suicide in the world and this tragic situation is worsening. My research program will address this call to action through collaborating with Indigenous youth and experts in the field, including traditional healers, to co-design a scalable Youth Model of Mental Health Care to reduce the rates of inter-generational trauma leading to mental illness and suicide/self-harm in young Indigenous Australians."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008650"^"http://purl.org/au-research/grants/nhmrc/2008650"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Integrating social science evidence into the fight against vaccine-preventable and vector-borne diseases in the Australasian, South East Asian and Pacific regions.,Investigator Grants"^"Rejection of preventive health measures like vaccination is a global issue. Knowing what drives it is crucial to how health authorities respond but they donât currently have tools to measure these drivers . This research adds social / behavioural data and new analysis methods to health authoritiesâ toolkit, e allowing new understanding of how diseases behave in human populations, and how humans behave around those diseases, enabling targeted public health interventions to reduce disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008652"^"http://purl.org/au-research/grants/nhmrc/2008652"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"In situ visualisation of cell fate,Investigator Grants"^"Maintaining millions of blood cells every day is crucial for health and development. When this process is compromised, we can develop a range of diseases including cancer and a compromised immune system. To understand how this complex system is regulated, we have developed technology to watch blood cell behaviour in living tissue. Using this approach, I aim to develop new ways of driving healthy blood cell production and eliminating cells that cause disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008692"^"http://purl.org/au-research/grants/nhmrc/2008692"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Inflammatory Responses to Programmed Cell Death Signalling,Investigator Grants"^"Inflammatory cytokines are the alarms that cells in our body engage to protect us against infections. However, when made in excess cytokines contribute to diseases such as arthritis, heart disease and hereditary inflammatory syndromes. This project aims to define the molecular mechanisms by which inappropriate cell death induces damaging levels of cytokines to cause disease. Understanding how inflammation is controlled at the molecular level will allow the design of new, targeted, therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008697"^"http://purl.org/au-research/grants/nhmrc/2008697"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Geospatial applications for the control of Tropical Infectious Diseases in the Asia-Pacific Region,Investigator Grants"^"My research program will improve geographical mapping to better prevent, detect, and manage malaria, dengue, and intestinal worms in tropical countries. Projects include developing systems to rapidly map and report new cases of malaria to facilitate effective interventions, building an early warning system for dengue, and predicting high-risk areas for intestinal worms. The research will improve in the prediction, early warning, and rapid response to control and elimination of these diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008698"^"http://purl.org/au-research/grants/nhmrc/2008698"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel nanotechnology strategies towards a new paradigm of precision nanomedicine,Investigator Grants"^"Nanotechnology offers exciting prospects for many devastating diseases such as cancer. Despite the clinical success of a few nanomedicines, the development of cancer nanomedicines for effective and targeted delivery to pathogenic areas has been limited. This project aims to develop revolutionising nanomedicines capable of simultaneous administration of two or more drugs in targeted cancer disease for synergistic therapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008699"^"http://purl.org/au-research/grants/nhmrc/2008699"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Diagnosis and Therapy based on new Mechanisms of Autoinflammatory Disease,Investigator Grants"^"Mutations of our genetic code can affect cells of our immune system, leading to a functional loss or gain that can cause recurrent infection, or in some cases, promote autoimmunity and autoinflammation. Our investigation of these inborn errors of immunity will advance our understanding of disease mechanisms, and the fundamental workings of our immune system, in order to identify and improve therapies that will potentially treat a range of inflammatory diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008702"^"http://purl.org/au-research/grants/nhmrc/2008702"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Moving beyond one-size-fits-all: Exploring the optimal doses of physical activity and sedentary behaviour across the lifespan for prevention of non-communicable chronic diseases,Investigator Grants"^"It is well known that physical inactivity is a risk factor for the development of non-communicable chronic diseases. This research program will determine the optimal doses of physical activity and sedentary behaviour during childhood, adolescence, adulthood and old age to prevent mental and physical health conditions. This research program will inform the development of strategies to reduce the social and fiscal burden of non-communicable chronic diseases in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008715"^"http://purl.org/au-research/grants/nhmrc/2008715"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards elimination of tuberculosis,Investigator Grants"^"The development of new safe and effective vaccines is necessary for the control of tuberculosis, the leading infectious cause of death globally. Bacillus Calmette-GuÃ©rin (BCG), the only licensed tuberculosis vaccine, prevents severe forms of tuberculosis in children, but fails to protect adults. This project aims to further develop a new tuberculosis vaccine, to perform pre-clinical efficacy studies and to increase BCG coverage in vulnerable children in Far North Queensland and Papua New Guinea."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008723"^"http://purl.org/au-research/grants/nhmrc/2008723"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using genetics to identify optimal times to intervene on early life growth and reduce future risk of cardio-metabolic disease,Investigator Grants"^"The prevalence of cardiovascular disease and diabetes is increasing and the financial burden on society is substantial. Children who have unfavourable growth through early life are at increased risk of these diseases. This study aims to perform the largest genetic study of fetal growth and body mass index over childhood, and then investigate the relationship between early life growth and future risk of diseases like diabetes. Knowledge gained will inform the design of public health initiatives."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008727"^"http://purl.org/au-research/grants/nhmrc/2008727"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying the underlying causes and discovering novel therapeutic treatments for chronic visceral pain (CVP),Investigator Grants"^"Chronic visceral pain is a major but underappreciated clinical, social and economic challenge affecting &gt;1.5 billion people globally. Leading forms of chronic visceral pain include irritable bowel syndrome, endometriosis and bladder pain syndrome, but all lack effective treatments. Using scientific models, human biospecimens and translational science my program will identify the causes of these prevalent forms of chronic pain and develop novel treatments for these debilitating conditions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008735"^"http://purl.org/au-research/grants/nhmrc/2008735"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Real-time prediction and monitoring of head and neck cancer treatment,Investigator Grants"^"Survival in patients with advanced head and neck cancer remains &lt;12 months in the majority. Immunotherapy has durable response, however &lt;20% of patients derive benefit. My program of research uses the patientâs tumour to test responses to new drugs and select the best therapy. The research applied novel, innovative methods and detects cancer using blood samples. Novel clinical trials will be designed to improve patient outcomes and avoid unnecessary side effects and drive down health care cost."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008737"^"http://purl.org/au-research/grants/nhmrc/2008737"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Phenotyping Neurobehavioural Disorders in People with Epilepsy,Investigator Grants"^"Neurobehavioural disorders like depression, psychosis, and cognitive impairment are common in people with epilepsy. Recent discoveries suggest there may be a shared genetic underpinning of the two. This project aims to identify whether there are distinct profiles of neurobehavioural disorders in families who carry epilepsy genes. Exploring the genetic basis of neurobehavioural disorders will improve detection and management of comorbid neurobehavioural disorders in epilepsy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008743"^"http://purl.org/au-research/grants/nhmrc/2008743"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A single cell, single molecule and multi-omics approach to identifying novel targets in heart failure,Investigator Grants"^"Heart failure (HF) is a significant problem in our society. Fibrosis is associated with virtually all forms of CV disease and leads to problems with heart contraction. We hypothesise that a deeper understanding of fibrosis will facilitate cardiac regenerative medicine. Our grant focuses on technologies that allow us to understand tissue complexity down to the level of single cells. Applying these methods, we hope to revolutionise our understanding of cardiac health, ageing and disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008774"^"http://purl.org/au-research/grants/nhmrc/2008774"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Partnering with patients to assess and address loneliness in chronic kidney disease,Investigator Grants"^"Strong social connections and healthy lifestyles are vital for the health of people with chronic kidney disease. This research program will establish world-first evidence of the predictors and impacts of loneliness in CKD. In partnership with consumers, it will identify patient and caregiver priorities for interventions to reduce loneliness and improve social connections, and implement these patient-prioritised interventions in a novel trial to improve patient-centred care and outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008781"^"http://purl.org/au-research/grants/nhmrc/2008781"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Driving Improvements in Ovarian Cancer Survival through Molecular and Clinical Studies,Investigator Grants"^"The Investigator grant would support Professor Bowtell, one of the worldâs leading ovarian cancer researchers. His work focuses on clinical problems of chemotherapy resistance, investigator of rare, exceptional survival patient cohorts, and the development of new therapeutic approaches. His studies are underpinned by the Australian Ovarian Cancer Study (AOCS), one of the worldâs most sophisticated clinical cohort studies of ovarian cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008793"^"http://purl.org/au-research/grants/nhmrc/2008793"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Cell Therapies for Newborn Infants: Translating Promise to Benefits,Investigator Grants"^"Premature babies are at increased risk of brain injury and cerebral palsy. Stem cell therapies offer a paradigm shifting treatment strategy for preterm brain injury. Over the next five years, I will lead a world-first research program to evaluate umbilical cord blood derived cell therapies as an early treatment of brain injury in high-risk preterm infants. I will conduct three proof of concept studies that are crucial to progress my research pipeline of cell-based therapies for preterm infants."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008813"^"http://purl.org/au-research/grants/nhmrc/2008813"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New Knowledge and Research Capacity for Health Impacts of Global Environmental Change with Big Data, Novel Approach and New Technology,Investigator Grants"^"This Investigator Grant research program will produce extremely significant outputs, including transformative changes to guidelines on global environmental change (e.g., climate change adaptation strategy, air quality standard and extreme weathersâ early warning system), new information to ensure direct impacts on public health policy and practice, and development of novel research methods for environmental epidemiology and strengthening the Australiaâs leadership in the field."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008839"^"http://purl.org/au-research/grants/nhmrc/2008839"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for people with Illness Anxiety Disorder,Investigator Grants"^"Illness anxiety disorder emerges early in life, causing great distress and disability, but if we detect and treat it early, this can yield great benefits in quality of life, and improved mental and physical health. This program of research will discover the best ways to assess, diagnose, and detect Illness anxiety disorder, improve access to evidence-based treatment using technology-based solutions, and develop new and improved treatments for Illness Anxiety Disorder."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008853"^"http://purl.org/au-research/grants/nhmrc/2008853"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Age-associated properties of intraepithelial lymphocytes, and their relation to intestinal diseases,Investigator Grants"^"Inflammatory bowel disease (IBD) and colorectal cancer are a severe burden to those affected. While the peak onset age of IBD lies in early adulthood, colorectal cancer predominantly affects people over 50 years of age. How gut immunity fails in the context of age is poorly understood. This program will establish cornerstones of the intestinal immune system over different stages in life, and thereby help to design better treatment strategies that are adjusted to an individualâs age."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008871"^"http://purl.org/au-research/grants/nhmrc/2008871"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Repetitive DNA as a contributing factor to tauopathy,Investigator Grants"^"The genome contains many regions of repetitive DNA sequence, some of which, termed mobile elements, can "copy-and-paste" themselves into new segments of the host genetic material. While a lot is known about the molecular mechanism behind their mobility, less is known about how mobile elements contribute to diseased states such as neurodegeneration. This project will investigate how mobile elements are regulated in tau pathology and whether this is age- or cell-specific."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008887"^"http://purl.org/au-research/grants/nhmrc/2008887"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Microbiome Manipulation to Treat and Cure Inflammatory Bowel Disease,Investigator Grants"^"Immunosuppressive therapies for inflammatory bowel disease cause side effects and often donât achieve remission. Targeting gut bacteria, which cause these disorders, is a promising alternative strategy. My programs have shown that faecal transplantation (FMT) is effective in ulcerative colitis, and identified key causative &amp; protective bacteria. I will now assess FMT in Crohnâs disease, define how diet &amp; bacteria combined cause inflammation, and identify bacteria causing disease complications."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008909"^"http://purl.org/au-research/grants/nhmrc/2008909"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Outcomes in Inflammatory Bowel Disease: A Multifaceted Program of Research,Investigator Grants"^"Inflammatory bowel diseases (IBD) are chronic disorders involving damage to the gut. IBD is thought to result from an inherited tendency to develop an exaggerated immune response to the gut bugs. IBD adversely impacts patientsâ quality of life, psychological and social functioning. This research program seeks to develop new treatments and use existing treatments more effectively, discover factors contributing to IBD development and explore cost-effective ways of optimally caring for patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008911"^"http://purl.org/au-research/grants/nhmrc/2008911"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing the food allergy epidemic through prevention and early intervention,Investigator Grants"^"One in ten Australian infants has food allergy. My research program aims to reduce this burden and give every child the best chance of going to school without food allergy. Using high-quality clinical trials, I will test strategies to prevent food allergy (e.g.: infant vitamin D drops), and early intervention strategies to treat young children newly diagnosed with food allergy. Through established national collaborations, I will ensure my research findings rapidly become standard clinical care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008913"^"http://purl.org/au-research/grants/nhmrc/2008913"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unconventional T cells: Fundamental biology and therapeutic potential,Investigator Grants"^"There are many cell types in the human immune system that we still do not understand, in particular, a group of white blood cells broadly known as unconventional T cells. These cells detect abnormalities in molecules such as lipids, signatures of microbial infection, and drug metabolites, and they play a unique role in infection, cancer, allergy, autoimmunity, and tissue maintenance. This project aims to better understand the development and function of these cells in health and disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008920"^"http://purl.org/au-research/grants/nhmrc/2008920"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Taking neuroinflammation out of TDP-43 proteinopathies,Investigator Grants"^"Abnormal accumulation of proteins inside cells of the central nervous system is a disease hallmark of ALS/FTLD. I have discovered that one protein in particular, TDP-43, triggers an inflammatory response that precedes overt disease symptoms. My investigation of this inflammatory pathway will define how it triggers cell death. Further, understanding how TDP-43 causes disease will aid drug development and advance our knowledge of the pathogenesis of these incurable conditions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008921"^"http://purl.org/au-research/grants/nhmrc/2008921"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Better treatments for autoimmune kidney disease and vasculitis,Investigator Grants"^"Severe kidney disease caused by autoimmune inflammation of small blood vessels has no cure, and treatments cause significant side effects. However, opportunities exist for therapies that target only the abnormal parts of the immune response. Work in this application will provide a pathway for the development and testing of these new approaches, by understanding how disease occurs and which parts of the critical proteins involved are the culprits in these damaging and debilitating diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008928"^"http://purl.org/au-research/grants/nhmrc/2008928"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"SPatially ACcurate Evaluation (SPACE) of Cancer Biopsies,Investigator Grants"^"Almost all suspected cancer patients have tissue biopsies manually examined. For decades, histological images are essential for diagnosis and treatment-decision making. Such an image diagnosis, however, fails to identify many cell types and their molecular signatures that underpin cancer metastasis. This program aims to establish a paradigm-shifting approach that maps spatially defined molecular data to tissue images, allowing for mechanistic understandings and accurate prediction of metastasis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008955"^"http://purl.org/au-research/grants/nhmrc/2008955"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"CultureCare: Co-designing an aged care decision aid for the South Asian communities to empower informed and culturally safe decision making about aged care services,Investigator Grants"^"This program of work seeks to develop a decision aid to empower older people and their families from South Asian backgrounds to plan, navigate and appraise aged care services to ensure these meet the needs of the older person. In this work, members of the South Asian community will be involved at every step of the project to ensure that the decision aid is culturally relevant, meets the needs of the community and is useful in the decision making process."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008956"^"http://purl.org/au-research/grants/nhmrc/2008956"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the health and wellbeing of transgender Australians,Investigator Grants"^"Transgender Australians are arguably among the most marginalised and socioeconomically disadvantaged groups in our community with high rates of depression, suicidality and a lack of research to guide optimal gender-affirming hormone and surgical interventions. This project will provide robust evidence to improve the health and well-being of the transgender community to guide treatment guidelines, and health policy, to enable trans people to live a life without barriers and discrimination."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008971"^"http://purl.org/au-research/grants/nhmrc/2008971"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Nutritional Psychiatry: Investigation and translation of personalised nutritional therapies for depression,Investigator Grants"^"Mental disorders account for the leading cause of disability. Dietary interventions represent a novel efficacious treatment to avert this significant burden. To advance the field of Nutritional Psychiatry, we need to establish how diet affects depression, who is most receptive to treatment, and design guidelines on how best to integrate diet into mental health care. My program of research will advance the evidence base and facilitate translation of this new knowledge into policy and practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008981"^"http://purl.org/au-research/grants/nhmrc/2008981"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A molecular investigation into T cell antigen receptor function and dysfunction in humans,Investigator Grants"^"I am a biomedical researcher who focuses on understanding processes central to infection and immunity. My research program covers the pathogenesis of infectious human diseases, adaptive and innate immunity and autoimmunity. I use biochemical approaches and structural biology as my main research tool, and my research program, which involves an international network of basic, clinical and industrial collaborators, has considerable relevance to applied outcomes for human immunological diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008983"^"http://purl.org/au-research/grants/nhmrc/2008983"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Leveraging human genetics to inform treatment in fatty liver disease,Investigator Grants"^"Fatty liver disease affects 1 in 3 Australians and a quarter will develop liver failure or cancer; it has no drug treatments. The disease is characterized by tremendous variability in its clinical course, in part due to a lack of understanding of its genetic basis. To move towards personalised medicine, this program will undertake human and small animal studies to develop novel gene-based tests for diagnostics and risk classification and identify genes that are targets for drug development."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008990"^"http://purl.org/au-research/grants/nhmrc/2008990"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing the burden of DNA viruses on human health,Investigator Grants"^"I aim to improve health by understanding how viruses interact with our bodies. This includes processes inside cells that keep microbes like the cold sore virus dormant. Also the way in which the white blood cells that allow our immune system to remember and respond more quickly to an infection after vaccination choose the parts of a virus to target. Finally we will find ways to help people on some treatments for diseases like multiple sclerosis avoid a common virus that is dangerous for them."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009005"^"http://purl.org/au-research/grants/nhmrc/2009005"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Primordial prevention of cardiovascular disease from childhood,Investigator Grants"^"Cardiovascular disease (CVD) is the leading cause of death worldwide. The risk factors for CVD begin to develop in childhood. Given the increasing rates of poor health in children worldwide, my research program will identify factors contributing to cardiovascular health in childhood, establish new ways to detect children at risk of developing CVD, and will develop strategies to improve cardiovascular health in children that can be easily implemented into policy and practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009010"^"http://purl.org/au-research/grants/nhmrc/2009010"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Dormant Cancer Cell Life Cycle,Investigator Grants"^"In many major cancers, tumour cells spread to the skeleton and hide there in a long-term âdormantâ state where they resist current therapies. When they are âwoken upâ, they cause cancer relapse, at which point prognosis is poor. My vision is to devise new treatments that eradicate these rare dormant cells, so as to cure cancers that spread to bone. I will achieve this by defining the cell and molecular pathways, in dormant cells and in the surrounding bone, that control dormancy and relapse."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009026"^"http://purl.org/au-research/grants/nhmrc/2009026"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Hypoxaemia detection and management for at-risk newborns and children in Sub-Saharan Africa,Investigator Grants"^"Low blood oxygen levels (hypoxaemia) are common in COVID-19, pneumonia, and many other illnesses. In low-resource settings, many patients who need oxygen will not receive it, and could die. My research aims to make oxygen more accessible and safe to patients, particularly small newborns, children, and people living in remote locations. I will test a new device to deliver oxygen to babies more safely, and test whether introducing pulse oximetry to small clinics saves lives."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009035"^"http://purl.org/au-research/grants/nhmrc/2009035"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming the prevention and treatment of child and adolescent obesity,Investigator Grants"^"Obesity in children &amp; adolescents is a serious problem with immediate and future complications. My vision is to lead an interdisciplinary program of research in preventing obesity in childhood and providing safe, effective treatments to children and adolescents living with obesity. My work will result in recommendations for targeting early childhood obesity prevention, personalised approaches to obesity treatment, and models of care &amp; costings for paediatric obesity treatment in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009047"^"http://purl.org/au-research/grants/nhmrc/2009047"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Alleviating anaemia in mothers and babies worldwide,Investigator Grants"^"Anaemia can cause fatigue, lethargy, and impair health outcomes during pregnancy and in children, and affects over 1.7 billion people. I will develop and test innovative new solutions to reduce anaemia in children and pregnant mothers, and use samples from these studies to drive new discoveries that will inform development of next generation improved treatments. Finally, I lead the WHO Collaborating Centre on anaemia control, enabling our findings to be quickly translated into practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009050"^"http://purl.org/au-research/grants/nhmrc/2009050"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Personalising colorectal cancer prevention strategies with a risk stratification tool,Investigator Grants"^"Bowel cancer is the second leading cause of cancer death in Australia. People who are at increased risk for this cancer are recommended to have colonoscopies every 3-5 years, with minimal personalisation to the individualâs risk factors (such as age, diet and lifestyle). This study will develop a computerised risk factor tool to personalise cancer prevention strategies for this high-risk subgroup of the population thereby utilising colonoscopy resources more efficiently."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009062"^"http://purl.org/au-research/grants/nhmrc/2009062"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mining the Molecular Machinery of Cell Death for Novel Drug Targets,Investigator Grants"^"Programmed cell death is a process the body uses to kill cells that are no longer needed, damaged or dangerous, e.g. those that have become cancerous or infected with viruses. Our studies have shown that the pathways that control cell death are targets for therapy, e.g. in cancer. We will continue to uncover the molecular details of how these pathways are regulated to provide new strategies for the development of therapeutic agents to treat diseases characterised by cell death malfunction."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009075"^"http://purl.org/au-research/grants/nhmrc/2009075"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Inflammasome inhibitors as new first-in-class anti-inflammatory therapies,Investigator Grants"^"Inflammation drives many devastating human diseases, and there are currently no effective treatments for many such diseases. My research program aims to leverage my validated discovery and development pipeline to deliver new first-in-class anti-inflammatory drugs to treat devastating diseases such as chronic liver disease and inflammatory bowel disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009079"^"http://purl.org/au-research/grants/nhmrc/2009079"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing genetics to halt the sneak thief of sight.,Investigator Grants"^"Glaucoma is the leading cause of irreversible blindness worldwide. In the early stages it is asymptomatic, and as such many people present at advanced stages of the disease when irreversible vision loss has already occurred. This research will reduce blindness and visual impairment from glaucoma through an improved prediction of high-risk individuals for developing glaucoma, and by the development of new therapies stemming from a better understanding of the molecular mechanisms of this disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009096"^"http://purl.org/au-research/grants/nhmrc/2009096"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Fall prevention: innovation and translation,Investigator Grants"^"Falls are a major health care problem for older adults and people with neurodegenerative disorders. This program will evaluate novel fall prevention interventions in older people and people with multiple sclerosis and Parkinsonâs disease. By developing software, diagnostic tools and balance training systems, my program intends to improve the health and wellbeing of older people and clinical populations with balance impairments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009136"^"http://purl.org/au-research/grants/nhmrc/2009136"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Personalised Melanoma Risk Score: Development and Evaluation of a Co-Designed Toolkit for Nation-Wide Implementation,Investigator Grants"^"Personalised risk prediction models that combined the effects of several genetic and non-genetic factors are rapidly being implemented in clinical practice. However, there is little implementation research on personalised risk, and data on the patient reported outcomes and risk management behaviour is scarce. For this study, I will develop a framework that provides guidance regarding optimal risk communication and a pathway for the successful translation of personalised risk information."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009152"^"http://purl.org/au-research/grants/nhmrc/2009152"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Stereo-EEG and precision neuropsychology: optimising epilepsy surgery and minimising neurocognitive risk,Investigator Grants"^"To guide safe and successful epilepsy surgery, many patients may require sensors to be placed in the brain to map seizures. Electrical impulses can also be delivered through these sensors to test the function of different brain regions so that important brain structures are not removed. However, we do not know the best way to test language and memory. This project will develop a new method to assess brain function in patients with epilepsy in order to improve surgical outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009163"^"http://purl.org/au-research/grants/nhmrc/2009163"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dissecting the impacts of the bacterial host versus plasmid on the AMR burden,Investigator Grants"^"Plasmids, mobile DNA, transmit antimicrobial resistance (AMR). This project will use an innovative approach of experimental evolution and the latest DNA and RNA sequencing technology to study how AMR plasmids spread and evolve in multidrug-resistant Klebsiella pneumoniae strains within different clinical settings. Expected outcomes include enhanced knowledge in bacterial-plasmid co-evolution critically needed for targeted surveillance, detection and control strategies to curb the spread of AMR."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009177"^"http://purl.org/au-research/grants/nhmrc/2009177"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Genetically defining and pharmacologically exploiting new oncogenic dependencies in Myc-driven lymphoid cancer,Investigator Grants"^"I will develop new treatments for blood cancers like multiple myeloma (MM) and B-cell lymphoma that share biological features associated with resistance to conventional treatments. By genetically editing the cancer-causing genes in MM and B-cell lymphoma, I have identified new (non-chemotherapy) drug targets that can overcome treatment resistance. My research will validate such drug targets and devise new therapies to improve patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009203"^"http://purl.org/au-research/grants/nhmrc/2009203"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes in patients with sepsis through precision medicine,Investigator Grants"^"Patients with life threatening infections may die or have major residual health issues. Previous attempts to treat such patients have focussed mainly on the infecting agent. It is now recognized that the genetic and biological make-up of the patient also plays a major role in the response to treatment. This work will improve the understanding of life threatening illnesses which will then be used to personalise patient treatments for improving outcomes with life threatening infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009209"^"http://purl.org/au-research/grants/nhmrc/2009209"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A National Wastewater Surveillance Program for Antimicrobial Resistance,Investigator Grants"^"This fellowship aims to provide a world-class surveillance method for antimicrobial use and antimicrobial resistance genes in Australia's general population through wastewater-based epidemiology. Expected outcomes include building capacity to objectively measure antimicrobial use and antimicrobial resistance in the general population. Significant benefits expected include a cost effective, rapid surveillance tool to meet the emergent needs of bacterial disease outbreaks."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009216"^"http://purl.org/au-research/grants/nhmrc/2009216"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel approaches to preventing perinatal death and disability from birth asphyxia,Investigator Grants"^"Fetal distress is often caused by lack of oxygen because the poorly functioning placenta limits oxygen and nutrient supply to the baby. Lack of oxygen can cause brain injury and death. Sildenafil increases blood flow to the placenta potentially reducing this risk. The proposed body of work will address this problem and will develop tools to identify at-risk babies and evaluate if Sildenafil reduces the risk of injury related to birth asphyxia and rates of emergency caesarean section."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009231"^"http://purl.org/au-research/grants/nhmrc/2009231"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Inflammation and chronic infections in the pathogenesis of Alzheimerâs disease: the role of amyloid cross-seeding.,Investigator Grants"^"This project seeks to evaluate the pathological role of inflammation and infections in the development and progression of Alzheimerâs disease, the most common cause of dementia. The knowledge generated in this study will guide future drug discovery and development approaches against Alzheimerâs disease, especially for people who have faced acute or chronic inflammations or have been affected by bacterial and fungal infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009237"^"http://purl.org/au-research/grants/nhmrc/2009237"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Neuroinflammation in schizophrenia,Investigator Grants"^"Schizophrenia is debilitating disorder in need of a cure. Inflammation along with macrophage invasion occurs in the brains of ~40-45% of the people with schizophrenia. I aim to block immune cell invasion and test if the symptoms of schizophrenia can be reversed. Through studies of the human brain, basic science studies and novel investigator initiated clinical trials, I will continue to develop strategies to dampen neuroinflammation and to prevent damaging immune cells entering the brain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009253"^"http://purl.org/au-research/grants/nhmrc/2009253"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Strengthen the role of health economics in perinatal health to inform priority setting and funding decisions,Investigator Grants"^"My program will develop new health economics methods to guide government decisions and help achieve the best health outcomes for children through more efficient and fair health care services during pregnancy and the year after birth."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009254"^"http://purl.org/au-research/grants/nhmrc/2009254"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Creating an active Australia through active systems: Co-production of multi-sectoral population physical activity strategies,Investigator Grants"^"To prevent chronic disease, Australians need to become more physically active. This proposed research examines the value of solutions that promote physical activity, including changes to urban planning and transport. The research combines scientific evidence and local expertise to develop a decision-making tool to help predict the health, economic and environmental impacts of different solutions. The findings will guide policymakers in adopting the best strategies to promote physical activity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009264"^"http://purl.org/au-research/grants/nhmrc/2009264"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unravelling the Contributions of Sleep Dysfunction to Alzheimerâs Disease and Dementia,Investigator Grants"^"My research program will determine whether poor sleep should be a therapeutic target for reducing dementia risk. Using longitudinal cohort studies, I will identify the changes in sleep that most strongly predict the risk of Alzheimerâs disease and dementia. Results will guide targeted sleep interventions to reduce dementia risk and help select at risk subjects for inclusion in dementia prevention trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009278"^"http://purl.org/au-research/grants/nhmrc/2009278"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mathematical modelling to support policy decisions on COVID-19 vaccination in Australia,Investigator Grants"^"Vaccination against COVID-19 is underway globally. However, even as the virus is controlled by vaccination, it will be very difficult to eliminate COVID-19 completely, and we will need additional vaccine doses to boost protection against current and variant strains. I will use mathematical models to estimate the health benefit of COVID-19 vaccines, and to inform policy planning for longer-term, sustainable COVID-19 vaccine programs in Australia and regionally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009280"^"http://purl.org/au-research/grants/nhmrc/2009280"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Endovascular Neuromodulation,Investigator Grants"^"The blood vessels provide access to regions of brain and nerves in the body that enable treatment with implantable devices. Interventional techniques enable a method of implanting a device while avoiding open brain surgery. Building off of work already achieved over a 6 year period, this grant progresses a body of world-first research that is proving the safety and efficacy of the first applications in paralysis and epilepsy in this new field of medicine."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009283"^"http://purl.org/au-research/grants/nhmrc/2009283"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing Resuscitation Errors,Investigator Grants"^"Error-free decisions made during resuscitation are fundamental to the subsequent recovery of the critically ill. A computer-assisted, resuscitation decision support system has already been shown to reduce clinical errors and improve outcomes during the resuscitation of the severely injured. This project will research and develop the system to include cardiac, stroke, sepsis, pediatric, toxidrome and obstetric emergencies and ascertain the effectiveness in these domains as well.."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009287"^"http://purl.org/au-research/grants/nhmrc/2009287"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining a novel waste disposal mechanism that aids vascular homeostasis and prevents inflammation,Investigator Grants"^"The survival of our cellular building blocks is crucial to prevent disease. One way in which our cells maintain their health is through disposing of cellular waste. This project will investigate a new waste disposal system employed by key cells that line the vascular system. Through advanced mouse models and imaging techniques, this project will determine how our cells survive under healthy and disease conditions, and how disposing of their waste correctly can prevent harmful inflammation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009288"^"http://purl.org/au-research/grants/nhmrc/2009288"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reproductive bodies across borders: Enhancing fertility management among culturally and linguistically diverse women in Australia.,Investigator Grants"^"This project will explore CALD womenâs perception and experiences of fertility control, focusing on fertility decision-making, contraception, and management of unplanned pregnancies, areas that have previously been underexplored. It will address CALD womenâs health literacy and fertility control support needs through the co-design and evaluation of an online health educational resource, a knowledge translation exhibition and recommendations for health promotion and healthcare provision."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009295"^"http://purl.org/au-research/grants/nhmrc/2009295"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translating lifestyle-based mental health care into practice,Investigator Grants"^"We now know that providing clinical care to people with mental health problems that improves their diet, physical activity and sleep, while reducing their smoking, drug and alcohol use is highly beneficial for their mental health as well as their physical health. Yet this type of care is not typically offered as part of routine mental health care. My research will produce evidence that addresses this gap to improve the lives of individuals with mental health concerns in Australia and beyond."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009303"^"http://purl.org/au-research/grants/nhmrc/2009303"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes in peritoneal dialysis through patient-centred clinical trials,Investigator Grants"^"Globally, the number of people living with kidney disease requiring dialysis or transplantation is growing. Peritoneal dialysis (PD), a form of home-based therapy, has been promoted by the international community as a solution to overcome this crisis. Yet, globally only 11% of patients on dialysis receive PD and the number of people choosing PD therapy for their kidney disease is declining. My research program is focussed on patient-important outcomes to directly address these deficiencies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009306"^"http://purl.org/au-research/grants/nhmrc/2009306"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Safeguarding the next generation: Using data to map and address injury-related harm in adolescence,Investigator Grants"^"Globally, injury is a preventable cause of harm. This research focuses on preventing injury among adolescents and aims to assess and benchmark data on adolescent injury in Australia and the Western Pacific region, while also expanding understanding of the impact of remoteness and alcohol on adolescent fatal and non-fatal injury in urban and rural New South Wales, informing a pilot co-design process to develop an alcohol and injury prevention intervention for rural dwelling adolescents."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009308"^"http://purl.org/au-research/grants/nhmrc/2009308"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing T cell immunity to boost vaccine efficacy,Investigator Grants"^"The recent SARS-CoV-2 pandemic has highlighted the need for rapid, large-scale vaccine development. This research program will study how specific types of T cells can be activated in order to improve the immune response to vaccines, with the goal of identifying new vaccine platforms that can be successfully deployed in future pandemics. This work will advance our knowledge of vaccine-related immunology and significantly improve human health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009309"^"http://purl.org/au-research/grants/nhmrc/2009309"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Deciphering the impact of non-coding mutations in congenital heart disease,Investigator Grants"^"Enhancers are non-coding regions of genomic DNA that play a crucial role in determining cellular identity. They are over-represented at genetic variants associated with disease. The goal of this proposal is to identify enhancers causal to human disease using in vivo high-throughput imaging and quantitative biology. The focus is to uncover the functional consequences of human enhancer variants in congenital heart disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009322"^"http://purl.org/au-research/grants/nhmrc/2009322"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Safer anaesthesia for children - optimizing perioperative outcomes by advancing and translating knowledge into clinical practice using an international, interdisciplinary approach,Investigator Grants"^"One in 20 children in Australia undergoes surgery each year. Children are particularly at risk of breathing problems during and after anaesthesia. I am investigating methods to predict, prevent and treat these problems. I am investigating ways to minimise the effects of anaesthesia on the developing brains of babies and improving the clinical tools available to paediatric anaesthetists. My goal is to ensure that when a child needs a vital operation, it is as safe and pain-free as possible."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009323"^"http://purl.org/au-research/grants/nhmrc/2009323"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Restoring the Fair Go: which policies and practices are likely to reverse growing health inequities in Australia post-COVID-19,Investigator Grants"^"Australia has become a less equal society. My âRestoring the Fair Goâ program will analyse the underlying economic and health inequity trends, assess the policies that have contributed to these inequalities and determine how these can be reversed. The program will explore Australian policymaker and citizens perspectives on inequality and draw comparisons to other OECD countries. Practical policy proposals will be developed to help Australia build back from COVID-19."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009324"^"http://purl.org/au-research/grants/nhmrc/2009324"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Alcohol use during pregnancy: Understanding and improving health outcomes in offspring,Investigator Grants"^"The aim of this research is to gain understanding of how small amounts of alcohol during pregnancy can impact child development across the first two decades of life and to test the effectiveness of a program that aims to reduce some of this burden. The world's largest datasets for examining prenatal alcohol exposure will be used to provide concrete evidence of the impacts. It is anticipated the findings will provide critical new insights important for families, practitioners, and policy-makers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009326"^"http://purl.org/au-research/grants/nhmrc/2009326"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Implementation research: Delivering impact at the interface between reproductive and metabolic womenâs health,Investigator Grants"^"As an active clinician, academic and leader, I bring an exemplary track record, team and research program aiming to generate and translate new knowledge to improve women's health internationally, during the reproductive years and beyond. My research program addresses patient and clinician priorities, links to international guidelines and has far reaching translation programs to directly improve women's health. Target conditions include polycystic ovary syndrome, early menopause and pregnancy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009336"^"http://purl.org/au-research/grants/nhmrc/2009336"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing tissue-resident regulatory T cells to fight cancer,Investigator Grants"^"Specialised immune cells called regulatory T cells (Tregs) reside in almost all organs of the body where they play a central role in preventing autoimmunity and inflammation. Tregs, however, aggravate cancer by antagonising the activity of beneficial, cancer killing immune cells and limiting cancer immunotherapy. This proposal aims to discover mechanisms utilized by Tregs to populate distinct tissues and tumours. These mechanisms will be harnessed to target Tregs for the treatment of cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009339"^"http://purl.org/au-research/grants/nhmrc/2009339"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing CD4+ Regulatory T Cells to Enhance Formation of Protective Immunity Against Human Viruses,Investigator Grants"^"In order to fight off infection we need specialised white blood cells, called helper T cells, to activate immune responses. A specialised helper T cell, called a regulatory T cell, are key orchestrators of immune memory, which protect against re-infection. This study will explore the role for regulatory T cells in generating protective immunity, which is the foundation of vaccine efficacy. This information will aid the design of better treatments and vaccines for infectious diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009340"^"http://purl.org/au-research/grants/nhmrc/2009340"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Personalised Nutrition Support,Investigator Grants"^"My research program in precision and personalised nutrition technologies will generate new knowledge on cost-effective models of care to reduce diet-related health risks, especially for under-served groups based on life-stage, socio-economic status or geographic location. My research findings will improve health and well-being for those at elevated diet-related chronic disease risk and be rapidly translated to lower the healthcare burden related to poor nutrition."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009380"^"http://purl.org/au-research/grants/nhmrc/2009380"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Addressing racialised health inequities in cancer,Investigator Grants"^"Cervical cancer can be eliminated by vaccination, screening and treatment (three pillars of elimination). Aboriginal and Torres Strait Islander women experience rates of cervical cancer comparable with less developed regions of the world despite other Australian women having the lowest rates in the world. This Indigenous led research program will focus on overcoming racial inequities via strategic culturally safe interventions focused on the three pillars of elimination."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009389"^"http://purl.org/au-research/grants/nhmrc/2009389"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for people with Multiple Sclerosis,Investigator Grants"^"Multiple sclerosis is a disabling neurological condition with a profound impact on the community. This proposal builds on years of successful MS research to develop a "human" model to study MS. Using advanced genetic techniques to understand why MS is more common in families. To understand how genes, the environment, and personal behaviours influence MS risk and progression. How information can be used to improve MS and how to translate discoveries into meaningful outcomes rapidly."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009408"^"http://purl.org/au-research/grants/nhmrc/2009408"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using modelling to guide the control of hepatitis C as a public health threat,Investigator Grants"^"During this grant I will use epidemic and economic modelling to guide health policy responses to hepatitis C in Australia and internationally. My findings will inform decisions by national governments and global health organisations on how to best find and cure people with hepatitis C. I will leverage my own and my collaboratorsâ memberships on global panels to ensure that lives are saved around the world because approaches to hepatitis C elimination are evidence-based and cost-effective."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009409"^"http://purl.org/au-research/grants/nhmrc/2009409"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mitochondria live imaging in mammalian preimplantation embryos,Investigator Grants"^"One type of organelle, mitochondria, are in the spotlight to improve pregnancy success of women suffering reduced fertility. This project will provide insights into mitochondrial integrity using cutting-edge non-invasive live imaging of the preimplantation embryo. We will uncover in real-time how mitochondria move, being sorted in subpopulations and how the parental mitochondrial heritage plays a role. Our findings will open new ways to refine mitochondrial therapies in reproductive medicine."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009419"^"http://purl.org/au-research/grants/nhmrc/2009419"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing the harms of inappropriate medicalisation of women's reproductive health,Investigator Grants"^"Womenâs reproductive health is an under-researched area with many areas of uncertainty, increasing the risk of inappropriate medicalisation and harm. The recent explosion of technology-based products focused on womenâs health is expanding this issue on a massive scale. Using mixed methods and involving key stakeholders, this research program aims to a) understand the impacts of three increasingly popular technologies on women and b) find ways to reduce inappropriate medicalisation and harm."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009432"^"http://purl.org/au-research/grants/nhmrc/2009432"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"NextGen evidence synthesis to maximise data utility and improve health outcomes,Investigator Grants"^"To bring together results from different studies, researchers would traditionally extract results from journal articles. Often, not all required information is available in these articles. New methods bring together full datasets of previous studies. This research program will develop these methods, looking at how to 1) best share data and 2) find and exclude fraudulent or low-quality studies. The program will also apply these methods looking at 1) babies born too early and 2) childhood obesity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009447"^"http://purl.org/au-research/grants/nhmrc/2009447"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Biomimetic nanoparticles as a gene delivery platform for combinational brain tumour treatment,Investigator Grants"^"Gene engineering shows exciting potential in biomedical applications including cancer therapies. However, effective therapies for brain tumour remain limited due to the cascade brain delivery challenges, which markedly limits their translational potential. This project aims to develop a new treatment strategy for the delivery of state-of-the-art gene therapies directly into the brain, which may provide a new effective and safe therapy for brain tumour patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009464"^"http://purl.org/au-research/grants/nhmrc/2009464"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Decoding the drivers of food choices towards sustainable self-management of obesity,Investigator Grants"^"Excessive eating of caloric foods is increasing the number of people who suffer obesity. Available treatments focus too much on personal efforts to reduce eating, and do not pay enough attention to the joint role of mental states, attractive foods and overwhelming marketing. I will use new research tools, such as brain scans taken while eating, mathematical algorithms made to reveal subconscious aspects of behaviour and virtual reality to assist people with obesity to change food choices."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009476"^"http://purl.org/au-research/grants/nhmrc/2009476"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Predictive biomarkers of response, resistance and toxicity with immunotherapy in melanoma,Investigator Grants"^"Immunotherapy has activity across many cancers, none more so than melanoma where approximately half the patients with metastatic disease may be cured. Half the patients do not benefit, however, and the drugs can cause toxicity and are expensive. At present, clinicians have little ability to predict who will and will not respond to therapy or get toxicity, nor the mechanisms underlying this. Improving this understanding will improve patient outcomes and reduce costs to the healthcare system."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009504"^"http://purl.org/au-research/grants/nhmrc/2009504"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Ribosome biogenesis and disease,Investigator Grants"^"Ribosomes are macromolecular machines that synthesise all cellular proteins and their catalytic core, the ribosomal RNAs, are synthesised from hundreds of ribosomal genes in a sub-nuclear body termed the nucleolus. This application continues my work on developing drugs that target the nucleolus for cancer therapies and ribosomopathies and investigate new non-ribosomal functions of the nucleolus that we believe are important for normal cellular development and which are dysregulated in disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009507"^"http://purl.org/au-research/grants/nhmrc/2009507"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Heat and Health: Building resilience to a warming planet across the human lifespan,Investigator Grants"^"Each year peak temperature records are repeatedly broken around the world. We already know the health effects of extreme heat can be potentially devastating, from pregnancy through to older age. This investigator grant will explore different ways to increase our resilience to a warming world across the entire lifespan in way that is sustainable for the future, protects the most vulnerable, and helps reduce the risk of other diseases that are aggravated by heat stress."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009529"^"http://purl.org/au-research/grants/nhmrc/2009529"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising palliative care services to deliver better value health care for older people,Investigator Grants"^"The recent report from the Royal Commission into Aged Care Quality and Safety in Australia highlighted substandard palliative care in Australiaâs aged care system. This research will transform the way in which palliative care services are delivered for older people by designing and evaluating new approaches to ensure quality palliative and end of life services in the residential and community aged care system."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009548"^"http://purl.org/au-research/grants/nhmrc/2009548"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advancing Australian human challenge trials for priority pathogens,Investigator Grants"^"In human challenge models, healthy volunteers are given a carefully monitored infection, with healthcare support, to learn how diseases work and how to stop them. I built the worldâs only strep throat human model and will use it to test vaccines to stop Strep A diseases, which affect ~1 billion people and kill &gt;500,000 annually. I will build challenge models for other important diseases (like pneumonia) and work with the public and participants to maximise the impact of this kind of research."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009550"^"http://purl.org/au-research/grants/nhmrc/2009550"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Risk and resilience in Alzheimer's pathogenesis, cognitive decline and clinical disease progression,Investigator Grants"^"Alzheimerâs disease is the most common form of dementia, and the number of people living with it will triple by 2050. There is currently no cure for Alzheimerâs disease, and the only means of slow the growing epidemic is to delay onset. My research program aims to identify risk and resilience factors of Alzheimerâs disease. This will uncover novel disease-modifying strategies, improve clinical trial design, and develop algorithms that will predict individualsâ rate of disease progression."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009551"^"http://purl.org/au-research/grants/nhmrc/2009551"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Modulating protein-protein interactions in disease,Investigator Grants"^"Healthy lives are powered by countless interactions between proteins that induce normal body functions. Infections, mutations, physical/chemical damage wear down our immune defences and lead to disease. This program will create new knowledge and approaches to discover new medicines, larger than conventional drugs but smaller than antibodies. They will modulate protein-protein interactions on or in cells to suppress inflammatory/metabolic diseases in rodents, on a path to clinical trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009554"^"http://purl.org/au-research/grants/nhmrc/2009554"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting Follicular Helper T cells to Boost Protective Humoral Immunity,Investigator Grants"^"After vaccination, the immune system is activated and acquires the ability to secret antibodies that recognise and destroy pathogens. However, vaccines donât always induce sufficient immunity. The interactions between different types of immune cells play an essential role in regulating the generation of high-quality antibody immunity. This research will investigate the mechanisms governing this process. The new knowledge will have broad applications for infection control or vaccine design."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009564"^"http://purl.org/au-research/grants/nhmrc/2009564"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advancing peptide-based drug design,Investigator Grants"^"I will use molecules called peptides to make safer, more effective medicines. These next-generation drugs will have fewer side effects than existing drugs due to their highly specific interactions with their target sites in the body. In the past pharmaceutical companies have not been able to utilise peptides because of technical challenges associated with their synthesis and delivery. My work has led to solutions to these problems that will be exploited to develop new drugs for pain and cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009572"^"http://purl.org/au-research/grants/nhmrc/2009572"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel methods for analysing causal pathways to disease in longitudinal studies,Investigator Grants"^"Health research studies obtain increasingly detailed data from participant biosamples that could in principle provide key insights into disease causality. However, the analytical tools and expertise for realising this potential are lacking. This program aims to develop, disseminate and apply novel data analysis methods that address this gap, as well as building biostatistical capacity in this area. Program outcomes will be urgently needed tools, expertise and new knowledge for improving health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009577"^"http://purl.org/au-research/grants/nhmrc/2009577"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Tackling multimorbidity in women across the life course: Building the evidence for improved prevention strategies and care pathways,Investigator Grants"^"Multimorbidity, where a person has two or more chronic conditions, is increasing and is more common among women than men. Women also face different risks for multimorbidity, and some can have conditions that interact and require complex care plans. My research addresses gaps in our understanding of how multimorbidity develops in women and of the corresponding care plans. The new knowledge will inform more personalised and co-ordinated care for prevention and management of multimorbidity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009612"^"http://purl.org/au-research/grants/nhmrc/2009612"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving evidence synthesis methods to enhance decision making about public health and policy interventions,Investigator Grants"^"Systematic reviews synthesize available research to determine whether policy, health service delivery, and public health interventions are effective. Statistical methods underpin the validity of the findings in systematic reviews. This research will evaluate and develop statistical methods for systematic reviews with the aim of improving the quality of reviews and ensuring healthcare decisions are based on reliable research syntheses."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009633"^"http://purl.org/au-research/grants/nhmrc/2009633"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing medication-related harm in people living with dementia in residential aged care,Investigator Grants"^"People who live in aged care facilities, particularly those living with dementia, often take multiple medications and are at increased risk of medication-related harm. My research aims to reduce medication-related harm by addressing key steps in the medication-management cycle where errors and harm can occur. I will work with consumers, aged care providers and health care professionals to ensure my findings are translated into practice to improve quality of life for people living with dementia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009642"^"http://purl.org/au-research/grants/nhmrc/2009642"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting skeletal muscle for the treatment of insulin resistance,Investigator Grants"^"Insulin resistance is a condition that leads to high-blood glucose and poor muscle function. It is the fastest growing chronic disease in Australia and the major contributor to type-2 diabetes and sarcopenia. We urgently need new treatment strategies. We have identified a series of novel therapeutic targets for the treatment of insulin resistance. This project will analyse these therapeutic targets in preclinical models and improve our understanding of the molecular events of insulin resistance."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009670"^"http://purl.org/au-research/grants/nhmrc/2009670"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes in advanced lung and gynaecological cancers through innovations in clinical trials,Investigator Grants"^"Lung and ovarian cancers are major causes of cancer-related deaths in Australia and worldwide. Improving outcomes for these cancers is a national priority. The overall aim of this project is to better personalise patient treatment and improve their cancer outcomes. The specific objectives are to develop new therapies and strategies for combination treatment, identify new biomarkers, evaluate benefits and harms from treatments, and improve selection of patients for more appropriate therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009675"^"http://purl.org/au-research/grants/nhmrc/2009675"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using clonal multi-omics to better understand haematopoiesis,Investigator Grants"^"Our body must continually produce white blood cells to fight infection. When this production goes wrong it can lead to too few cells (immune deficiency) or too many (leukemia). We will examine this process using cutting edge single cell technologies to trace the developmental origins and pathways of individual cells as they mature. In this way, we will learn how to treat these diseases and inform new ways to boost immunity or treat immune and inflammatory diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009707"^"http://purl.org/au-research/grants/nhmrc/2009707"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reconstructing ancestral viruses to fight current and future flavivirus outbreaks,Investigator Grants"^"I am a co-inventor of a powerful toolset combining advanced structural biology and rapid virus engineering that enables the investigation of flavivirus structure and immune response at the molecular level. This project integrates these approaches to resurrect ancient flaviviruses and explore the structural evolution of non-human primate flaviviruses, which will be used to understand viral evolution, improve outbreak preparedness and design safer and more effective vaccines."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009711"^"http://purl.org/au-research/grants/nhmrc/2009711"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Driving rational improvement of vaccines against respiratory viruses,Investigator Grants"^"Respiratory viruses, such as influenza and human coronaviruses, impose a significant burden on human health and present major pandemic risks. There is a critical need for highly effective vaccines to protect susceptible human populations. This research program will expand our understanding of fundamental drivers of protective immunity against respiratory viruses and integrate these insights in the design and testing of novel vaccine concepts that produce durable and efficacious immunity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009726"^"http://purl.org/au-research/grants/nhmrc/2009726"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing sex disparities in stroke through a deeper understanding of risks and management patterns,Investigator Grants"^"Each year, 11,000 Australians die from one of the biggest killers in Australia and globally, stroke. There is high demand for effective prevention and treatment strategies. However, published evidence suggests that women and men experience the disease and its medical care differently. My research aims to better understand why such differences exist and how to provide sex-specific, strategies to improve survival from stroke."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009727"^"http://purl.org/au-research/grants/nhmrc/2009727"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing a community-led coordination and response guide for a syphilis outbreak in Aboriginal communities,Investigator Grants"^"My program of research has two phases. Phase 1 will evaluate the how the World Health Organization establishes and deploying outbreak teams to different countries. Phase 2 aims to 1) evaluate Australia National Notifiable Surveillance System with a focus on the identification of Aboriginal people and alerts for potential outbreaks and 2) to develop a community-based coordination guide for syphilis outbreaks that includes Aboriginal leadership, governance and our biggest strength, our culture."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009730"^"http://purl.org/au-research/grants/nhmrc/2009730"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Addressing evidence gaps to improve adolescent the sexual and reproductive health,Investigator Grants"^"My research focuses on identifying opportunities to improve the sexual and reproductive health of adolescents living in Australia and other parts of the world. This involves working with adolescents and health services to co-design and test new strategies to deliver sexual and reproductive health that is specifically focussed on the needs of young people."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009732"^"http://purl.org/au-research/grants/nhmrc/2009732"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing a multi-omics platform for the diagnosis of mitochondrial disease,Investigator Grants"^"Mitochondrial Diseases (MDs) are the most common inherited metabolic disorders. They can be caused by changes in more than 300 different genes and affect any or all of our organ systems. New genomic (DNA) technologies have increased our ability to diagnose MDs from less than a quarter of patients to about a half. DNA is the blueprint for protein. This study seeks to further improve the diagnostic rate by using new âproteomicâ technologies that can detect changes in thousands of proteins at once."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009736"^"http://purl.org/au-research/grants/nhmrc/2009736"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translating precision antibiotic dosing into better outcomes for severe infections,Investigator Grants"^"Millions of people die from infections around the world each year, in part, from inadequate antimicrobial use. Antimicrobial dosing is an aspect of therapy which clinicians can control and improve if given sufficient information. My research program will explore the benefits of using a dose that is optimised for an individual patient, to ensure the patient is cured from that infection, and not contribute to the emergence of antimicrobial resistant bacteria."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009750"^"http://purl.org/au-research/grants/nhmrc/2009750"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Macrophage Biology in Health and Disease,Investigator Grants"^"Macrophages are cells of the innate immune system. They are found in every organ and act as the body's waste disposal system and contribute to repair of damaged tissue. In many diseases, their functions are out of control and they contribute to injury and symptoms. In this project we aim to understand how macrophages are made and controlled and to exploit that knowledge to develop new therapies in regenerative medicine."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009765"^"http://purl.org/au-research/grants/nhmrc/2009765"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mitigating the consequence of preeclampsia for mother and child,Investigator Grants"^"Preeclampsia, a condition unique to pregnancy, is a major cause for premature birth, death and disability for both mother and baby. No treatment exists that can control the disease to reduce these risks. This research assesses a promising new therapy derived from broccoli sprouts that could prolong pregnancy, reducing the risk of preterm birth. New approaches to diagnosing preeclampsia earlier and to prevent women from poor health outcomes in the years that follow will also be explored."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009767"^"http://purl.org/au-research/grants/nhmrc/2009767"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving assisted reproductive technology outcomes - a personalised approach,Investigator Grants"^"One in seven couples have problems conceiving. Assisted reproductive technology (ART) is the last resort for all couples with prolonged unresolved infertility. There is a lack of personalised evidence-based guidance on choosing the best treatment strategies during ART. I will systematically evaluate the effectiveness and safety of treatment options in multiple steps during ART and provide a personalised treatment pathway to improve ART outcomes in couples with infertility."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009771"^"http://purl.org/au-research/grants/nhmrc/2009771"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Addressing Health Inequality Experienced by People with Intellectual Disability,Investigator Grants"^"People with intellectual disability face stark health inequalities, die prematurely from potentially avoidable causes and experience poor access to preventative health care. This project will find out why there are gaps in health care for people with intellectual disability, determine how these gaps affect people and develop better responses in healthcare for people with intellectual disability."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009776"^"http://purl.org/au-research/grants/nhmrc/2009776"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Increasing the value of evidence from nutritional epidemiology,Investigator Grants"^"In nutrition research, observational studies are fundamental sources of evidence as it is often impossible or unethical to conduct randomized controlled trials. Unfortunately, many nutritional epidemiological studies fail to provide useful evidence due to poor data analysis methods. My research will improve the quality of evidence from nutritional epidemiology by developing practical solutions to the challenges of dietary data analysis by advancing analysis methods and tools."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009782"^"http://purl.org/au-research/grants/nhmrc/2009782"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Lost in translation: Accelerating the implementation of digital interventions in youth mental health,Investigator Grants"^"Mental ill-health affects one in four young Australians. Digital interventions can deliver high-quality accessible mental health care to those in need, however, they currently sit disconnected from our overburdened, antiquated mental health system. My research program will address this historic failure of research translation, by refining, evaluating, and disseminating a blueprint for digital mental health implementation â propelling Australian youth mental health care into the 21st century."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009783"^"http://purl.org/au-research/grants/nhmrc/2009783"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Super-Responders and Super-Survivors â how to dramatically improve cancer outcomes,Investigator Grants"^"Ovarian cancer and other rare cancer types have low survival rates. My program will study women who achieve very long remissions (âSuper-Respondersâ) following PARP inhibitor + immune therapy and âSuper-survivorsâ, individuals who develop three or more cancers. The underlying genetic mechanisms for this are poorly understood. By studying both, we expect to discover key molecular and immune pathways that should underpin effective therapies to prevent cancer recurrence."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009798"^"http://purl.org/au-research/grants/nhmrc/2009798"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovative public health interventions to control the global burden of Strep A disease,Investigator Grants"^"Strep A causes over 500,000 deaths in the world each year, especially due to rheumatic heart disease. Scabies is a major driver of Strep A skin infection in our region. I propose to tackle the problem with 2 innovative approaches. First, I will test new vaccines using a human model of Strep A infection and in a large clinical trial. Second, I will investigate how mass treatment for scabies can impact on Strep A skin infection and rheumatic heart disease, and I will test new drugs and diagnostics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009800"^"http://purl.org/au-research/grants/nhmrc/2009800"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovations in Clinical Trials Research: from personalised medicine to population health,Investigator Grants"^"Well-designed clinical trials including translational research are critical for real advances in healthcare. The proposed research involves major clinical trials evaluating new treatments and strategies in cancer, cardiovascular disease and perinatal medicine; novel methods for better trials; and integrating evidence for better decision-making in healthcare. The aim is to integrate clinical research into routine care and use translational science to optimise treatment for individual patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009808"^"http://purl.org/au-research/grants/nhmrc/2009808"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving back pain care in Australia,Investigator Grants"^"Over the next five years, this research program will improve the care provided for back pain in Australia, the number one cause of disability. To accomplish that goal, a series of health policy evaluations at the national and state level, a randomised trial to reduce unnecessary lumbar surgeries and improve return to work, and two studies to investigate barriers and enablers of the right care for back pain will be conducted."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009820"^"http://purl.org/au-research/grants/nhmrc/2009820"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Nicotinamide adenine dinucleotide as a novel target for ageing and dementia,Investigator Grants"^"A better understanding of novel molecular targets of disease to use in diagnostics and therapeutics for age-related cognitive impairment and dementia is urgently needed. My research program will test the hypothesis that raising intracellular NAD+ levels can (1) slow down the onset of dementia-related neuropathology; (2) alter dementia biomarker trajectories; and (3) moderate behavioural/cognitive deficits, in established in animal models and humans cohorts."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009840"^"http://purl.org/au-research/grants/nhmrc/2009840"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of clinical tests to improve treatment for ovarian cancer patients,Investigator Grants"^"The aim of this program is to improve ovarian cancer survival. In other cancers, tumour tests at diagnosis are used to guide treatment. I will utilise the resources of the international Ovarian Tumour Tissue Analysis (OTTA) consortium, that I lead, to develop tumour tests to determine the best treatment for each patient. This will include; if they should have surgery before chemotherapy, if they need an alternative to the commonly used chemotherapy, and predicting response to new treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009843"^"http://purl.org/au-research/grants/nhmrc/2009843"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Tau - A diagnostic and therapeutic target in Alzheimer's Disease,Investigator Grants"^"Toxic forms of âtauâ protein in the brain are part of the cause of Alzheimerâs disease. This condition is difficult to diagnose, and there are no treatments to stop progression. My research focuses on developing a blood test measuring the levels of toxic tau in patients attending Australian memory clinics. The program will also undertake a world-first clinical trial of an oral drug (SAMe) that targets the tau protein to understand whether this can slow the progression of Alzheimerâs disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009852"^"http://purl.org/au-research/grants/nhmrc/2009852"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Lipid trafficking and storage: from cell biology to novel therapies against diseases,Investigator Grants"^"Lipids represent a major class of molecules in life. They are associated with many common human diseases such as obesity, diabetes, heart disease and cancer. A major gap in knowledge is how our cells store and transport important lipids such as cholesterol. This proposal aims to investigate mechanisms governing the storage and trafficking of lipids, and to also apply the new knowledge to developing novel compounds/therapies against cancer and other diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009866"^"http://purl.org/au-research/grants/nhmrc/2009866"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Health Risk Assessment of Bushfire Smoke on Children and Pregnancy Outcomes,Investigator Grants"^"This Investigator Grant program will fill the knowledge gaps in whether bushfire smoke have impacts on children and pregnancy outcomes using new technology, novel approaches and big data analyses. The outcomes will result in improved environmental exposure assessment and reduced hazard of bushfire smoke, leading to substantial gains in population and environmental health. Importantly, this work will enhance capacity building and advance the development of bushfire epidemiology."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009873"^"http://purl.org/au-research/grants/nhmrc/2009873"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Global Programme on Epidemiology, Early Detection and Intervention for Children with Cerebral Palsy in Low- and Middle-Income Countries,Investigator Grants"^"Cerebral palsy (CP) is the leading cause of childhood disability with an estimated 50 million people affected globally. However, majority of the children with CP living in low- and middle-income countries (LMICs) do not receive timely diagnosis and intervention. I propose a global research programme across Asia, Africa and South America to study the burden, causes and suitable approaches for early detection and intervention for children with CP in LMICs to improve their lives."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009878"^"http://purl.org/au-research/grants/nhmrc/2009878"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Personalised medicine to improve outcomes for men with prostate cancer through seamless integration of novel imaging and targeted therapy (theranostics),Investigator Grants"^"This grant will enable me as a clinician-scientist to improve outcomes for men with prostate cancer, a disease resulting in more than 3000 deaths in Australia annually, by using a technology called theranostics. Theranostics uses radioactive tumour seeking molecules to integrate whole body imaging and a targeted treatment. I will develop clinical trials with global impact and use artificial intelligence image interpretation to better define patient prognosis and select optimal therapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009885"^"http://purl.org/au-research/grants/nhmrc/2009885"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Deciphering the heterogeneity of chronic breathlessness: implications for more personalised management of the symptom,Investigator Grants"^"Chronic breathlessness is a debilitating symptom affecting &gt;300,000 Australians with chronic, progressive conditions. This innovative program combines epidemiological, basic science and health services research to generate a world-first classification of clinical sub-types of chronic breathlessness. This will provide more personalised symptom management, and ultimately deliver improved health outcomes and independence, and directly inform clinical practice and reduce health service use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009940"^"http://purl.org/au-research/grants/nhmrc/2009940"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translating oocyte biology discoveries to clinical practice,Investigator Grants"^"I am reproductive biologist studying factors that regulate the intrinsic quality of unfertilised eggs. I have produced and patented the use of unique growth factors produced by the egg that enhance egg quality in women. Bringing together industry and world-leading clinics, I am developing new forms of hormone-free infertility treatment for cancer and infertile patients, which I will apply in widespread clinical practice over the next 5 years."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009957"^"http://purl.org/au-research/grants/nhmrc/2009957"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing new therapies targeting innate immune mediated inflammation in neurodegenerative disease,Investigator Grants"^"Brain diseases such as Parkinsonâs disease and motor neuron disease remain a burden on society with few effective treatments. Recent studies have documented a key role for the immune system and inflammation in accelerating neurodegenerative disease progression. This project will identify new drugs that can tame the inflammation cascade in the brain, to help treat these diseases. It will assist in the progression of these drugs into human clinical trials to ultimately improve patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009965"^"http://purl.org/au-research/grants/nhmrc/2009965"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Integrating lipidomic, metabolomic and genomic studies to define causal metabolic pathways in cardiometabolic disease: Delivering precision medicine solutions for Australia.,Investigator Grants"^"Our metabolism plays a central role in the development type 2 diabetes, cardiovascular disease, age related dementia and some cancers. We plan to use new technology (genomics and metabolomics) to understand how our genes and environment combine to influence our metabolism and our health. We will use this new information to develop new tests for risk assessment and early detection and develop new treatments to maintain health and to prevent, attenuate or treat these common metabolic diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009982"^"http://purl.org/au-research/grants/nhmrc/2009982"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building a foundation for equitable population-scale genomic medicine,Investigator Grants"^"Genomic technologies, such as whole-genome sequencing, are already transforming our ability to diagnose, predict, and treat many diseases. However, to ensure that genomic medicine is accessible and useful to everyone, we need more powerful tools for analysis, new databases representing all Australian communities, and new approaches to identify targets for therapeutic drugs. My program will develop methods and resources to establish the foundations for equitable population-scale genomic medicine."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009991"^"http://purl.org/au-research/grants/nhmrc/2009991"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Role of Gut-Bacteria in Dementia and Implications for Future Nanomedicine,Investigator Grants"^"My research and recent clinical evidence indicate the involvement of gut-bacteria in the early-onset and accelerated progression of dementia in Alzheimer's Disease. This project will investigate the molecular mechanisms for this toxic communication between gut-bacteria and the brain, and develop a nanotechnology-based approach to block this communication. It will open new therapeutic opportunities to control the progression and inhibit the early-onset of dementia in Alzheimerâs Disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009998"^"http://purl.org/au-research/grants/nhmrc/2009998"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing the power of diverse data to model population impacts of injury and inform health and social policy,Investigator Grants"^"This investigator grant program will transform thinking about the long-term impacts of injury and the complex interplay between health and social sectors. The program will establish cross-sectoral data platforms with the real-world capacity to fundamentally change how we use data to characterise injury and its impacts. The findings will drive evidence-informed public health and social policy planning and investment to reduce the population impacts of injury."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010008"^"http://purl.org/au-research/grants/nhmrc/2010008"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing the impact and burden of substance use on mental health,Investigator Grants"^"Substance use and mental health are both major public health issues that commonly occur together. The relationship between them is not well understood. This work will use advanced statistical models to quantify the relationship, predict how much harm substance use is causing to mental health, and identify how much harm could be prevented by better policy. The knowledge gained will inform policies on how to reduce disease burden caused by substance use on mental health in Australia and overseas."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010037"^"http://purl.org/au-research/grants/nhmrc/2010037"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining the mechanisms that drive cell competition and plasticity in stomach cancer.,Investigator Grants"^"Cancers of the upper digestive tract (stomach) are composed of a diverse mixture of cell types that function differently depending on the stage of cancer progression. Understanding exactly how the different cell types interact with each other to promote cancer growth at various stages of disease (early, intermediate and late-stage) is crucial in order to develop better cancer therapies to extend patient survival."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010051"^"http://purl.org/au-research/grants/nhmrc/2010051"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mitigating the impacts of infectious disease emergencies,Investigator Grants"^"While public health and social measures have been central to the COVID-19 response and saved lives, many uncertainties remain as to their optimal use. Governments have been repeatedly required to balance the consequences of an uncontrolled outbreak against the social and economic costs of interventions. Over the next five years, I will use modelling and decision science to support the development of more tailored and adaptive response policies for COVID-19 and inevitable future pandemics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010053"^"http://purl.org/au-research/grants/nhmrc/2010053"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Designing and translating novel therapies for diabetes and kidney disease,Investigator Grants"^"Four million individuals die from diabetes each year and half of these are less than 50 years old. Individuals with earlier onset diabetes in Australia and their families are personally impacted by diabetes specific health issues such as kidney disease. During this five year program of research we aim to better understand the factors responsible, and to progress therapies which may reduce diabetes and kidney disease if made available to these individuals including Indigenous Australians."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010055"^"http://purl.org/au-research/grants/nhmrc/2010055"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Health workforce investment to incentivise universal health coverage,Investigator Grants"^"Health workers including doctors, nurses and community health workers are crucial to population health and a major driver of healthcare costs. In low- and middle-income nations, there has been little attention to the most effective way to finance and organise health workers despite the large costs in lost health and wasted expenditure caused by investing in ineffective care. This Fellowship will generate economic evidence to drive rational healthcare investment in low- and middle-income nations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010063"^"http://purl.org/au-research/grants/nhmrc/2010063"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the mental health of trans and gender diverse young people,Investigator Grants"^"The aim of this research program is to improve the mental health of trans and gender diverse (henceforth trans) children and young people. One stream will be dedicated to better understanding the experiences of trans young people where gaps in knowledge still exist. The other stream will focus on the development of novel interventions to improve the mental health of trans children and young people at the individual and family levels."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010064"^"http://purl.org/au-research/grants/nhmrc/2010064"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Bridging the clinico-pathological divide: improving neuroimaging analysis and applications in dementia,Investigator Grants"^"Dementias are a group of incurable and fatal disorders caused by progressive deterioration of the brain function. This program will identify the gradual brain changes that cause symptoms of dementia (e.g., problems with thinking, language, behaviour and everyday skills) to develop. Greater understanding of how the brain changes throughout the disease course will lead to better diagnosis of dementia and contribute to develop medical treatments to stop the progression of the underlying disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010070"^"http://purl.org/au-research/grants/nhmrc/2010070"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for men with advanced prostate cancer through innovative clinical trials and biomarker development.,Investigator Grants"^"Prostate cancer (PC) is a common disease and the median survival advantage from novel androgen receptor targeted agents for men with castration resistant disease is measured in months and is not cumulative due to underlying cross-resistance. My research program aims to understand the biology of aggressive forms of PC, define new immune and molecular targets and undertake novel biomarker driven clinical trials that will co-develop new combinations and biomarkers for optimal patient selection."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010072"^"http://purl.org/au-research/grants/nhmrc/2010072"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"RetinaAGE as a novel biomarker for ageing and cardiovascular risk,Investigator Grants"^"The back of the eye (retina) is a window to our blood vessels and nervous system and can be easily imaged. I have developed and pilot tested an AI algorithm that can accurately predict age using retinal photos. The gap between age predicted by the algorithm and chronological age, known as RetinaAGE, can predict premature death and cardiovascular events. This project will test RetinaAGE in individuals of different ethnicities and translate this AI into a system that will be tested in clinics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010084"^"http://purl.org/au-research/grants/nhmrc/2010084"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Molecular and genomic profiling of rogue lymphocytes in autoimmune disease using single-cell genomics,Investigator Grants"^"Autoimmune disease occurs when the immune system turns "rogue" and attacks tissues within the body. The exact cause of human autoimmune diseases are unknown. A major hurdle in autoimmune disease research is identifying the rogue disease-causing immune cells from normal immune cells. I have developed novel technology capable of identifying and characterising rogue immune cells which will advance our understanding of how these cells arise and persist, and help develop more targeted therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010088"^"http://purl.org/au-research/grants/nhmrc/2010088"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Tailoring implementation for forgotten populations in chronic disease management,Investigator Grants"^"Using evidence in clinical practice is challenging when the evidence does not describe how the treatment works or include participants from the population of interest. The aim of this fellowship is to extend research evidence by identifying how treatments for chronic conditions work, and whether they apply to under-served populations in Australia. This information will improve the use of evidence in clinical practice and the uptake of evidence-based treatments for forgotten populations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010091"^"http://purl.org/au-research/grants/nhmrc/2010091"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Research generating evidence to optimise pneumococcal disease prevention,Investigator Grants"^"This research program aims to develop an in-depth understanding of various streptococcus pneumoniae (SP) infections that could be serious and even life threatening. Antibiotic resistance and how COVID-19 and influenza could make people vulnerable to SP infections will be two key areas explored. This research is expected to feed directly in to practice and policy relating to pneumococcal disease surveillance and optimizing prevention using vaccinations during COVID-19 pandemic and beyond."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010100"^"http://purl.org/au-research/grants/nhmrc/2010100"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing an Oral Nanoformulation for Preventing Cancer Recurrence,Investigator Grants"^"Triple negative breast cancer (TNBC) is a highly aggressive disease with high recurrence rate following primary treatment. This project aims to develop an oral nanoformulation for preventing TNBC recurrence by reducing systemic copper level. This formulation is based on an advanced nanobiotechnology which is expected to enable primarily localised copper depletion in the intestine and reduce systemic exposure, thereby minimising adverse off-target effects and improving therapeutic outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010110"^"http://purl.org/au-research/grants/nhmrc/2010110"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Outcomes after Extracorporeal Membrane Oxygenation,Investigator Grants"^"Extracorporeal membrane oxygenation is a potentially lifesaving support for patients with severe cardiac or respiratory failure, but the underlying evidence base remains limited. Over the last 7 years, i have build leading program of research, which has led to the development of a national ECMO registry and a large RCT of ECMO for cardiac failure. With this fellowship, i will extend this work to generate new high quality knowledge in major evidence gaps, including a new clinical trial."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010124"^"http://purl.org/au-research/grants/nhmrc/2010124"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Neonatal Resuscitation,Investigator Grants"^"Over 5% of all babies worldwide need help breathing in the seconds after birth. Failing to breath kills more than 1 baby every minute. My grant will investigate simple ideas that may make birth safer for the baby, including: understanding how the baby begins breathing air after birth, augmenting the respiratory drive of premature babies to spontaneously breathe after birth, and helping babies breathe before cutting the umbilical cord so that they are still being supported by their mother."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010128"^"http://purl.org/au-research/grants/nhmrc/2010128"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving care for low back pain,Investigator Grants"^"Low back pain is the number-one cause of disability worldwide, affecting an estimated 540 million people at any one time. The disease burden due to low back pain has increased by 54% since 1990, threatening the sustainability of health care systems globally. My research will address the growing burden of low back pain by providing new knowledge on the effect of analgesic medicines and on works to improve the research translation of evidence into care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010134"^"http://purl.org/au-research/grants/nhmrc/2010134"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Revealing how tolerance checkpoints fail in human autoimmune diseases and how to target therapy,Investigator Grants"^"Prof Goodnow will lead a program of research defining the root cause of human autoimmune diseases and using these discoveries to guide better targetted treatment for these important, chronic diseases. The research employs new single cell genomic technologies to pinpoint the DNA and other molecular abnormalities that allow rare cells within the immune system to escape the bodyâs normal control processes, and instead attack one or other part of the body to cause autoimmunity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010136"^"http://purl.org/au-research/grants/nhmrc/2010136"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preventing stillbirths and improving care after loss,Investigator Grants"^"In Australia, over 2000 families suffer the tragedy of stillbirth each year. By building on my achievements in rapidly translating new research into maternity care, I will lead my outstanding team to reduce stillbirth rates by 20% and reconcile inequities in stillbirth rates by Australia by 2025. I also anticipate a reduction in adverse neonatal outcomes. When stillbirth or neonatal death does occur, my research aims to ensure all women and families receive optimal care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010141"^"http://purl.org/au-research/grants/nhmrc/2010141"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the role of predictive coding in visual processing: from neural circuits to whole brain systems,Investigator Grants"^"The simple act of perceiving an object in the world depends not only on the incoming sensory information, but also on the brainâs predictions about the objectâs likely identity. This research will characterise the neural mechanisms responsible for predictive coding of visual information. I will combine brain imaging and analogous visual tasks in humans and animal models, and apply novel computational methods to reveal a common code for perception in whole brain systems and individual neurons."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010149"^"http://purl.org/au-research/grants/nhmrc/2010149"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding complex I assembly for better diagnosis and future treatment,Investigator Grants"^"Almost all cells in the human body need to produce energy so they can survive and grow. This is achieved by tiny generators in the cell called Mitochondria. When Mitochondria are unable to produce the energy the cell needs it dies and this leads to Mitochondrial Disease, which affects 1 in 2000 people. This project aims to understand one of the biggest contributors to Mitochondrial Disease- called Complex I Deficiency. This will lead to better diagnosis of patients and treatments in the future."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010154"^"http://purl.org/au-research/grants/nhmrc/2010154"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Gold Electronic Skins for Remote Biodiagnostics,Investigator Grants"^"This interdisciplinary Eng-IT-Med research program aims to develop artificial intelligence-powered soft gold electronic skins for âhealthâ monitoring of living organisms, including cells, tissues, organoids whenever one wants wherever one wants by a wireless smartphone. It is expected that this program will generate groundbreaking knowledge/technologies in remote monitoring of biological systems, deliver translational outcomes in industries and train a large cohort of workforces."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010156"^"http://purl.org/au-research/grants/nhmrc/2010156"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Decoding the epigenome of the tumour microenvironment for improved patient outcomes in prostate cancer,Investigator Grants"^"Just as people in big cities rely on a complex infrastructure network for their daily lives, cancer cells depend on the surrounding tumour microenvironment. Studying the behaviour and interactions of the neighbouring cells is crucial to understanding how a tumour develops and progresses. I will scrutinize the molecular information in prostate tumour microenvironment cells to learn how they emerge and function to promote cancer, and to identify new molecular markers to guide treatment decisions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010203"^"http://purl.org/au-research/grants/nhmrc/2010203"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building heart muscle to treat cardiomyopathies,Investigator Grants"^"Cardiovascular disease is our major societal and economic health burden. Many types of heart disease are due to a lack of functioning heart muscle cells either resulting from the massive loss of these cells following a heart attack or to the toxic effects of certain drugs in adults, or to inadequate heart growth in children; causing heart failure or death. This study aims to stimulate heart muscle cells to divide, thereby building heart muscle to improve heart function, well-being and survival."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010212"^"http://purl.org/au-research/grants/nhmrc/2010212"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Behavioural and social science to close gaps in vaccination coverage,Investigator Grants"^"COVID-19 has cost trillions in economic loss globally and devastated entire nations. The pandemic now has the capacity to be much better controlled with vaccination. But the best vaccines - those against COVID-19 and other diseases - are of no use if the public will not, or cannot, take them. This research will help countries to gather a better understanding of why people don't vaccinate and what to do about it."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2000367"^"http://purl.org/au-research/grants/nhmrc/2000367"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Combination immune therapy for type 1 diabetes,Clinical Trials and Cohort Studies Grants"^"This clinical trial will test whether a combination of two safe therapies, abatacept and nasal insulin, can stop the immune attack that causes type 1 diabetes. Sixty-two children and young adults with recently-diagnosed type 1 diabetes will receive either abatacept and nasal insulin or abatacept and nasal placebo for one year to determine if combined immune therapy preserves pancreas function and decreases the need for insulin therapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009677"^"http://purl.org/au-research/grants/nhmrc/2009677"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mining the host-pathogen interface to deliver a drug pipeline for treating intractable and emerging infections,Synergy Grants"^"Emerging viruses and antibiotic-resistant superbugs are the most important challenge to human health in the 21st century. New viruses such as SARS-CoV2 and Zika, as well as antibiotic resistant superbugs, emerge regularly and rapidly, urgently requiring new therapies. Our multidisciplinary Synergy team has demonstrated success in drug development and will create new drugs to avert the imminent global health disaster posed by emerging viruses and superbugs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009851"^"http://purl.org/au-research/grants/nhmrc/2009851"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Linking clinical and basic science discovery to find new treatments for alcohol use disorder,Synergy Grants"^"More than a million Australians meet criteria for an alcohol use disorder, making it a leading cause of death, injury and many diseases. Current treatment is often ineffective and research receives limited attention with no new medications in 20 years. We will create a program for treatment development. We will test new medications and new behavioural treatment in experimental animals before moving to human trials. The approach links outstanding basic science and clinical research groups."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009923"^"http://purl.org/au-research/grants/nhmrc/2009923"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Roadmap Options for Melanoma Screening in Australia (Melanoma-ROSA),Synergy Grants"^"Melanoma is Australiaâs third most common cancer and the earlier a melanoma is diagnosed the better the patient outcomes. Our program will co-design with consumers a blueprint for a NEW nationwide strategy for effective melanoma screening to inform practice and policy. We anticipate our program will generate evidence that will translate into a targeted melanoma screening program that is equitable in its reach, trustworthy for patients and clinicians, and cost-effective to the system."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010268"^"http://purl.org/au-research/grants/nhmrc/2010268"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Tackling Australiaâs low screening participation to prevent bowel cancer morbidity and deaths,Synergy Grants"^"Fifteen years after rollout, participation in our national bowel cancer screening program continues to lag behind comparable programs globally. We have not yet cracked even 50% participation despite the programâs world class free postal test kit and national registry. Current methods at getting people to screen are not working for most people. We content this due to failure to assess novel interventions in randomised controlled trials within the NBCSP."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010275"^"http://purl.org/au-research/grants/nhmrc/2010275"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for lung cancer patients: Discovering targetable vulnerabilities in lung cancer,Synergy Grants"^"Lung cancer is the leading cause of cancer-related mortality. One major hurdle faced in the clinic is that many patients fail to respond to currently available anti-cancer drugs. We will leverage the expertise of a diverse team of scientists and clinicians to tease apart the processes that can cause lung cancer to become refractory to current treatments. The discoveries made in this proposal will catalyse translational programs that will lead to improved ways to detect and treat lung cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010287"^"http://purl.org/au-research/grants/nhmrc/2010287"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining the role and therapeutic manipulation of the gut-lung axis in respiratory disease,Synergy Grants"^"Emphysema is an enormous clinical issue that needs effective treatment. Gut diseases cause lung inflammation. We show that gut bacteria (the microbiome) are altered and can be modified with targeted dietary interventions. We will define these changes and rapidly screen new diet for effectiveness in the lab and then test the most effective in clinical trials in patients. We will define how the new therapies work and progress new interventions to human treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010290"^"http://purl.org/au-research/grants/nhmrc/2010290"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Interventions for better life-time mental health outcomes for young Australians with disability,Synergy Grants"^"This research program brings together academic researchers from multiple disciplines to address the entrenched social, economic and mental health disadvantage experienced by Australian youth with disability. In partnership with advocacy groups and government, we will generate new evidence about interventions, including policy reforms, that can reduce the gap in mental health and wellbeing between young people with disability and their non-disabled peers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010562"^"http://purl.org/au-research/grants/nhmrc/2010562"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^""Integrative-omics" for precision medicine in the epilepsies,Synergy Grants"^"Epilepsy affects 4% of the population, with an estimated annual cost of $12.3 billion in Australia in 2019. This is largely due to devastating epilepsies known as Developmental and Epileptic Encephalopathies (DEEs). Patients have uncontrolled seizures, developmental impairment and a high risk of early death. We will bring computational expertise to integrate multiple biological measurements from patients with DEEs to reveal underlying disease dynamics and target new treatment approaches."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010716"^"http://purl.org/au-research/grants/nhmrc/2010716"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"STopping Acute Rheumatic Fever Infections to Strengthen Health (STARFISH),Synergy Grants"^"Rheumatic Heart Disease (RHD) is a serious disease caused by preventable Strep A infections, disproportionately affecting Indigenous Australians. Knowledge gaps remain on how to eliminate RHD, and preventing acute rheumatic fever (ARF, the step before RHD) is key. In a global first STARFISH brings together a diverse team of experts to tackle the root causes â social determinants â providing evidence as to how environmental health and housing interventions can stop Strep A spread and prevent ARF."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010736"^"http://purl.org/au-research/grants/nhmrc/2010736"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Cerebral Palsy SYNERGY Network to Protect, Repair and improve Outcomes,Synergy Grants"^"Cerebral Palsy (CP) is a life-long condition that affects movement and learning due to early brain injury. Recent research has reduced the number of infants being born with CP by 30 percent and now 70 percent of children will now walk. Our CP Synergy Network will develop new early tests to detect CP, treatments to prevent CP and repair and rehabilitate those with early brain injury that leads to Cerebral Palsy guided by a national consumer network and a diverse multidisciplinary clinical team."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010766"^"http://purl.org/au-research/grants/nhmrc/2010766"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"SERPICO Stroke: Synergistic Enhancement of Research design with Precision analytics to Improve Clinical Outcomes in Stroke.,Synergy Grants"^"Our Stroke synergy brings a diverse and revitalised cross-disciplinary team to harness our data infrastructure and pursue a whole new research direction for stroke. We will conduct a suite of new clinical trials with advanced statistical designs to improve trial efficiency. We will also develop completely new brain function and physical frailty measures to predict stroke outcome with embed cost-effectiveness analysis across all our activities to identify new ways to help patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010849"^"http://purl.org/au-research/grants/nhmrc/2010849"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Rational design of novel CARs for safe and effective brain cancer immunotherapy,Synergy Grants"^"Glioblastoma is a deadly brain cancer with &lt;5% survival, 5 years after diagnosis. There are no curative treatments so novel approaches are urgently required. This project will improve therapy options for brain cancer by using immunotherapy, an approach showing great clinical promise. Using genetically engineered blood cells designed to specifically kill cancer cells, this project will use cutting edge technology to make new cell therapies and test them in preclinical models of brain cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011100"^"http://purl.org/au-research/grants/nhmrc/2011100"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving patient outcomes through implementation of digital and diagnostic innovations for infections in cancer,Synergy Grants"^"Fever and sepsis complicate the management of cancer and occur in up to 90% of patients receiving treatment for certain types of cancer, and in some cases infection is the leading cause of early mortality. Gaps in the management of infection in cancer include lack of access to diagnostic tests and specialist care. This project will incorporate new technologies to deliver life saving care pathways for these vulnerable patients on a national scale."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011139"^"http://purl.org/au-research/grants/nhmrc/2011139"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding and averting blood cancer resistance to therapy,Synergy Grants"^"Blood cancers account for one-sixth of all cancer deaths. To substantially reduce this we need to establish why current treatments, including new targeted and immune therapies, fail. We are bringing together experts in different areas of science (biology, bioinformatics, imaging, immunology) and medicine (molecular diagnosis, treatment) to dissect why leukaemias and lymphomas become resistant to new therapies and design strategies to either prevent resistance occurring or to overcome it."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011204"^"http://purl.org/au-research/grants/nhmrc/2011204"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IMPACT: IMplementation of x-ray PhAse-Contrast Tomography to transform cancer diagnosis,Synergy Grants"^"Techniques used for breast and lung cancer imaging miss 20-40% of cancers and use unnecessary radiation. We will clinically implement a novel technique called propagation-based phase-contrast computed tomography (PB-CT) which will exploit X-ray refraction in addition to X-ray absorption. PB-CT increases image signal, offering significantly improved cancer detection and reduced radiation dose. This work will transform cancer diagnosis in Australia and internationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011277"^"http://purl.org/au-research/grants/nhmrc/2011277"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Respecting the Gift - Empowering Indigenous Communities in Genomic Medicine,Synergy Grants"^"Genomic medicine represents a step change in medical sciences. Yet Indigenous Australians are not represented in, engaged with, nor have equitable access to the benefits of genomic research. Our national consortium will build Indigenous leadership in genomics through Empowering Communities; data sciences; understanding genomic variation; uncovering multi-omic signatures of disease; and translate these findings to health care, ensuring Indigenous peoples can lead genomic research on their terms."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011329"^"http://purl.org/au-research/grants/nhmrc/2011329"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"National Precision Health Research Translation for Breast and Prostate Cancer Prevention and Early Detection,Synergy Grants"^"This program will make the next benchmark advance in saving lives from breast and prostate cancer by i) expanding our understanding of the genomic risk factors and improving individualised risk prediction, ii) extending our understanding of Australian attitudes, views and preferences on returning clinically actionable genomic information and iii) enabling an informed pilot study to demonstrate the feasibility of population genomic testing in the Australian setting."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010310"^"http://purl.org/au-research/grants/nhmrc/2010310"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Impaired mucociliary clearance drives Bronchiectasis progression,Ideas Grants"^"How bronchiectasis develops and progresses in the lung remains a mystery. One of the key features of bronchiectasis is the inability to clear mucus from the airways which leads to mucus stagnation. We have a identified a defect in production of the cells critical to moving mucus in the airways in samples taken from patients with bronchiectasis. By identifying the causes of this defect we may be able to reverse it and restore healthy mucus clearance in patients that suffer with bronchiectasis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010319"^"http://purl.org/au-research/grants/nhmrc/2010319"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"OPN as an Immune Checkpoint in KRAS Mutant Colorectal Cancer,Ideas Grants"^"Bowel cancer is a very common disease that will be diagnosed in 1/12 Australians living to age 85 and leads to over 4000 deaths annually. Subgrouping of colorectal cancers based on gene changes can predict response to therapy. Our research project specifically focuses on bowel cancers with a KRAS mutation that are usually resistant to currently available therapies. We are using cutting edge technology to identify novel approaches to therapy that will improve outcomes for these patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010330"^"http://purl.org/au-research/grants/nhmrc/2010330"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"SPARC as a key regulator of breast cancer metastasis and resistance to therapy,Ideas Grants"^"` The extracellular matrix or 'matrix' surrounds all cells and is very important in regulating cell behaviour. In cancer, the matrix is dramatically altered, typically making the cancer more aggressive. We recently developed new ways to study the matrix in breast cancer and in particular during cancer cell spread to other organs. We have uncovered exciting new matrix targets associated with breast cancer metastasis, and this project will validate their potential as novel therapeutic targets."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010332"^"http://purl.org/au-research/grants/nhmrc/2010332"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Programmable correction of mitochondrial DNA mutations,Ideas Grants"^"Mitochondrial diseases (MD) may occur at any age, affect any body organ, and may result in severe disability and often death. The prognosis for children with mitochondrial disease is especially grim and devastating for families. There are no known cures and it is not possible to predict the future of a child with mitochondrial disease. We have created unique RNA editing tools that can reverse mutations in cells and potentially improve energy metabolism in patient and in vivo models of MD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010336"^"http://purl.org/au-research/grants/nhmrc/2010336"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preclinical evaluation of a streptococcal peptide based specific diagnostic for rheumatic fever and the identification of proteins responsible for the pathogenesis of rheumatic heart disease,Ideas Grants"^"Rheumatic Heart Disease (RHD) is the commonest heart disease in children and young adults. While efforts have been made to control Strep infections that lead to RHD they are ineffective as NO SPECIFIC TEST for timely diagnosis is available. We have identified immune antibodies produced in RHD that can help the development of a new cost effective SPECIFIC test. During this project we will also identify the pathways that lead to heart damage and train and mentor three Indigenous Research Cadets."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010382"^"http://purl.org/au-research/grants/nhmrc/2010382"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Machine learning models for personalised epilepsy management,Ideas Grants"^"We will use clinical and genetic information to develop machine learning models to help clinician to select the most effective drug for individual epilepsy patients, and to identify patients likely has drug-resistant epilepsy at the time of diagnosis. These models will be validated in a new multicentre cohort of patients with newly diagnosed epilepsy in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010384"^"http://purl.org/au-research/grants/nhmrc/2010384"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Changing the paradigm to improve outcomes for Aboriginal children in out-of-home care,Ideas Grants"^"The evidence is clear that increasing the fit between service provision (research, policy, practice and resources), and the culture, values and needs of Aboriginal families and children is key to improving health and wellbeing outcomes. Building on the solid foundation of our previous work, this project will change the paradigm and co-design a personalised intervention support program to improve the health and wellbeing outcomes for Aboriginal children in out-of-home care and their families."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010390"^"http://purl.org/au-research/grants/nhmrc/2010390"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dual-function ribonucleases: unexpected agents of antibiotic resistance,Ideas Grants"^"Bacterial pathogens use a group of enzymes called metallo-Ã-lactamases (or MBLs) that enable them to be multi-drug resistant. Our project aims to determine how MBLs have evolved from harmless and widespread ribonucleases, both deep in the past and potentially very recently in response to modern use of antibiotics. These insights will provide valuable functional and structural information that will enable the development of urgently needed strategies to combat Ã-lactam antibiotic resistance."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010400"^"http://purl.org/au-research/grants/nhmrc/2010400"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing structural insights to block pneumococcal manganese uptake,Ideas Grants"^"Streptococcus pneumoniae is the worldâs foremost bacterial pathogen. In Australia, bacterial infections are responsible for more than 9,000 deaths every year, and the economic burden associated with treating diseases due to S. pneumoniae infections is more than $1 billion annually. This proposal aims to define how manganese, an essential trace element, is scavenged by S. pneumoniae during infection and then use a novel antimicrobial therapeutic strategy to block this pathway and prevent disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010405"^"http://purl.org/au-research/grants/nhmrc/2010405"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Genotype Imputation Resources for Productive Genetic Disease Studies of Indigenous Oceanic Sub-Populations,Ideas Grants"^"Indigenous Oceanic sup-populations are perhaps the least-represented of any population in genetic studies. We are proposing productive applications to conduct genetic disease studies by deploying the Indigenous Oceanic genetic analysis resources to promote complex genetic disease studies in these sub-populations. The outcomes will lead to improved disease diagnosis, interventions, treatments, and understanding the interplay of genetic and environmental factors in diseases of IO sub-populations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010464"^"http://purl.org/au-research/grants/nhmrc/2010464"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The role of Piezo1 and TRPM4 ion channels in pathophysiology of cardiac mechano-electric coupling,Ideas Grants"^"Heart hypertrophy is an important risk factor for premature death from a heart disease. In this project we propose to study a new cellular signalling pathway causing heart hypertrophy due to systemic increase in blood pressure. The biological molecules central to this new cellular pathway are the Piezo1 and TRPM4 ion channels underlying contractions of the heart muscle. This project aims to establish a novel paradigm in our understanding of the molecular origins of heart hypertrophy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010522"^"http://purl.org/au-research/grants/nhmrc/2010522"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using renewal theory to develop personalised classification and treatment for atrial fibrillation,Ideas Grants"^"Atrial fibrillation is the most common disorder of heart rhythm in the Australian community. It is characterised by disordered electrical waves, and mini-tornadoes of electricity called rotors. We have recently developed equations which can accurately predict the number and population distribution of rotors. Here, we will harness this discovery to perform a combination of clinical, experimental, simulation and technology development projects to develop personalised approaches to AF treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010530"^"http://purl.org/au-research/grants/nhmrc/2010530"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Prediction of preterm birth using vaginal microbiology,Ideas Grants"^"Recently, our team developed a vaginal microbial DNA test that successfully predicted up to 45% of spontaneous preterm birth (sPTB) cases in mid-gestation pregnant women, the majority of whom were Caucasian (75%). Our next steps are to maximise the testsâ ability to predict sPTB in Aboriginal women, whose vaginal microbiology differs, and to use pre-pregnancy vaginal microbiology to predict sPTB risk in all Australian women prior to conception."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010532"^"http://purl.org/au-research/grants/nhmrc/2010532"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A new model of Ã-Spectrin function: understanding how the skin protects neurons from damage,Ideas Grants"^"The spectrin cytoskeleton is thought to function like a spring within neurons to allow them to bend and stretch â protecting them from damage induced by mechanical stress. Human mutations in spectrins cause severe neurological disorders with debilitating symptoms. We propose that spectrins function in tissue surrounding neurons to protect them from damage, and not within them as previously thought. This could revolutionise our understanding of disorders associated with spectrin dysfunction."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010551"^"http://purl.org/au-research/grants/nhmrc/2010551"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Resolving prostate cancer health disparities through population-scale genomic interrogation,Ideas Grants"^"Geography (environment) and ethnicity (genetics) are significant predictors of prostate cancer (PCa) mortality, specifically Africa or African ancestry. This project harnesses the power of whole genome interrogation and an intercontinental (Australia and Africa) and interethnic (European, African and Asian) study design, to distinguish the genetic and non-genetic factors contributing to PCa disparities. The hypothesis, non-genetic forces leave a âhallmark of DNA damageâ in the evolving tumour."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010571"^"http://purl.org/au-research/grants/nhmrc/2010571"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Heterochromatin instability as a molecular driver of haematopoietic ageing,Ideas Grants"^"Ageing of the blood and immune system leaves elderly people more susceptible to infections and blood cancers. Given our ageing population, strategies that can either rejuvenate or slow this process are urgently needed. We have identified an epigenetic pathway that controls blood system ageing. This proposal will provide a comprehensive understanding of this epigenetic pathway in blood system ageing, and determine whether activating this pathway can slow-down or reverse the ageing process."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010593"^"http://purl.org/au-research/grants/nhmrc/2010593"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preparing Australia for the next pandemic: Managing controversy; promoting trust.,Ideas Grants"^"This project addresses the question: how can we better prepare our institutions and Australian society for the next pandemic? COVID-19 has been characterised by uncertainties about transmission risks and the effectiveness of precautionary strategies, undermining confidence in experts and authorities. This project will develop guidance and practical resources to improve social preparedness for the next pandemic, and promote greater trust within and between expert groups and the broader community."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010600"^"http://purl.org/au-research/grants/nhmrc/2010600"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting Renal Energy Metabolism in Kidney Injury and Disease,Ideas Grants"^"Short-term acute kidney injury and permanent chronic kidney disease affects 1 in 10 Australians. It is unknown how these diseases are interlinked and related to obesity. A lack of energy supply in kidney cells could be the shared link and we will test this theory by targeting energy proteins in the kidney with a new drug O304. We anticipate knowledge generated by our innovative project will catalyse the development of new targeted treatments to improve kidney patient care and quality of life."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010610"^"http://purl.org/au-research/grants/nhmrc/2010610"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New approaches to cancer treatment through mRNA display,Ideas Grants"^"This proposal will pioneer the development of a new class of molecules that will block the activity of proteins that regulate gene expression and have been shown to be promising targets for a range of diseases, predominantly cancer. These molecules have the potential to be much more selective and potent than existing molecules and to also open up new directions for cancer therapy by allowing previously intractable molecular targets to be addressed."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010611"^"http://purl.org/au-research/grants/nhmrc/2010611"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A gene-editing strategy for telomere-related bone marrow failure,Ideas Grants"^"A subset of inherited bone marrow failure (BMF) syndromes is caused by mutations in genes that protect the ends of chromosomes, or telomeres. The only curative therapy for BMF is bone marrow transplant, which has a high rate of mortality and complications. We will use the latest developments in gene editing of bone marrow stem cells to develop a strategy for correcting mutations in telomere-related genes in the patientâs own cells, providing a potentially curative therapy for inherited BMF."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010632"^"http://purl.org/au-research/grants/nhmrc/2010632"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel Hormone Analogues as an Innovative Endocrinological Intervention for the Anaemia of Chronic Disease,Ideas Grants"^"Anaemia of chronic disease (ACD) is a severe cause of morbidity &amp;amp; mortality in millions of people with cancer or inflammatory diseases. ACD is due to excessive levels of hepcidin, a hormone that prevents gut iron uptake, which inhibits the use of iron for making red blood cells. Thus, excessive hepcidin leads to debilitating anaemia. This proposal will develop innovative Null Hepcidin Analogues that have no hormonal activity, but lead to excretion of excessive hepcidin, thereby curing the anaemia"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010647"^"http://purl.org/au-research/grants/nhmrc/2010647"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Alternative splicing: A novel target to improve outcomes in acute myeloid leukaemia,Ideas Grants"^"In 2013, we made a breakthrough discovery that certain parts of genes, previously considered âJunk DNAâ, are actually carrying signals to control the amount of proteins produced in cells. Our preliminary work now suggests these signals controlling protein levels can be faulty in cancers. Here, we wish to determine if these faulty signals could be exploited to better manage a deadly blood cancer called acute myeloid leukaemia (AML). Our work will spur the development of novel therapy for AML."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010654"^"http://purl.org/au-research/grants/nhmrc/2010654"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building an Evidence-Base to inform Post-Traumatic Stress Disorder (PTSD) Treatment for Culturally and Linguistically Diverse Communities,Ideas Grants"^"How someone appraises trauma and deals with emotion is core to treating posttraumatic stress disorder (PTSD). Yet these treatments are based on research emphasising Western values. There is an urgent need to examine what appraisals and emotion regulation should be targeted in PTSD treatments for trauma survivors from other cultural backgrounds. This research examines cultural influences on appraisals and emotion regulation in PTSD to improve treatment outcomes for culturally diverse Australians."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010701"^"http://purl.org/au-research/grants/nhmrc/2010701"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Driving quality in delirium care through a patient-centred monitoring system in palliative care,Ideas Grants"^"Delirium - sudden confusion and difficulty thinking related to illness, injury or medical treatment - is serious, distressing, and often not addressed for people in hospital at end of life. We will develop and test a new way to monitor delirium in palliative care that involves patients, their family, and staff. The system will align with national quality initiatives, tackle a complex and long-standing clinical issue, and be a key step forward for global quality improvement in palliative care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010704"^"http://purl.org/au-research/grants/nhmrc/2010704"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Epithelial mechanics and the fate of cancer,Ideas Grants"^"Many common cancers originate in epithelial tissues, such as the breast, lung, colon and skin. All such cancers first begin as one cancer (transformed) cell within its epithelial tissue of origin, and these can be potentially eliminated by the epithelium to protect against cancer. This research proposal tests how abnormal function of the host epithelium can increase the risk of a newly-transformed cell being retained in the body to progress into a clinically significant tumor."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010711"^"http://purl.org/au-research/grants/nhmrc/2010711"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Modelling intellectual disability caused by mutations in chromatin-modifying enzymes to develop ameliorating treatments,Ideas Grants"^"Intellectual disability is a condition that affects speech, motor-coordination and emotional interactions. In cases where it is caused by a reduction in enzyme activity, it may be possible to improve patient outcome by providing more substrate for the enzymatic reaction or by inhibiting the opposing enzymatic activity. We propose to model human genetic disorders in mice to study new treatment options."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010717"^"http://purl.org/au-research/grants/nhmrc/2010717"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Global analysis of metabolic targets in Leishmania parasites,Ideas Grants"^"There is an urgent need to develop new drugs to treat human leishmaniasis, a disease that causes debilitating and life-threatening diseases in millions of people worldwide. This project will systematically investigate the function of all metabolic enzymes in Leishmania pathogens using newly developed genetic and analytical tools. The findings of this study will be used to triage Leishmania metabolic enzymes for drug development, with the view of generating more effective anti-parasitics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010743"^"http://purl.org/au-research/grants/nhmrc/2010743"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Immune mechanisms underpinning remission of allergy,Ideas Grants"^"There is no cure for food allergy. Treatments in development have been shown to induce remission of allergy. This can be transient or long-lasting. We will employ state-of-the-art approaches to characterise the immune changes underpinning remission, particularly whether remission is persistent (long-lasting) or transient. This knowledge would enable the development of more effective long-term treatments for food allergy by providing new targets for intervention, possibly offering a cure."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010757"^"http://purl.org/au-research/grants/nhmrc/2010757"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"COVID-19-induced vascular complications: mechanisms and potential therapies,Ideas Grants"^"The coronavirus SARS-CoV-2 is responsible for the disease COVID-19, which causes significant lung dysfunction. Importantly, reports have observed COVID-19 symptoms that are not associated with the lungs, such as blood clots, vessel inflammation and leakage of fluid from vessels into tissues. These virus-induced vessel defects can lead to the death of patients. Here, we aim to understand exactly how these vessel defects occur to develop treatments for patients with acute and long term disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010763"^"http://purl.org/au-research/grants/nhmrc/2010763"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Brain injury in intimate partner violence: Insight into a silent pandemic,Ideas Grants"^"Intimate partner violence (IPV) is a worldwide problem that primarily affects women. Although &amp;gt;90% of IPV survivors report symptoms consistent with traumatic brain injury (mTBI), how IPV-related TBI contributes to the lived experience of IPV victims has been remarkably understudied. This translational project will characterise the effects of IPV-related TBI. By doing this, we will be able to development interventions, and change practice and policy, to improvement the well-being of IPV victims."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010778"^"http://purl.org/au-research/grants/nhmrc/2010778"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Are nicotine replacement therapy and varenicline safe and effective for women trying to quit smoking during pregnancy?,Ideas Grants"^"This project will measure the safety and effectiveness of two quit smoking medicines during pregnancy. It will use routinely collected data from Australia, New Zealand and the Nordic countries, for over 400,000 women who smoked during pregnancy. Women who used nicotine replacement therapy or varenicline during pregnancy will be compared to women who smoked but did not use these medicines in relation to quitting and adverse birth outcomes and neurodevelopmental problems among their children."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010781"^"http://purl.org/au-research/grants/nhmrc/2010781"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Engineering of novel insulin analogues for improved management of diabetes,Ideas Grants"^"Diabetes is a major global health condition affecting nearly 0.5 billion people. Insulin is an essential treatment for Type 1 and, increasingly, Type 2 diabetes. However, it is difficult to both manufacture and handle as it aggregates rapidly in solution making storage and accurate dosing difficult. We will develop novel modified insulins that are biologically active, long-acting, aggregate-free and which self-respond to increases in glucose levels therefore greatly improving diabetes therapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010784"^"http://purl.org/au-research/grants/nhmrc/2010784"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mapping B-cell fate to improve humoral immunity to malaria,Ideas Grants"^"Malaria killed half a million people in 2019. While ~60 vaccines exist against viral or bacterial diseases, no effective vaccines exist against malaria-causing parasites. Immunity to malaria can be mediated by antibodies. This depends on immune cells called B- and T-cells, conducting a choreographed series of interactions in immune organs. This process appears defective in malaria for reasons unknown. We will determine these reasons, and provide new ways for boosting immunity to malaria."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010795"^"http://purl.org/au-research/grants/nhmrc/2010795"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Oncofetal ecosystem in advanced Hepatocellular Carcinoma: Implications for Identifying Immunotherapy response,Ideas Grants"^"Each year ~1800 Australians succumb to hepatocellular carcinoma (HCC). The lack of effective treatment options is a major contributing factor to the poor outcomes. A new immunotherapy treatment which activates the body's immune system, has demonstrated significant efficacy. However, this treatment does not work for all patients. Therefore, we will identify which patients will benefit from this treatment and provide biomarkers, with the overall purpose of guiding clinical decision making."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010804"^"http://purl.org/au-research/grants/nhmrc/2010804"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Measuring healthy ageing: finding an autophagy biomarker for a scalable clinical test,Ideas Grants"^"The cells of our bodies possess a powerful recycling system that removes damaged material that accumulates with age and causes diseases such as dementia and atherosclerosis. Although scientists know how to increase this recycling system in laboratory models, we cannot easily measure this function in humans. This study aims to develop easy methods to measure cell recycling in humans so that we can increase the activity of this recycling system to support healthy ageing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010812"^"http://purl.org/au-research/grants/nhmrc/2010812"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mechanisms underlying cortical hyperexcitability in amyotrophic lateral sclerosis,Ideas Grants"^"The current research grant will use novel neurophysiological tools to study brain activity in patients with motor neuron disease/amyotrophic lateral sclerosis. We anticipate that excessive brain activity, called cortical hyperexcitability, will be caused by reduction in activity of cortical inhibitory nerves, increase in activity of cortical excitatory nerves and increase in persistent sodium currents. Treatments, targeting the abnormal brain processes, are likely to be developed."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010813"^"http://purl.org/au-research/grants/nhmrc/2010813"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Metabolic and molecular protection against mtDNA mutations,Ideas Grants"^"Mitochondria are powerhouses of the cell. Their assembly and function are encoded by a small mitochondrial genome. Mutations in the mitochondrial genome can cause devastating metabolic disorders and have been linked to many common age-related diseases. This project will reveal how cells invoke protective measures to overcome these mutations, thus revealing new mechanisms that can be exploited to combat mitochondria-associated disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010841"^"http://purl.org/au-research/grants/nhmrc/2010841"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Coxiella pathogenesis and Effector-Effector Interplay,Ideas Grants"^"Coxiella causes the human infection Q fever. Coxiella has a cohort of virulence proteins that interfere with the human cell. This research will uncover how these proteins function, and interact with each other, to cause disease. This will contribute important new knowledge of pathogenesis that will highlight novel intervention targets. We will also learn how these virulence proteins manipulate human cell functions which are involved in a range of human diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010899"^"http://purl.org/au-research/grants/nhmrc/2010899"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Neuropharmacology of decision-making: causal brain network modelling across species,Ideas Grants"^"Decision making is a critical aspect of human cognition that is frequently impaired in clinical disorders. This project will identify the fundamental brain processes governing decision making by studying both monkeys and humans while they perform the same cognitive task. We will identify the critical brain networks that allow organisms to efficiently make decisions and the chemicals which modulate these networks. Our knowledge will inform treatment of clinical disorders of decision making."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010901"^"http://purl.org/au-research/grants/nhmrc/2010901"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating myristic acid as key mediator of memory via myristoylation,Ideas Grants"^"Despite the fact the that human brain is made of nearly 60 percent fat, the vast majority of studies on the mechanism of memory and neurodegeneration primarily focused on protein and genetic changes. Here, we discovered that myristic acid production derived from brain cell phospholipids correlates with memory acquisition. Using state-of-the-art mass spectrometry and super-resolution microscopy, we will establish the role of myristic acid in learning and how it is affected during ageing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010917"^"http://purl.org/au-research/grants/nhmrc/2010917"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting neuropilin in SARS-Cov-2 neuronal uptake and transport,Ideas Grants"^"COVID-19 is associated with a variety of neurological symptoms, ranging from a transient loss of smell and taste to headaches to severe ischaemic damage in fatal cases. The long-term consequences of potential interactions of the causative virus, SARS-CoV-2, with brain cells are currently unknown but could be linked to intractable neuronal degeneration as previously found with the 1918 influenza pandemic. We will investigate the uptake and transport of the virus and find ways to block infection."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010919"^"http://purl.org/au-research/grants/nhmrc/2010919"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Detecting Referable Glaucoma Using Artificial Intelligence,Ideas Grants"^"Glaucoma is a leading cause of blindness worldwide affecting over 300,000 Australians. While treatments are available to delay vision loss, no cure for glaucoma exists, making early identification of at-risk individuals an utmost priority. We have developed a model that can accurately detect early glaucoma-specific changes in the eye. In this project, we will evaluate the performance of our model in comparison to assessments made by glaucoma specialists to determine its efficacy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010939"^"http://purl.org/au-research/grants/nhmrc/2010939"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Molecular mechanisms underlying the pathogenesis of complex I dysfunction and mitochondrial disease,Ideas Grants"^"Mitochondria are the powerhouses of our cells that produce the chemical ATP for functions such as muscle contraction and triggering of nerves. Mitochondrial Complex I is a molecular motor that helps to make this ATP and defects in this motor cause mitochondrial disease, resulting in early childhood death. In this project we will study how Complex I is assembled and determine how defects in this assembly pathway leads to disease. New insights into therapeutic approaches will be investigated."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010955"^"http://purl.org/au-research/grants/nhmrc/2010955"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating complement C5a receptor 2 as a therapeutic target for diabetic kidney disease,Ideas Grants"^"Kidney disease is a serious and common complication of diabetes and the leading cause of kidney failure worldwide. We have found that the complement system, which is a normal part of the immune system, is overactivated in diabetes and leads to kidney injury. We propose studies to not only understand how complement leads to kidney disease in diabetes, but also to identify novel therapeutic targets to enable the development of new treatments for diabetic kidney disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010979"^"http://purl.org/au-research/grants/nhmrc/2010979"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel antibody-based treatment for polymicrobial sepsis.,Ideas Grants"^"Sepsis or blood poisoning kills more than 7000 Australians every year and there is no cure for this disease. Using the CRISPR gene editing technology, we identified and characterized the receptor protein responsible death during sepsis in mice. We also have developed antibodies against the human counterparts of this receptor. We propose to test these antibodies in mice and human sepsis patients. We also propose to test a diagnostic marker for sepsis-associated mortality in sepsis patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010992"^"http://purl.org/au-research/grants/nhmrc/2010992"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting a novel epigenetic regulator of Hodgkin lymphoma, H2A.B, for treament of cancer,Ideas Grants"^"We have identified a novel key regulator of Hodgkin Lymphoma, epigenetic factor, histone H2A.B. This proposal aims to develop novel therapeutic tools that would target H2A.B and potentially provide a more specific and less toxic treatment for Hodgkin Lymphoma patients. We will use Modular Nanotransporters, a highly specific intracellular delivery system, to target H2A.B for degradation and we will use the small molecule kinase inhibitors for functional inactivation of H2A.B."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010998"^"http://purl.org/au-research/grants/nhmrc/2010998"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting metabolism to improve healthy ageing,Ideas Grants"^"Ageing is the largest risk factor for chronic diseases that account for most of the financial burden of disease and 90% of deaths in Australia. The goal of this project is to test a new small molecule drug in mouse models of ageing to test the hypothesis that it will improve healthy ageing by decreasing age-related organ deterioration. Success of this project would provide support for clinical translation that could benefit individuals and society by decreasing disease incidence."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011004"^"http://purl.org/au-research/grants/nhmrc/2011004"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting caloric efficiency to treat obesity-related diabetes,Ideas Grants"^"Diabetes is a major unmet medical need in Australia. We have recently discovered a new class of drug that reverses obesity and pre-diabetes in mice. The objectives of this project are to determine whether this drug is effective in a mouse model of very severe obesity-related diabetes, and to determine if new drug coatings will improve drug exposure so that it can be taken orally once per day. Success of this project will provide vital data needed to support clinical translation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011010"^"http://purl.org/au-research/grants/nhmrc/2011010"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Elucidating the function of host-derived cysteine in bacterial virulence,Ideas Grants"^"Our immune system responds to stomach infection with Helicobacter pylori by producing high levels of defence molecules called reactive oxygen species (ROS). However, H. pylori can withstand ROS, and they fail to clear the infection, but in the long term, ROS damage the stomach lining resulting in disease. This project tests the hypothesis that H. pylori uses amino acids cysteine and cystine available in the stomach lining to combat ROS. The outcomes will aid future design of new antimicrobials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011020"^"http://purl.org/au-research/grants/nhmrc/2011020"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Cytotoxic T cell granules â a matter of life and death,Ideas Grants"^"Humans are protected from infections and cancer by a subset of immune cells called cytotoxic lymphocytes, which can recognised and kill rogue cells. Despite an enormous clinical interest, how these cells mature from a naive inactive to a fully activated state is poorly understood. The aim of the current proposal is to investigate that process, and thus provide a better understanding of how the immune system works and how it can be better utilised to treat cancer and other diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011033"^"http://purl.org/au-research/grants/nhmrc/2011033"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"ComBATing lethal prostate cancer with combination Bipolar Androgen Therapy,Ideas Grants"^"For 80 years, the main way to treat advanced prostate cancer has been to cut off the supply of male hormones. Unfortunately, this only works temporarily and it compromises quality of life. Surprisingly, new clinical trials show that the opposite approach â supplying excess testosterone â is effective and improves quality of life. Our novel idea is to boost the efficacy of testosterone therapy, and ensure more patients benefit, by combining it with a second drug."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011042"^"http://purl.org/au-research/grants/nhmrc/2011042"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Establishing a new bone pathologic pathway and solving problems of diagnosis in chronic orthopaedic infections,Ideas Grants"^"Orthopaedic and other bone infections are difficult to diagnose, treat and cure. Hard bone is a unique niche for host-pathogen interaction that provides both serious treatment challenges and new opportunities for improving patient outcomes. Using analysis of human patients, unique animal and human models of bone infection, our proposal will revolutionise diagnosis and understanding of complex infections such as periprosthetic joint infection and diabetic foot infection."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011044"^"http://purl.org/au-research/grants/nhmrc/2011044"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"COMBAT - A Combination B-and T-Cell Epitope Vaccine to Futureproof COVID-19 Vaccine,Ideas Grants"^"We are proposing a vaccine that contains only safe components of the SARS-CoV-2 virus, yet effectively elicits protective immunity. The vaccine works by inducing antibodies capable of preventing the virus from attaching to lung cells, and killer T cells that destroy virus-infected cells. This highly innovative approach will generate a much needed safe and prophylactic 2nd generation modular vaccine, ideal for âvaccine updateâ that will have a major impact on health and society more generally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011047"^"http://purl.org/au-research/grants/nhmrc/2011047"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Immunoglobulin A degradation by the gut microbiome,Ideas Grants"^"The antibody immunoglobulin A (IgA) plays an important role in the immune response to microbial species at mucosal surfaces. Pathogenic bacterial species are known to degrade IgA in the gut to aid their virulence; however, little is known about this activity in commensal bacteria. Here, we aim to study a novel protein identified in a gut commensal bacterium that can potentially degrade IgA, and determine if this protein activity has downstream consequences to disease susceptibility."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011083"^"http://purl.org/au-research/grants/nhmrc/2011083"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mapping the Beneficial Effects of Exercise in humans using Personalised Phosphoproteomics,Ideas Grants"^"Exercise has major health benefits and can prevent many diseases. For example, it is very effective in diabetes by improving insulin action. However, exercise is poorly tolerated by many creating a need to define the mechanism for these benefits. Using cutting-edge technologies we have identified a new lead that might underpin exercise effects on insulin action. This project will characterise this novel pathway in humans, bringing us a step closer to finding a drug that mimics exercise."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011115"^"http://purl.org/au-research/grants/nhmrc/2011115"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining the inflammatory T cell landscape in ankylosing spondylitis,Ideas Grants"^"Ankylosing spondylitis, or AS for short, is a common inflammatory arthritis that affects joints of the spine and pelvis. There is no cure for AS. Cells of the immune system called T cells are known to be important in AS but the details of how these cells work in the disease are unclear. Our work will define exactly how T cells work in AS. This world-first knowledge will permit design of new treatments focused specifically on preventing harmful aspects of T cell function that contribute to AS."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011119"^"http://purl.org/au-research/grants/nhmrc/2011119"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Legumain at the cutting edge of oral cancer,Ideas Grants"^"Oral cancer patients suffer from profound pain and the survival rate is low due to the spread of the cancer. Effective therapies to treat oral cancer pain and prevent its spread are currently lacking. We have identified an enzyme that promotes cancer pain, and drugs that block its activity are effective at relieving pain. We will test the contribution of this enzyme to cancer spread and determine whether drugs blocking its activity are effective at preventing spread and alleviating pain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011120"^"http://purl.org/au-research/grants/nhmrc/2011120"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"When sporadic disease is not sporadic - exploiting cryptic relatedness to unravel MND genetics,Ideas Grants"^"Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with a significant genetic component underlying both the hereditary and sporadic forms of disease. Using a global cohort of ~10,000 ALS cases, we aim to uncover unrecognised ancestral relationships between patients in order to detect new genes that cause ALS or influence the progression of the disease. We will also harness the power of artificial intelligence to predict prognosis and inform clinical care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011129"^"http://purl.org/au-research/grants/nhmrc/2011129"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Vaccine nonspecific effects of live and non-live vaccines: understanding the mechanisms and potential consequences.,Ideas Grants"^"Increasing evidence suggests that in addition to protecting us against specific diseases, vaccines can also confer nonspecific effects that are defined as effects on health unrelated to the disease targeted by the vaccine. In this proposal, we will investigate how different vaccines may shape how our innate immune system responds to subsequent infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011143"^"http://purl.org/au-research/grants/nhmrc/2011143"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Evaluating anti-fibrotic drugs for intracochlear fibrosis,Ideas Grants"^"Cochlear implantation is currently the best method for hearing restoration and has been shown to improve speech understanding in the majority of patients. The acute and long-term outcomes of cochlear implantation remain variable and can be unpredictable. One reason for this variability is the formation of scar tissue around the electrode which, in some cases can lead to device failure. In this study we will determine if anti-fibrotic drugs can reduce the formation of this scar tissue."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011172"^"http://purl.org/au-research/grants/nhmrc/2011172"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A new role for gut pH in blood pressure regulation,Ideas Grants"^"High blood pressure continues to be a major, poorly controlled but modifiable risk factor for cardiovascular death. Diets high in fibre are associated with lower blood pressure via the production of substances as a result of fibre digestion by gut microbes. We found that these same substances lower gut pH. This new mechanism could have major implications for the management of hypertension in the future."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011193"^"http://purl.org/au-research/grants/nhmrc/2011193"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a nociceptive measuring device capable of differentiating chronic pain states,Ideas Grants"^"Pain measurement is an essential element in any medical assessment, including diagnosis, monitoring of disease progress and evaluation of treatment effectiveness, but there is no common or easy method of objective pain measurement. This study aims to create an biosensor "neuron-on-chip" cell-based device with the machine learning driven capacity to measure and discriminate between various chronic types by analysing serum samples from animal models of chronic pain and human patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011200"^"http://purl.org/au-research/grants/nhmrc/2011200"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel therapies for slowing vision loss caused by retinal degeneration,Ideas Grants"^"Death of the light sensitive cells of the eye, the photoreceptors, is one of the leading causes of visual impairment in Australia. Our data indicate accumulation of intracellular waste within photoreceptors is a critical driver of their death. The aims of this project are to define the molecular pathways causing waste accumulation and find treatments that enhance waste recycling in photoreceptors to slow the devastating progression of vision loss."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011209"^"http://purl.org/au-research/grants/nhmrc/2011209"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mapping sex differences in the journey of an individual with coronary heart disease through the healthcare system,Ideas Grants"^"A general practice visit is often the first point of contact with the health system and a gateway to other specialist health services. However, data from different services are not easily âjoined upâ making it difficult to look across the patientâs care journey. This project will join all health attendances for patients with heart related symptoms. This high-quality âjoined upâ research will contribute to improvements in the provision of health services and patient outcomes in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011217"^"http://purl.org/au-research/grants/nhmrc/2011217"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"TARGETING DEREGULATED EPIGENETIC MECHANISMS IN LYMPHOMA,Ideas Grants"^"Diffuse large B-cell lymphomas (DLBCL) are aggressive tumors, with 40% patients not responding to the conventional chemotherapy treatment or relapsing after treatment. In this proposal, we will evaluate new epigenetic therapies to treat these lymphomas, targeting the non-inherited environmental factors that control the function of genes. We predict that the results from this project will drive new clinical trials for DLBCL patients with TET2 or CREBBP mutations, which represent 1 in 3 patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011220"^"http://purl.org/au-research/grants/nhmrc/2011220"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Regenerative surgery for liver disease using human iPSC-derived liver organoids,Ideas Grants"^"This project will develop a new treatment for liver disease. Using a patientâs own stem cells, we will generate the key components of liver tissue and combine this into mini-liver units called organoids. Organoids will be transplanted into the body (in the groin), for initial development around a major artery/vein, forming a âsecond liverâ in the body. We will then remove diseased liver tissue and replace this with the second liver, in a surgical procedure similar to liver transplantation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011299"^"http://purl.org/au-research/grants/nhmrc/2011299"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Deciphering incomplete penetrance of subfertility,Ideas Grants"^"Infertility is one of the most common chronic health issues involving young adults. Infertility has many causes and is associated with other conditions including elevated risk of type 2 diabetes, heart disease and mental health issues such as anxiety and depression. The goal of the project is to discover genes that influence female fertility levels. This work is crucial to bridge the gap between accurately predicting who is at risk of infertility and how best to treat patients as individuals."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011314"^"http://purl.org/au-research/grants/nhmrc/2011314"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Generating a higher order kidney by understanding and controlling nephron connectivity,Ideas Grants"^"Engineering replacement kidney tissue for the treatment of chronic kidney disease has the potential to revolutionise kidney disease treatment. We previously used human stem cells to generate many nephrons, the filtering units of the kidney. In this project, we will focus on how to induce connections between these nephrons to ensure a common path for urine exit. This will bring us one stem closer to a stem-cell derived replacement kidney."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011334"^"http://purl.org/au-research/grants/nhmrc/2011334"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Can psychedelics treat anorexia nervosa? Insights into the therapeutic effects of psilocybin in an animal model,Ideas Grants"^"Anorexia nervosa (AN) is a debilitating disorder which is currently untreatable. Phase 1 clinical trials of psilocybin are underway in patients with AN, however the biological mechanisms of psilocybin remain inadequately understood. This project, which will inform patient selection to avoid unfavourable effects, utilises the activity-based anorexia rat model combined with sophisticated techniques to furnish an understanding of psilocybinâs actions on weight loss, cognition and brain function."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011342"^"http://purl.org/au-research/grants/nhmrc/2011342"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel modelling of childhood obesity to improve decision making and close the gap,Ideas Grants"^"Children from Aboriginal and Torres Strait Islander, other culturally and linguistically diverse groups, and socioeconomically disadvantaged groups are most affected by obesity. We will use novel modelling methods to assess childhood obesity prevention programs for future savings in healthcare costs, improvements in quality of life and impacts on inequalities. We will work with relevant stakeholders to ensure that resources are prioritised for the best and fairest obesity prevention programs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011344"^"http://purl.org/au-research/grants/nhmrc/2011344"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Elucidating the impact of oxidative stress on the early development of human placental villi using human stem cell derived placentoids,Ideas Grants"^"The placenta supports the life of the baby. Nutrients, waste and oxygen cross special placental cells (trophoblasts) at the boundary between fetal and maternal circulation. Early in pregnancy, trophoblasts may experience premature rises in oxygen levels that can damage the placenta and risk maternal and fetal health. A newly developed experimental system will be used to study how oxygen fluxes impact trophoblast health to better understand the cause of placental defects at the cellular level."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011355"^"http://purl.org/au-research/grants/nhmrc/2011355"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New strategy to safely and effectively reduce diabetic kidney disease,Ideas Grants"^"Diabetic kidney disease (DKD) is a catastrophic disease with no effective treatment to reduce scarring and inflammation, the major pathological features of DKD. We have found a new target and generated a prototype drug, CHA-061, to safely inhibit this target, which led to concurrent inhibition of inflammation and fibrosis in animal models of DKD. This grant will study the structure-activity relationship of this prototype inhibitor in order to generate a more effective therapy to combat DKD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011391"^"http://purl.org/au-research/grants/nhmrc/2011391"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing novel CAR T cell therapy approaches to treat prostate cancer,Ideas Grants"^"Prostate cancer is the most common cancer in Australian men and second leading cause of death. The major clinical challenge is to offer more effective treatments for men with advanced prostate cancer, particularly those who have failed all available therapies. This project will provide preclinical evidence that CAR T cell immunotherapy is effective for prostate cancer and will inform future clinical trial development."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011398"^"http://purl.org/au-research/grants/nhmrc/2011398"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a defective interfering RNA based antiviral approach to treat infections by SARS-CoV-2 and emerging variants,Ideas Grants"^"Specific therapy for severe disease caused by SARS-CoV-2 is limited. The ability of viruses to become resistant to a therapy may be obstacle for antiviral development. This project develops a unique platform, using virus-specific antiviral RNA, as a unique and possibly âantiviral-resistanceâ proof approach that could be deployed as a therapeutic for COVID-19 and also help to solve the challenge of viral pandemics from known and unknown viruses, especially other human pathogenic coronaviruses."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011447"^"http://purl.org/au-research/grants/nhmrc/2011447"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel single treatment for two serious complications of allogeneic stem cell transplantation: acute graft-versus-host disease and sinusoidal obstruction syndrome.,Ideas Grants"^"Acute graft versus host disease (GVHD) is a frequent and devastating complication of allogeneic stem cell transplantation, which is the use of stem cells from a donor related or unrelated to the patient who is the recipient. It is mediated by immune activation and inflammation. We have developed a new drug (Anti-VCAM-CD39) that has anti-inflammatory and immune suppressive properties. We will test the efficacy of this drug to simultaneously treat GVHD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011462"^"http://purl.org/au-research/grants/nhmrc/2011462"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The role of memory engrams in the cortex,Ideas Grants"^"Memory formation is one of the great mysteries of the brain. Memories are not only crucial for survival, but they make us who we are. This project will address where, and how, memories are formed in the brain and provide insight into new targets to treat disorders of memory."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011467"^"http://purl.org/au-research/grants/nhmrc/2011467"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining the impact of chronic lung disease on COVID-19 and developing effective therapies,Ideas Grants"^"COVID-19 disease is driven by virus-induced, hyper-inflammation that damages the lungs. Patients with chronic lung disease, such as chronic obstructive pulmonary disease (COPD) and tuberculosis (TB), have increased severity of COVID-19 disease. Using our models of TB and smoking-induced COPD, we will define how chronic lung disease increases the severity of COVID-19, how CoV2 infection exacerbates TB and COPD, and identify effective drugs that suppress this inflammatory damage to the lung."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011471"^"http://purl.org/au-research/grants/nhmrc/2011471"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optogenetic restoration of high-sensitivity vision with ChRmine, a novel Type I opsin,Ideas Grants"^"Inherited retinal disease (IRD) is the commonest cause of blindness in people of working age. Sight loss in IRD is due to the loss of light-sensitive cells inside the eye called the rods and cones. However, the light-insensitive nerve cells in the eye, which normally relay information from the rods and cones to the brain, persist. This project aims to introduce a new, highly light-sensitive protein called ChRmine into these cells to make them light-sensitive, thereby restoring vision."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011481"^"http://purl.org/au-research/grants/nhmrc/2011481"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Characterisation of novel genetic variants in Hyperekplexia and Dravet Syndrome: Identifying the Unknown Knowns,Ideas Grants"^"All people carry 3 million points-of-variation (variants) in their individual genetic code which can be accurately read but only partially interpreted. This study, with collective world-wide efforts of neurologists and scientists, will enhance our interpretation of variants that are overlooked in routine clinical genetic testing. Outcomes of this study will improve our understanding of neurological disorders and provide a methodological pathway to rapidly detect the splicing variant defects."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011513"^"http://purl.org/au-research/grants/nhmrc/2011513"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Intraneuronal Immunotherapy to treat Alzheimerâs Disease,Ideas Grants"^"Dementia is the single greatest cause of disability in older Australians and the second leading cause of death. At present, dementia can only be managed through symptomatic treatment with limited therapeutic effects. Current immunotherapies for dementia are limited to the small amount of toxic protein accessible outside neurons. This project will develop new immunotherapeutics that clear problematic proteins inside neurons in order to halt and reverse the course of dementia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011540"^"http://purl.org/au-research/grants/nhmrc/2011540"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of multifaceted glucose-plus therapies - A focus on Hexosaminidase A (HEXA),Ideas Grants"^"Type 2 diabetes (T2D) is a cause of heart attacks, stroke, and kidney failure. Patients with T2D also commonly suffer from liver disease and increased blood lipids. We have recently identified Hexosaminidase A (HEXA) as a protein secreted by the liver that reduces high blood glucose levels and blood lipids, and improves insulin sensitivity and liver disease in diabetic mice. This project will investigate if HEXA is a useful therapeutic target for the treatment of metabolic disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011547"^"http://purl.org/au-research/grants/nhmrc/2011547"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Human pain genes as a window into pain mechanisms and modern pain management,Ideas Grants"^"Chronic pain affects ~20% of the adult population at any one time, most people will suffer from chronic pain at some stage in their lives, and available pain treatments do not help the majority of pain patients. In this project we use new genomic knowledge and techniques to gain basic insight into pain biology and develop new gene editing therapies to treat extreme untreatable chronic pain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011557"^"http://purl.org/au-research/grants/nhmrc/2011557"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A microRNA NanoChip Technology for Predicting Childhood Type 1 Diabetes Risk,Ideas Grants"^"Type 1 diabetes (T1D) involves destruction of insulin-producing cells. Current clinical tests, although useful to diagnose T1D, cannot accurately predict future T1D as they measure blood-based molecules that arise following the destruction of insulin producing cells. Through this study, we use a novel test (like a pregnancy test) that offers the capacity to measure a different class of blood-based molecules, which can help identifying T1D progression. Early detection can help prevent diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011558"^"http://purl.org/au-research/grants/nhmrc/2011558"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigation of novel immune pathways for improving cancer immunotherapy,Ideas Grants"^"The epithelium of the gastrointestinal tract separates our body from the intestinal content. Its barrier function is crucially promoted by immune cells named intraepithelial lymphocytes (IELs) that sense cellular stress and recognise microbial agents. We show that IELs play a critical role in preventing bowel cancer progression. We will discover new genes and molecular pathways that promote the anti-cancer functions of IELs, leading to discovery of novel drug targets to treat bowel cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011560"^"http://purl.org/au-research/grants/nhmrc/2011560"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Breast Cancer Dormancy - Mechanisms and Development of Rational New Therapies,Ideas Grants"^"Over 85% of breast cancer deaths are caused by the spread of the cancer cells to vital organs, leading to organ failure and death. Once these secondary tumours establish, our current therapies are not effective, at best, they delay the growth and further spread of the cancer. Tumour cells can lie dormant for up to 20 years before relapse. The aim of this project is to test novel therapies for their ability to kill these dormant tumour cells before they can grow into new tumours."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011584"^"http://purl.org/au-research/grants/nhmrc/2011584"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting necroptosis in the race to treat acute and chronic inflammation,Ideas Grants"^"Necroptosis, a form of programmed cell death, is an important weapon used by our bodies to prevent the spread of viruses, bacteria and even cancer. We have discovered that many populations have developed genetic changes that may enhance necroptosis and increase inflammation in the body. We propose that these changes are the key to understanding why only some people develop severe life threatening symptoms to infections, and the key to designing more effective therapies for inflammatory diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011590"^"http://purl.org/au-research/grants/nhmrc/2011590"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Glioblastoma - inhibition of P2X7R as a potential therapeutic target for treatment of this aggressive cancer.,Ideas Grants"^"Glioblastoma is a highly fatal human brain cancer generally affecting young adults, with survival time of only 12 months after diagnosis despite treatment. Our work is showing very promising results where inhibiting a particular cell membrane protein, P2X7R (with a particular drug AZ10606120) can significantly reduce tumour proliferation. AZ10606120 was better than the currently available chemotherapy, Temozolomide. This is very exciting and warrants urgent further study via this Ideas grant."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011592"^"http://purl.org/au-research/grants/nhmrc/2011592"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Normative reference ranges for brain phenotypes in psychiatry,Ideas Grants"^"Psychiatry is one of the few remaining fields in medicine where biological tests are seldom used to inform treatments and guide diagnoses. We aim to improve the utility of brain imaging in psychiatry through the development and provision of healthy reference ranges for measurements of brain structure extracted from a patient's MRI scan. This project charts a way forward towards personalised brain medicine in psychiatry."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011595"^"http://purl.org/au-research/grants/nhmrc/2011595"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Prolonging survival in glioblastoma through quiescence inhibition,Ideas Grants"^"Most people diagnosed with the brain cancer glioblastoma die within 15-months. The cancer is so deadly because it rapidly returns after therapy. Glioblastoma returns because of slowly dividing cancer stem cells that resist treatment. Our strategy is to eliminate these cells by forcing them to divide quickly during chemotherapy. This project will test targeted molecules in organoid and pre-clinical animal models of the disease to establish an evidence base for Phase 1 trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011627"^"http://purl.org/au-research/grants/nhmrc/2011627"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Single Cell Basis for the Emergence of Drug Resistance during Azacitidine Therapy in Myelodysplastic Syndromes and Acute Myeloid Leukemia,Ideas Grants"^"Myelodysplasia and acute myeloid leukemia are blood cancers that arise in abnormal blood stem cells in the bone marrow. Azacitidine (AZA) is a drug that helps re-establish blood cell production in ~50% of patients. It is ineffective in the remainder. We will test whether AZA works in responders by improving the fitness of abnormal blood stem cells and their surrounding cells and modulating immune cells that help eliminate abnormal blood cells. This will guide drug discovery for non-responders."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011633"^"http://purl.org/au-research/grants/nhmrc/2011633"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel pathways to abstinence from alcohol seeking,Ideas Grants"^"Relapse to drinking after a period of treatment remains a fundamental problem for sufferers of alcohol-use disorders. This project uses a suite of state of the art technologies in a well validated pre-clinical animal model to identify how the brain gates this propensity to relapse. It will provide critical new knowledge on which cells in which brain circuits to target as well as when to target them in order to prevent relapse and promote abstinence from drinking."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011634"^"http://purl.org/au-research/grants/nhmrc/2011634"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding Brain Cleaning in Obstructive Sleep Apnoea,Ideas Grants"^"During deep sleep, blood pressure falls and the brain rests. Production of toxic waste also slows while its removal increases. This brain cleaning process during sleep is thought to be crucial for preventing dementia. Obstructive Sleep Apnoea (OSA) is a common condition characterised by marked sleep and blood pressure disturbances. People with OSA have an increased risk for dementia. This study aims to investigate how sleep and blood pressure disturbances affect brain cleaning in people with OSA"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011728"^"http://purl.org/au-research/grants/nhmrc/2011728"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting metastatic triple-negative breast cancer with a selective oncogenic JNK inhibitor,Ideas Grants"^"While JNK is a potent oncogene in TNBC, there are no effective JNK-targeting therapies due to the fact that this signalling pathway regulates numerous cellular functions. Leveraging a recent screen of 114,000 compounds, we have identified a novel molecule, called K12, that specifically inhibits the tumour promoting activity of JNK. Now, we will further the preclinical evaluation of K12, to generate a world-first drug capable of preventing metastatic outgrowth in TNBC"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011730"^"http://purl.org/au-research/grants/nhmrc/2011730"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the pipeline for translation of therapies for serious complications of pregnancy,Ideas Grants"^"Preeclampsia and fetal growth restriction are deadly complications of pregnancy, without current therapies for either. Development of treatments is seriously limited, pregnant women are excluded from drug trials, due to concerns for both mother and baby. We have developed a dedicated pipeline for drug discovery for pregnancy; we will thoroughly test promising drug candidates and advanced delivery strategies. This proposal paves the way for much needed development of therapies for pregnant women."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011733"^"http://purl.org/au-research/grants/nhmrc/2011733"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The effects of early exposure to bushfires on adult brain structure and function,Ideas Grants"^"The effects of bushfire smoke inhalation on brain structure and function remain unknown. We will conduct the first systematic study of this issue, based on a cohort of monkeys born during the 2019-2020 bushfire season. The effects of pre- and post-natal bushfire exposure will be investigated in adult brain, using functional and structural MRI, cognitive tests, and neuropathological examination. This project will gain vital scientific data that may help guide future government action."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011747"^"http://purl.org/au-research/grants/nhmrc/2011747"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enabling early ovarian cancer diagnosis and prediction of platinum resistance,Ideas Grants"^"Ovarian cancer often gets diagnosed late, and at that stage survival outcomes are poor. Here, we propose to use a simple drop of blood, to detect combinations of proteins and changes in genetic material originating from cancer and immune cells, to support earlier, more accurate diagnosis and predict platinum resistance to avoid delay of personalised treatment. We also develop easy-to-use, low-cost Lab-on-a Chip devices to enable routine testing and monitoring at the point-of-care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011753"^"http://purl.org/au-research/grants/nhmrc/2011753"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Infiltrating central command to selectively alter autonomic function,Ideas Grants"^"The brain controls blood pressure and other internal organ functions that are necessary for life. In disease, this control does not work properly. This can be the cause of diseases like hypertension, but it also seems to happen in neurological conditions. It is not known why. Using a genetically modified virus that we made, we hope to find out exactly which neurons control organ function and then modify their activity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011761"^"http://purl.org/au-research/grants/nhmrc/2011761"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel regulator of interferon signalling,Ideas Grants"^"We have identified a new role for a protein called ARAP2 in regulating the immune response to infection. We have generated unique experimental models and have access to immune cells from 25 patients carrying ARAP2 mutations which will enable us to understand the role of ARAP2 in infectious diseases such as TB or Covid-19. This project offers the potential to identify and treat individuals at high risk of life-threatening infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011763"^"http://purl.org/au-research/grants/nhmrc/2011763"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing a novel immune check point for cancer killing,Ideas Grants"^"The Project Team aims to test the idea that a patients T cells can be âtunedâ to increase the ability of their own immune system to find, infiltrate, and kill pancreatic cancer cells.This may be beneficial as a stand alone therapy or most likely, work in synergy with emerging immune therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011767"^"http://purl.org/au-research/grants/nhmrc/2011767"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Rewriting the dogma of chromatin compaction: a new pathway for polycomb-mediated gene repression in development and disease,Ideas Grants"^"Polycomb repressive complexes are enzymatic complexes that safeguard the genome by preventing repressed genes from becoming active. The proposed study aimed at identifying how different types of polycomb repressive complexes work together to maintain genes in a compacted state that prevent their expression. The project aims to determine the cascade of molecular events that lead to chromatin compaction and to visualize this process in high resolution."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011768"^"http://purl.org/au-research/grants/nhmrc/2011768"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding and Treating Videogame Addiction in Young People,Ideas Grants"^"Excessive videogame play is causing harm to individuals and conflict among families. In the most severe cases players develop Internet Gaming Disorder. We will identify the factors that lead to addiction and based on this we will work with videogame players to design an intervention that will help people overcome IGD. The intervention will be based in software that videogame players are already using. We will evaluate the intervention and translate the knowledge we gain for use by others."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011770"^"http://purl.org/au-research/grants/nhmrc/2011770"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Upending the platelet paradigm: Targeting actin-driven membrane budding to modulate platelet production in health and disease,Ideas Grants"^"Platelets are the cells in the blood responsible for blood clotting and also contribute to wound healing and fighting infection. In a world first, we discovered how the body produces platelets, overturning a 100-year-old dogma. We will capitalise on our breakthrough to understand the diseases of platelet production, develop new therapies to control platelet levels, and generate new knowledge to overcome scalability problems preventing laboratory-based production of platelets for clinical use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011806"^"http://purl.org/au-research/grants/nhmrc/2011806"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming genomic surveillance of foodborne Salmonella infections with SalmonellaTracker: a standardised, high resolution and scalable platform,Ideas Grants"^"Salmonella infections are a major health burden with over 50,000 cases each year in Australia. Control of this disease requires rapid and accurate strain typing and tracking. In this project we will develop tools for national and international Salmonella genomic surveillance. These tools will facilitate the tracking, control and characterisation of Salmonella in both the human population and in the food production chain, reducing their global health burden."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011845"^"http://purl.org/au-research/grants/nhmrc/2011845"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A paradigm shift in lactational mastitis,Ideas Grants"^"Lactation mastitis is a debilitating inflammatory breast disease occurring in 1 in 5 Australian breastfeeding women. The disease causes lactation insufficiency, localised pain and rapid onset of fever, muscle aches, chills and fatigue, leading many women to use supplementary formula or cease breastfeeding altogether. This project will address key gaps in our understanding of the biological causes of mastitis and lead to improved prevention and treatment of this disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011853"^"http://purl.org/au-research/grants/nhmrc/2011853"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Illumination of Immune Checkpoint Therapy of Cancer: Molecular Imaging of Immunity with Copper Radiopharmaceuticals,Ideas Grants"^"Exciting developments in the treatment of cancer have involved developing ways to reinvigorate a patientâs own immune system to attack their disease. This type of therapy, called immune checkpoint therapy, produces remarkable outcomes for some patients but some do not respond. This research will develop the chemistry required to produce imaging agents to enable clinicians to identify patients suitable for immune checkpoint therapies using non-invasive Positron Emission Tomography (PET) imaging."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011883"^"http://purl.org/au-research/grants/nhmrc/2011883"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Creating Health in a New Home: A transformative approach to building evidence for refugee health across generations,Ideas Grants"^"Refugees experience serious health issues on arrival that demand specialised services. Little is known about refugee health after settlement and over generations and if tailored healthcare is needed. This study will deliver new evidence to plan appropriate cost-effective health services and programs. A roadmap will be designed with refugees to achieve health and evaluate outcomes. This innovative approach will empower refugees, placing them at the centre of their health decision making."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011912"^"http://purl.org/au-research/grants/nhmrc/2011912"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Communication training for mental health professionals: developing cultural sensitivity and capability to improve Aboriginal and Torres Strait Islander people mental health outcomes,Ideas Grants"^"This interventional study will be led by Indigenous researchers and mental health professionals and engage with Indigenous consumers, communities, services providers and policy makers to co-design, deliver and evaluate a communication training package for non-Indigenous mental health professionals. The goal is to improve health outcomes for Indigenous patients and build an accountable, more knowledgeable and culturally sensitive mental health workforce."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011940"^"http://purl.org/au-research/grants/nhmrc/2011940"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"CHIARI MALFORMATION: DEFINING PATHOPHYSIOLOGY AND TREATMENT GOALS,Ideas Grants"^"Chiari I malformation is a complex neurological disorder that has a significant impact on a patientâs quality of life. We do not understand what causes many of the symptoms (debilitating headache &amp;amp; cognitive deficits) and complications (spinal cysts). Indications for surgery and surgical goals are also controversial. This project addresses these knowledge gaps using integrated human studies and machine learning and is expected to develop imaging guidelines for surgical indications and success."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011953"^"http://purl.org/au-research/grants/nhmrc/2011953"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a novel glucose lowering medication targeting mTORC1 in osteoblasts.,Ideas Grants"^"New medications to lower blood sugar levels are desperately needed to help treat the many millions of people at risk of developing chronic diseases associated with obesity and Type 2 diabetes (T2DM). Our group has identified a new drug target in bone forming cells. This target becomes over-activated in obesity and decreases the ability of insulin to stimulate sugar uptake. In this proposal, we will develop a novel inhibitor and test the inhibitor in a model system of diet-induced T2DM."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011958"^"http://purl.org/au-research/grants/nhmrc/2011958"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New insights for reducing Aboriginal stillbirth: Community-led, integrated evidence for change,Ideas Grants"^"This project will work in partnership with Aboriginal Elders, communities and service providers to undertake the first large-scale examination of stillbirth among Aboriginal peoples. It aims to enhance our understanding of the risks to Aboriginal stillbirth, explore Aboriginal community knowledge and awareness of stillbirth risks, and progress Aboriginal-specific intervention strategies to support stillbirth education and awareness."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011959"^"http://purl.org/au-research/grants/nhmrc/2011959"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A FRET-based protein sensor for RNA detection, localisation and analysis,Ideas Grants"^"The ability to detect specific RNA molecules is a key aspect of diagnosis and pathogenesis of a variety of diseases. Recent developments from synthetic biology have provided us with robust designer RNA-binding proteins which can be used as sophisticated tools for detecting specific RNA molecules to understand the molecular basis of numerous diseases. Applying cutting edge âsingle-moleculeâ techniques to prototype molecules we will develop these tools for application as RNA detecting biosensors."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011963"^"http://purl.org/au-research/grants/nhmrc/2011963"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving therapeutic delivery of RNA,Ideas Grants"^"RNA based therapies show tremendous promise for treating many important diseases, however an effective method of delivering these drugs to the correct compartment of cells has not yet been discovered. This project will investigate the barriers existing at the cellular level that hinder RNA delivery. This knowledge will be used to engineer nanoparticles to help translate RNA technologies from the laboratory into the clinic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011969"^"http://purl.org/au-research/grants/nhmrc/2011969"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Modelling polycystic kidney disease in vitro,Ideas Grants"^"Autosomal Recessive Polycystic Kidney Disease (ARPKD) causes kidney and liver failure in babies and children. One quarter of babies born with ARPKD will not survive after birth. We have recently developed a method to recreate human kidney tissue from stem cells. We will generate stem cells using patient blood samples and use these to make a model of the patientâs ARPKD disease in the laboratory. We will use these patient models to screen for new, personalised treatments for patients with ARPKD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011978"^"http://purl.org/au-research/grants/nhmrc/2011978"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Î±1-adrenoceptor protein structures and selective tools: towards novel treatments for heart failure and Alzheimerâs disease,Ideas Grants"^"Heart failure and dementia are the top and fifth leading disease burdens in Australia respectively, highlighting the urgent need to identify new ways to treat and relieve the symptoms of these devastating diseases. Adrenaline receptors in our body called a1-adrenoceptors, have been implicated as playing an important role in heart failure and Alzheimerâs disease, but no suitable drugs exist to explore this further. This project will develop such tools using innovative approaches."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011990"^"http://purl.org/au-research/grants/nhmrc/2011990"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pathogenic membranes as therapeutic drug targets,Ideas Grants"^"Resistance of pathogens to drugs continues to emerge and intensify. While host defence peptides (HDPs) are a promising alternative to current drugs, many pathogens have also evolved resistance mechanisms through changes in their cell membrane. This application will apply a range of analytical tools to understand how bacteria change their cell walls in response to HDPs. The results will allow us to design new combination therapies to treat pathogenic infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012006"^"http://purl.org/au-research/grants/nhmrc/2012006"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Characterising the unique functional and pathological properties of a novel extracellular RNA binding protein in Amyotrophic Lateral Sclerosis,Ideas Grants"^"'FUS' is an important protein that causes aggressive, juvenile types of motor neuron disease (MND). FUS is also implicated in the most common sporadic forms of MND (90% of cases), but the mechanisms involved are unclear. We have found a new form of FUS that is unique because it exists outside the cell, unlike all other MND proteins. Importantly we have found that in MND patients this protein is abnormal. Here we will examine its normal function outside the cell and its role in MND."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012013"^"http://purl.org/au-research/grants/nhmrc/2012013"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the safety and efficacy of chimeric antigen receptor (CAR)-T cell therapies,Ideas Grants"^"Immunotherapy is the âfourth pillarâ of cancer treatment, alongside surgery, radiation and chemotherapy. We are investigating the manipulation of human immune cells to generate new and improved cancer treatments that âtrainâ a patientâs own immune cells to kill tumours. Preliminary results show potential for improved efficacy and patient safety compared to current immunotherapies. This grant will support further development of suitable âtrainedâ cells for potential use in human clinical trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012029"^"http://purl.org/au-research/grants/nhmrc/2012029"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying brain pathways regulating sympathetic nervous outflow in human hypertension,Ideas Grants"^"Hypertension is characterised by an increase in the activity of the sympathetic nerves. We will use magnetoencephalography, which records the magnetic field generated by brain neurones, coupled with simultaneous direct nerve recording to reveal which neurones in the brain are responsible for the generation of excess nervous activity in individuals with hypertension."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012051"^"http://purl.org/au-research/grants/nhmrc/2012051"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a diagnostic platform for preventative wound management,Ideas Grants"^"Early diagnosis, accurate evaluation, and appropriate wound management are vital to prevent the progression of a diabetic foot ulcer to the stage where amputation is required. Currently there are no effective biochemical tools to predict whether a patient will develop a chronic wound. We aim to develop a simple blood-based diagnostic/prognostic device that will provide an early indication of wound risk for people living with diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012072"^"http://purl.org/au-research/grants/nhmrc/2012072"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"3D Nuclear Re-organisation Potentiates Genomic Structural Variations in Prostate Cancer,Ideas Grants"^"When the cell divides not only does the DNA (genome) need to be replicated but so do the chemical modifications on top of the DNA called the âepigenomeâ. Here we ask how the genome and epigenome talk to each other during cell division and how this can go wrong in cancer. We will demonstrate that progressive alterations to our epigenome when the cell divides result in an increased risk of DNA rearrangements and the development of cancer. Our results will open new approaches for cancer strategies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012074"^"http://purl.org/au-research/grants/nhmrc/2012074"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The ADEPT study: Adaptive Diagnostics for Emerging Pandemic Threats in regional Australia,Ideas Grants"^"This project will develop regional diagnostic tests for serious infections, using technical advances made against COVID-19. We will apply these rapid, simple to operate technologies in regional Western Australia. This project will involve regional indigenous communities to reduce the physical, mental and cultural harm done when people are shipped out of country to run diagnostic tests for conditions that could be treated with confidence locally when an early, specific diagnosis is available."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012119"^"http://purl.org/au-research/grants/nhmrc/2012119"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the biology of adipose tissue regulatory T cells to treat metabolic disease,Ideas Grants"^"Our lab has identified a unique population of immune cell found in abdominal fat (Tregs) that functions to regulate glucose metabolism and are anti-inflammatory. In this proposal we aim to characterize the genes and signals found in fat that influence the function of these cells and understand how these signals differ between sexes. We also aim to understand how Tregs communicate with other cells found in fat, which will help us formulate new therapies for obesity and metabolic diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012140"^"http://purl.org/au-research/grants/nhmrc/2012140"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Myelin: wrapping up neural circuit function and behaviour,Ideas Grants"^"Almost half of all Australians aged 16-85 will experience mental illness in their life, yet we do not understand the underlying biological processes that contribute to mental ill health. This project aims to show how brain insulation adapts to and regulates brain function and learn how inappropriate insulation could underpin symptoms of mental health disorders."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012142"^"http://purl.org/au-research/grants/nhmrc/2012142"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Type 2 diabetes relief by UPR-mediated beta cell protection,Ideas Grants"^"Type 2 diabetes (T2D) is caused by insulin deficiency, with obesity a strong risk factor. However, only a small fraction of obese individuals develops T2D. Usually the pancreatic Ã-cells increase insulin release. This proposal will test the novel hypothesis that an adaptive response to stress helps Ã-cells increase insulin release and protect against T2D by preventing the conversion of Ã-cells to other pancreatic cell types. The studies are important for the development of novel therapy for T2D."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012166"^"http://purl.org/au-research/grants/nhmrc/2012166"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enhancers as a new target for diagnosing disorders of sex development.,Ideas Grants"^"Most human DNA is made up of regions that do not contain genes but instead carry important regulators that increase or decrease gene activity. Those that increase gene activity are called enhancers. This project aims to identify enhancers of genes that control testis or ovary development. We will determine whether disruption of these enhancers leads to a baby being born with a Disorder of Sex Development to improve diagnosis and clinical management of these patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012196"^"http://purl.org/au-research/grants/nhmrc/2012196"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel genetic barcoding approach to identify the vulnerabilities of lethal breast cancer clones,Ideas Grants"^"Metastasis is the primary cause of mortality for patients with breast cancer. There is an urgent need to better understand how breast cancer cells spread and resist standard therapy, to ?nd more effective ways to treat patients with metastatic disease. Our project aims at tracking the fate of thousands of human tumour cells during cancer progression to identify the genetic mechanisms responsible for the recurrence of the disease in vital organs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012211"^"http://purl.org/au-research/grants/nhmrc/2012211"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"On-Demand, Nanoparticle-Based Analgesia for Musculoskeletal Pain,Ideas Grants"^"Chronic pain associated with musculoskeletal disease causes a major burden on individuals and health care systems. In this study, we will assay changes in whole-animal pain behavior, and pain signaling, in response to therapeutic delivery of designer nanoparticles in models of osteoarthritis and bone cancer pain. This project is exciting because it will provide proof-of-principle for the use of nanoparticles for on-demand, site-specific analgesia for osteoarthritis and bone cancer pain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012225"^"http://purl.org/au-research/grants/nhmrc/2012225"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Uncovering the pathway between gluten immunity and adverse symptoms in coeliac disease and gluten sensitivity to define novel treatments and symptom biomarkers,Ideas Grants"^"Coeliac disease and gluten sensitivity are common illnesses in Australia often associated with unpleasant symptoms after gluten is consumed. Symptoms in some patients can be severe and impair quality of life. How gluten causes this is poorly understood. This study aims to understand the pathways that are important in the development of symptoms, the true triggers, and how gluten immunity is involved. This will enable targeted treatments to manage symptoms improving patient health and well-being."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012233"^"http://purl.org/au-research/grants/nhmrc/2012233"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Safeguarding health in International Investment Agreements,Ideas Grants"^"The âpost COVID-19 worldâ will require striking a balance between economic recovery and protection of population health. It is essential that International Investment Agreements (IIAs) do not undermine comprehensive and effective health regulation. This project will generate new evidence on 'best practice' health safeguards in IIAs, to prevent challenge to public health policy, and provide resources for the health and investment policy sectors to increase inclusion of strong health safeguards."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012250"^"http://purl.org/au-research/grants/nhmrc/2012250"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"USING HUMAN EMBRYONIC TESTIS ORGANOIDS TO MODEL REPRODUCTIVE DISORDERS,Ideas Grants"^"Some babies are born with atypical reproductive organs meaning the sex of the baby is not clear. If the cause is unknown, doctors can be left guessing as to the best treatment. We have recently created a âhuman embryonic testis in a dishâ model from stem cells. Here we will optimise its use to study genetic and environmental causes of reproductive disorders. Our findings will empower families and doctors to choose the right clinical care for these children, improving their health and wellbeing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012257"^"http://purl.org/au-research/grants/nhmrc/2012257"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Phase-Contrast Neuroimaging for Early Detection of Brain Injury at Birth,Ideas Grants"^"Early detection of brain injury that can occur before, during and around the time of birth is critical for the prevention of lifelong intellectual and physical disabilities. However, current imaging techniques are not able to resolve these types of injuries whilst preventative actions can still be taken. We aim to develop novel imaging technologies that will enable subtle brain injuries to be detected early and accurately in order to improve lifelong outcomes for many infants."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012263"^"http://purl.org/au-research/grants/nhmrc/2012263"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"TARGETING COLD TUMOURS WITH TRIPLE THERAPY,Ideas Grants"^"Patients with advanced metastatic disease have a very poor clinical outcome and are the main group of patients with an unmet clinical need. We know that very advanced cancers are resistant to the patient's immune system, and immune based therapies. In my program I will address these issues by (1) revealing how the patient's cancer avoids the immune system (2) create new types of T cells which will be resistant to the tumour immune evasion mechanisms (3) translate my findings into the clinic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012271"^"http://purl.org/au-research/grants/nhmrc/2012271"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A molecular and biophysical characterisation of host cell contribution to invasion by the Apicomplexan parasites,Ideas Grants"^"Disease causing Apicomplexan parasites, such as those causing malaria or cryptosporidiosis, must overcome the membrane barrier to infect their host cells. We have developed a novel 4D microscopy method to determine how these human pathogens penetrate the host membrane and how the host cell contributes to this process. Identifying which key factors are essential will improve current treatment strategies and give rise to a novel class of host directed therapies against this group of pathogens."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012273"^"http://purl.org/au-research/grants/nhmrc/2012273"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Adrenal-Targeted Nanobiotechnology: A Novel Therapy for Adrenal Disease,Ideas Grants"^"The adrenal gland produces hormones essential for life-long health. Conditions related to the disruption of these hormones affect 4 million Australians annually, at a cost of $2 Billion. Adrenal conditions require life-long drug replacement therapy, with no possibility of a cure. Through the use of a new adrenal specific delivery technology, we aim to develop novel drug treatments and single-injection cures for adrenal disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012285"^"http://purl.org/au-research/grants/nhmrc/2012285"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Eliminating hepatitis B in remote Indigenous settings: generating health economic evidence,Ideas Grants"^"Chronic infection with hepatitis B (CHB), which can cause liver disease including liver cancer, is common across NT Indigenous communities. Many people are unaware they have CHB and few engage in care. To address this, the NHMRC funded the HEP B PAST Project (2017) which aims to eliminate CHB from NT Indigenous communities. Results show a highly effective model of care. This new project will generate health economic evidence that is required to embed the HEP B PAST model into standard practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012286"^"http://purl.org/au-research/grants/nhmrc/2012286"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the establishment and persistence of community associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in resource-limited, high-burden settings: How can we reduce the burden of disease?,Ideas Grants"^"Methicillin resistant Staphylococcus aureus (MRSA) strain ST93 is a potentially dangerous pathogen of particular concern in resource-limited settings. Our research team has recently identified the highlands of Papua New Guinea as a hotspot for MRSA ST93 bone infections. Through this study we will determine the factors that enable the spread and persistence of ST93 in these settings and identify interventions to reduce the impact of ST93 in resource-limited communities."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012287"^"http://purl.org/au-research/grants/nhmrc/2012287"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using Cerebrospinal Fluid Liquid Biopsy for Detection of Mosaic Brain Mutations,Ideas Grants"^"Seizures can occur in patients with or without abnormalities in their brain. We have collected spinal fluid from a subset of these patients and we will use this precious resource to determine the contribution of genetic defects to the development of their seizures. The overall contribution of different types of genetic defects to seizures is not completely understood and this knowledge will improve outcomes for patients by ending their diagnostic odyssey and promoting new therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012290"^"http://purl.org/au-research/grants/nhmrc/2012290"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The mesenchymal stromal cell paradox â living cell therapy or dying therapeutic cell?,Ideas Grants"^"Mesenchymal stromal cells (MSCs) can dampen inflammation and aid tissue repair, but efforts to improve their clinical utility are hampered by our poor understanding of how they work. We have found that the therapeutic effects of MSCs depend on their cell death, which triggers immune suppression. Instead of focussing on viable MSCs, we will investigate how dying MSCs modify immune responses. Our discoveries will enable more effective cell therapies for a wide range of diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012301"^"http://purl.org/au-research/grants/nhmrc/2012301"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting the brain and sympathetic nervous system to improve outcomes in cancer cachexia,Ideas Grants"^"Cancer cachexia is the wasting of fat and muscle that occurs in late stages of a number of cancers. It is particularly prevalent in pancreatic cancer. One of the known causes for this wasting is increased activity of the sympathetic nervous system (SNS), also responsible for the 'fight or flight' response to danger. The SNS is under control of the brain, and this project will look at specific brain cells as therapeutic targets for treating cachexia in a mouse model of pancreatic cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012313"^"http://purl.org/au-research/grants/nhmrc/2012313"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating the role of cellular metabolism in regulating antigen presentation and tumour immune escape,Ideas Grants"^"In order to develop and progress, tumours must avoid elimination by the immune system. Understanding the mechanisms that allow tumours to evade the immune system is critical for developing strategies to overcome immune escape and enhance the efficacy of currently existing immunotherapies. This research will investigate the fundamental mechanisms by which aberrant cell metabolism contributes to immune evasion in cancer and identify strategies to restore tumour elimination by the immune system."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012330"^"http://purl.org/au-research/grants/nhmrc/2012330"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enabling next generation radiotherapy for cancer: Development of novel Quality Assurance instrumentation for Proton Therapy,Ideas Grants"^"Proton Therapy is a new form of radiotherapy that has many benefits over conventional radiotherapy and is particularly useful for childhood cancers. To maximise the benefits of proton therapy, we need to develop instruments called microdosimeters to accurately measure the physical and biological dose of radiation received by the patient. Our research will develop and test a novel microdosimeter for proton therapy to coincide with the opening of the new Australian Bragg Centre for Proton Therapy"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012342"^"http://purl.org/au-research/grants/nhmrc/2012342"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Does Chlamydia infection damage the ovary and compromise fertility?,Ideas Grants"^"The ability of Chlamydia to infect and damage the ovary has never been investigated. We will determine exactly how Chlamydia infects and damages ovarian tissues by studying aspects of ovarian function including hormone production, egg health, and fertility in our unique mouse model, and a cohort of human samples. We will also assess whether antibiotics, and our newly developed Chlamydia vaccine, can protect against ovary damage."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012351"^"http://purl.org/au-research/grants/nhmrc/2012351"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Exploring the therapeutic potential of genetically engineering macrophages with a Chimeric Signaling Switch Receptor in kidney diseases,Ideas Grants"^"Kidney diseases are a major cause of death and morbidity worldwide. Current treatments to delay progression of kidney diseases are few and largely ineffective, so that new therapies are urgently needed. We have recently developed an innovative approach to genetically engineer immune cells (macrophages) to treat kidney diseases. This study will determine the effectiveness of this new cell therapy in kidney disease models and whether it can be used to treat human kidney diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012362"^"http://purl.org/au-research/grants/nhmrc/2012362"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IS THE EVOLUTIONARY LOSS OF ACTN3 DETRIMENTAL IN MODERN SOCIETY?,Ideas Grants"^"Do you feel the cold or are you happiest in the depths of winter? A common null polymorphism in the skeletal muscle gene ACTN3 (R577X) has been described as a key gene during modern evolution due to its ability to improve muscle function and metabolism following cold exposure. We will explore the impacts of this gene further in modern humans by studying muscles from healthy and obese ACTN3 R577X mice and humans to determine how our ACTN3 genotype influences life in todays modern society."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012370"^"http://purl.org/au-research/grants/nhmrc/2012370"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development and mechanistic analysis of novel inhibitors of the dengue virus NS1 protein,Ideas Grants"^"Mosquito-borne flaviviruses such as dengue virus (DENV) cause significant morbidity and mortality in tropical and sub-tropical areas worldwide. The DENV NS1 protein is critical to multiple aspects of the viral life cycle and DENV pathogenesis, making it an appealing target of future antiviral therapies. In this project we will apply a rational multi-disciplinary approach to identify and mechanistically characterise unique NS1-targeting antiviral drugs and future NS1-related drug targets."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012371"^"http://purl.org/au-research/grants/nhmrc/2012371"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting dysregulated transcription in cancer through Cyclin-Dependent-Kinase 11,Ideas Grants"^"Many proteins cooperate to carefully control which genes are âonâ or âoffâ in our cells. Defects in gene control that cause cells to grow faster and to live longer than normal give rise to cancer. I will investigate the activity of a group of proteins called Cyclin-dependent-kinases (CDKs), that are essential for ensuring proper gene control and are essential for cancer cells to survive. This will allow us to design better strategies to block the activity of CDKs to kill cancer cells."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012373"^"http://purl.org/au-research/grants/nhmrc/2012373"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Determining the role of Target of Rapamycin Complex 2 (TORC2) in cancer cell proliferation,Ideas Grants"^"In normal cells, proliferation depends on the availability of nutrients. Tumour cells are usually ânutritionally stressedâ but survive despite this. This project aims to study the cellâs nutrient sensor â TOR Complex 2 â in order to elucidate how it facilitates cell division under nutrient stress. Better understanding of TORC2 signalling will improve future treatment strategies for patients with solid tumours."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012382"^"http://purl.org/au-research/grants/nhmrc/2012382"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Achieving benefit without harm: a next-generation glucocorticoid replacement,Ideas Grants"^"Over 2% of the worldâs population takes long-term steroid therapy to control unwanted immune system activity, despite the predictable, harmful side effects of steroids. A natural anti-inflammatory protein, GILZ, is increased as a result of steroid treatment, which is an important way that steroids work. Our studies will lead to a strategy to develop a drug that increases GILZ without the use of steroids, bringing about the protective effects of steroids without the harmful side effects."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012393"^"http://purl.org/au-research/grants/nhmrc/2012393"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The contribution of the gut to bipolar disorder,Ideas Grants"^"Bipolar disorder is a severe mental illness affecting many Australians. We provide evidence that specific gut cells may trigger the mood fluctuations that are central in bipolar disorders. Activation of these cells can alter brain activity via a pathway called the gut brain axis. This project will focus on understanding how serotonin release from these cells affects brain function in bipolar disorder and how we can target these cells to create new treatments for this disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012404"^"http://purl.org/au-research/grants/nhmrc/2012404"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Removing mosquito populations by releasing incompatible males: a species specific biocontrol for urban arbovirus vectors,Ideas Grants"^"Two mosquitoes, Aedes aegypti and Aedes albopictus, drive the global expansion of arboviruses such as dengue and Zika; both threaten Australia. With no effective vaccines and extensive insecticide resistance, new mosquito control tools are vital. By releasing reproductively incompatible males (males donât bite), we have successfully reduced aegypti populations in some Queensland towns by over 80% . We will now develop this technology into an efficient deployable product for Australia and beyond."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012418"^"http://purl.org/au-research/grants/nhmrc/2012418"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Applying reverse translation to the parkrun phenomenon to identify effective, sustainable methods for scaling-up public health interventions,Ideas Grants"^"parkrun is a free, weekly organised grass-roots mass physical activity event, which has spread across 23 countries with over six million registrants. It has succeeded where most researcher and government-led physical activity interventions have failed in terms of high participation, accessibility and sustainability. Our proposal analyses how parkrun has disseminated and been sustained throughout Australia and will derive models and principles to inform future public health interventions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012427"^"http://purl.org/au-research/grants/nhmrc/2012427"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Studying the persisting glial dysfunction occurring after preterm brain injury to uncover new therapeutic targets,Ideas Grants"^"We cannot treat brain damage in prematurely born babies despite it often leading to permanent brain injury and disability. Cells called glia are vital for building the brain and keeping it healthy. After early-life brain injury, we are learning that glia cannot perform these tasks as they should for many months. In this project, we will test if helping glia 'get back to workâ in the weeks or months after injury might be a way to repair the damaging effects of preterm birth."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012443"^"http://purl.org/au-research/grants/nhmrc/2012443"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving respiratory support for preterm infants at birth,Ideas Grants"^"In Australia, 92% of babies born very preterm need help to breathe at birth, which can injure their lungs and brains. While providing respiratory support with a face mask is the gentlest approach, it often fails because the babyâs vocal cords reflexly close if they stop breathing, which prevents air from entering their lungs. Our research focuses on helping these babies breathe at birth to improve the success of providing gentle respiratory support."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012453"^"http://purl.org/au-research/grants/nhmrc/2012453"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Communication via epigenetic mechanisms: cell cross-talk and male fertility,Ideas Grants"^"Male infertility is on the rise in Western society but the processes that drive sperm production are still poorly understood. We discovered a new epigenetics-based process that involves the transfer of important information between different cell types in the testis that is critical for the production of viable sperm. We aim to uncover the molecular mechanism of this process, which will provide new insights into the causes of male infertility."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012454"^"http://purl.org/au-research/grants/nhmrc/2012454"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Engineering chimeric antigen receptor (CAR) T cells that induce host anti-tumour immunity,Ideas Grants"^"This project will further enhance the therapeutic application of a gene-engineering based immune therapy involving a patients' own cells. To date this form of therapy has been effective in blood cancers but not solid tumours. We will aim to overcome this by developing technological and scientific advances which will make the immune cells more effective against solid tumours. These findings have the potential to provide treatment options for late stage solid tumour cancer patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012463"^"http://purl.org/au-research/grants/nhmrc/2012463"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigation of the structure of the influenza A virus genome and how it directs reassortment to generate novel strains,Ideas Grants"^"Pandemic influenza viruses acquire new properties through the swapping of gene segments known as reassortment. We will investigate the structure of the influenza A virus genome to dissect the molecular mechanism that enables specific genes to interact and be co-selected during reassortment. Our work will provide key insights into the probability of viruses with particular gene constellations emerging in the future, that will greatly benefit pandemic assessment and planning."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012471"^"http://purl.org/au-research/grants/nhmrc/2012471"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Eliminating HIV-infected macrophages; a neglected problem in HIV cure research,Ideas Grants"^"HIV cannot currently be cured due to the persistence of âsilentâ sources of HIV hidden within certain cells which are not sensitive to anti-HIV drugs. One type of immune cell that HIV hides in are called macrophages, and these cells are very hard for the immune system to destroy. We will study HIV infection in macrophages and identify ways to âwake upâ silent HIV in these cells and weaken them so that they can be eliminated from the body."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012474"^"http://purl.org/au-research/grants/nhmrc/2012474"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Opening the pathway to large data-driven patient-specific diagnostics using novel coronary angiogram analysis,Ideas Grants"^"This work will reform the medical practice of risk assessment for coronary artery disease and acute coronary artery syndrome by delivering the next generation of rapid, patient-specific, and high accuracy medical image-based risk assessment. Using innovative state-of-the-art engineering methods, including machine learning, large-scale computational modelling and image analysis, we will reveal new markers of cardiovascular risk in individuals for improved standard clinical care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012475"^"http://purl.org/au-research/grants/nhmrc/2012475"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"CRISPR Engineering of CAR T Cells to Enhance Efficacy in Solid Tumours,Ideas Grants"^"This project will further enhance the therapeutic application of a gene-engineering based immune therapy involving a patients' own cells. To date this form of therapy has been effective in blood cancers but not solid tumours. We will aim to overcome this by developing technological and scientific advances which will make the immune cells more effective against solid tumours. These findings have the potential to provide treatment options for late stage solid tumour cancer patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012498"^"http://purl.org/au-research/grants/nhmrc/2012498"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pursuing IRF4 as a therapeutic opportunity for lymphoid malignancies,Ideas Grants"^"The molecule IRF4 is essential to the function of the immune system. In this application we investigate mouse models with mutations in IRF4 that are identical to those found in patients with cancers of the immune system. We will investigate how these mutations affect binding of IRF4 to the DNA and how changes in the IRF4-DNA binding domain lead to formation of tumours and how this interaction can be targeted therapeutically."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012500"^"http://purl.org/au-research/grants/nhmrc/2012500"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mosquito-specific viruses: novel agents to control the transmission of arboviral pathogens,Ideas Grants"^"Insect-specific viruses are benign viruses that infect only insects and are transmitted from the insect to their offspring. We and others have shown that infection of mosquitoes with these benign viruses can inhibit infection of these mosquitoes by other viruses that cause human disease. In this grant, we plan to produce one or more strains of mosquitoes harboring these benign viruses for use in biological control programs against mosquito-borne diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012505"^"http://purl.org/au-research/grants/nhmrc/2012505"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using population-based data to improve maternal asthma management and offspring health and development,Ideas Grants"^"Asthma affects more than 30,000 Australian pregnancies each year and has been associated with a range of adverse pregnancy outcomes. This project will utilise population-based data to examine the effects of maternal asthma, as well as the use of individual asthma treatments during pregnancy, on child health and development from birth to 14-years of age and will provide direct evidence to support improvements in policy and practice related to optimising asthma management during pregnancy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012513"^"http://purl.org/au-research/grants/nhmrc/2012513"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the Diagnosis of Barrettâs Oesophagus with Dysplasia,Ideas Grants"^"Some patients with Barrettâs oesophagus are at greatly increased risk of developing oesophageal adenocarcinoma, the most common form of oesophageal cancer in Australia. Unfortunately, the current examination method is unreliable for diagnosing these patients prior to cancer, or for accurately predicting cancer risk. We will investigate a molecular test and the potential to develop an antibody test to improve diagnosis and prediction of cancer risk, and possibly reduce healthcare costs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012523"^"http://purl.org/au-research/grants/nhmrc/2012523"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A new way to see endometriosis,Ideas Grants"^"Endometriosis, a chronic and painful condition, affects ~10% women of reproductive age, and is characterized by growth of uterine-like cells outside the uterus such as the pelvis. However, why cells of the uterus end up in other parts of the body, and how they cause pain and other symptoms, are not well understood. This project will address these questions by studying the fundamental biology and function of uterine cells and exploring new diagnostic and therapeutic options for endometriosis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012530"^"http://purl.org/au-research/grants/nhmrc/2012530"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing a novel insulin receptor binding mechanism to therapeutic benefit,Ideas Grants"^"We aim to develop new insulin molecules that provide better blood glucose control to Type 1 and late stage Type 2 diabetic patients. A fascinating discovery from investigations of marine cone snail venom has provided the basis to develop a new class of diabetes therapeutics built on a cone snail derived "mini" insulin scaffold. This proposal outlines the steps required to translate our findings into the development of ultra fast acting insulin analogues for diabetes treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012535"^"http://purl.org/au-research/grants/nhmrc/2012535"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"iHSCs, repopulating haematopoietic stem cells derived from human pluripotent stem cells,Ideas Grants"^"The ability to make blood stem cells from human pluripotent stem cells would be beneficial for patients with leukaemia or bone marrow failure who cannot find a matched donor. We will compare the blood stem cells that we can now make in the laboratory with stem cells present in umbilical cord blood and we will use these comparisons to inform improvements in our methods. Success in this project will accelerate the translation of these human stem cell derived blood therapies to the clinic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012552"^"http://purl.org/au-research/grants/nhmrc/2012552"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Sex-differences in cellular aging and cardiovascular disease: Role of the AngIV/IRAP axis,Ideas Grants"^"High blood pressure and ageing increase the risk of heart disease. Young women are protected from heart disease, but lose this protection with age. Senolytics are a new class of drug that remove damaged (senescent) cells from the body. Senescent cells lose the ability to self-repair and trigger a cascade of reactions to promote disease. We will determine if a novel enzyme insulin-regulated aminopeptidase (IRAP) causes cell damage and disease, and test the efficacy of IRAP inhibitors."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012560"^"http://purl.org/au-research/grants/nhmrc/2012560"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Multi-analyte liquid biopsy-based biomarkers for oropharyngeal cancer,Ideas Grants"^"Throat cancer affects individuals at a relatively young age, who often go on to suffer from long-term treatment related morbidities. In addition, 20% of throat cancers reoccur. There is a desire to reduce the intensity of treatment to lessen severe side effects as well as to monitor response to treatment . We propose to use non-invasive, novel biomarkers to address these unmet clinical needs, thereby improving quality of life for cancer patients and significantly cutting healthcare costs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012567"^"http://purl.org/au-research/grants/nhmrc/2012567"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pioneering novel therapeutic strategies to enhance an anti-tumour immune response in Neuroblastoma,Ideas Grants"^"Neuroblastoma has one of the lowest survival rates of all childhood cancers. Immunotherapy stimulates an immune response against cancer cells yet still works poorly in neuroblastoma. This suggests that understanding how neuroblastoma evade immune system is critical to improving such therapies. Our research has found that copper plays a key role in tumours to evade the immune response. We are currently developing new strategies to reduce copper and activate the anti-tumour immune responses."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012569"^"http://purl.org/au-research/grants/nhmrc/2012569"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Only a matter of time? A comparison of caloric restriction versus time restriction of food intake.,Ideas Grants"^"The proposed study will compare the health benefits of limiting âwhenâ vs âhow muchâ is eaten on health in individuals at high risk of developing type 2 diabetes. The concept that marked improvements in health can be achieved by aligning food intake with circadian rhythms, without weight loss, is game changing. But we do not yet clearly understand how one performs against the other, or if both are required, in humans, since no trials have been performed."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012579"^"http://purl.org/au-research/grants/nhmrc/2012579"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining Chemotactic Signalling Networks to Identify New Anti-inflammatory Targets,Ideas Grants"^"A key feature of inflammatory diseases is infiltration of the affected tissues by white blood cells. White blood cell migration is controlled by âchemokineâ proteins that are produced in the tissues and activate receptor proteins on the blood cells. This project will characterise the molecular events leading from receptor activation to white blood cell migration. The results will guide development of medicines to control inflammatory diseases, including atherosclerosis and rheumatoid arthritis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012582"^"http://purl.org/au-research/grants/nhmrc/2012582"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel approach integrating genomics into the health economic modelling of therapeutics,Ideas Grants"^"Despite the increasing uptake of health economic models in practice, greater understanding of the impact of lifetime disease risk in costs and outcomes is fundamental for cardiovascular disease. This research project will utilise an innovative approach in health economic modelling that will provide evidence for the first time on the cost-effectiveness of new interventions. This in return will inform government policies, lead to efficient access to preventive therapeutics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012583"^"http://purl.org/au-research/grants/nhmrc/2012583"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeted Delivery of Nucleic Acid Therapeutics for Preventing Preterm Birth,Ideas Grants"^"Thousands of babies could be saved each year with a timely intervention for preterm birth. Current approaches are hampered by a lack of drug specificity. To address this, we first developed uterine-targeted nanocarriers for targeting interventions to the pregnant uterus. We now seek to leverage this platform for the targeted delivery of nucleic acid therapeutics. This bold strategy aims to modulate cellular phenotype in order to block the premature uterine contractions that cause preterm birth."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012600"^"http://purl.org/au-research/grants/nhmrc/2012600"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New pathways to improved stroke outcome: the importance of managing intracranial pressure.,Ideas Grants"^"Stroke is caused by a loss of blood supply that results in brain tissue death leading to disability. Delayed expansion of stroke injury can occur in the 24-48 hours after stroke. What causes this was previously unknown. We found that an increase in cerebrospinal fluid pressure that affects blood flow to the injury site is likely to blame. We have evidence that a change in the composition of cerebrospinal fluid drives this increase in pressure and we aim to design therapies to prevent it."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012601"^"http://purl.org/au-research/grants/nhmrc/2012601"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Leveraging innovative multi-omic approaches to understand and predict myeloma disease development,Ideas Grants"^"Multiple myeloma is a fatal bone marrow cancer which is universally preceded by a pre-cancerous stage known as MGUS. We currently have no way of identifying which MGUS patients will develop myeloma and no treatments to prevent this process. This study will develop clinical tools to identify which MGUS patients are at high risk of developing myeloma, and will identify new therapeutic targets, to revolutionise how we treat MGUS and myeloma and improve outcomes for these patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012620"^"http://purl.org/au-research/grants/nhmrc/2012620"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining a protective role for NLRC5 signalling in Helicobacter pylori disease,Ideas Grants"^"Helicobacter pylori infects the stomach of half the worldâs population and is a major cause of human disease. The body fights H. pylori infection by mobilising white blood cells to the stomach lining, but these responses can lead to lymphoma. We have identified a host protein, NLRC5, as being important in the generation of immune responses that protect against the development of this disease. The project will determine how NLRC5 protects against stomach lymphoma due to H. pylori infection."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012622"^"http://purl.org/au-research/grants/nhmrc/2012622"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Location! Location! Location! Geospatial control of memory B cell reactivation in vaccine-induced immunity,Ideas Grants"^"Vaccines are one of the great public health achievements in the modern era. However, vaccinology remains an empirical art and there is an urgent need to advance the science to realize its full potential, particularly in the face of pandemics such as COVID-19 and the emergence of virus variants that require booster injections. Here we propose to track the cell fate trajectories of memory B cells to determine the factors that are critical to generating a potent immune response to vaccination."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012657"^"http://purl.org/au-research/grants/nhmrc/2012657"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A new frontier in receptor biology relevant to treatment of disease,Ideas Grants"^"Disorders of colorectal function, especially constipation, are poorly responsive to drug therapy and are a substantial medical problem. This project should provide insights into the molecular basis for the voluntary defecation response that could provide the basis for novel therapeutic approaches to treat disorders of colorectal function."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012661"^"http://purl.org/au-research/grants/nhmrc/2012661"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Making peptide drugs orally bioavailable,Ideas Grants"^"Bioactive peptides have exciting therapeutic potential however they are limited by the fact that that they generally can't be taken orally and they don't last very long in the body. The goal of this project is to develop an approach that solves both of these problems and to develop new drug leads for the treatment of chronic pain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012674"^"http://purl.org/au-research/grants/nhmrc/2012674"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Submucosal glands as the origin of Barrettâs oesophagus and oesophageal adenocarcinoma,Ideas Grants"^"Barrettâs oesophagus is a relatively common benign condition that arises as a consequence of acid reflux. In some patients, Barrettâs progresses to oesophageal cancer, for which treatments are largely ineffective and thus outcomes are poor. This project addresses a vital gap in our knowledge regarding the cell of origin of Barrettâs oesophagus, which will enable the future development of effective strategies for early intervention or prevention of oesophageal cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012689"^"http://purl.org/au-research/grants/nhmrc/2012689"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Do patients with symptoms need a colonoscopy? A novel panel of non-invasive biomarkers to determine need for diagnostic investigation.,Ideas Grants"^"Gastrointestinal symptoms can raise concern for bowel cancer, but as they are often non-specific, it is difficult to determine what type of further clinical investigations are needed. There is a need for simple tests to determine the need for colonoscopy. Our study will establish the use of blood and stool tests for identifying disease risk. This will ensure that all symptomatic patients are reviewed for bowel cancer risk with tests that are independent of their symptoms."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012701"^"http://purl.org/au-research/grants/nhmrc/2012701"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The role of resident and circulating CD8 T cell memory in the control of liver infections,Ideas Grants"^"CD8+ tissue-resident memory T (Trm) cells are a specialized population of immune cells that act as front-line defenders against pathogens in organs such as the liver. In this study we will investigate how these and other T cells recognise and destroy pathogens like malaria that infect liver cells, without damaging the remaining liver tissue, with the aim of designing better vaccines against liver infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012704"^"http://purl.org/au-research/grants/nhmrc/2012704"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Applying machine learning to develop a smart and engaging chatbot to increase physical activity and improve health,Ideas Grants"^"As high levels of physical inactivity lead to a high disease burden in Australia, cost-effective population-based strategies are needed to increase activity levels. The main aim of this project is to develop a very sophisticated chatbot that applies artificial intelligence and machine learning to provide highly personalised physical activity advice, delivered just-in-time, based on real-time data (e.g., Fitbit, GPS, weather). Our project will enable 'precision medicine' for behavioural health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012718"^"http://purl.org/au-research/grants/nhmrc/2012718"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Effectiveness of empirically based tackle technique intervention to reduce the in-game risk of concussion,Ideas Grants"^"Concussion in collision sports, is a prominent community health concern, occurring mostly during tackles. To make the sport safer for all players, our research will reveal how a rugby playersâ tackles alters their head forces and how retraining their tackle technique can reduce their concussion risk. Our tackle coaching program will have an Indigenous focus as many players identify as Indigenous/Pasifika. We will use this information to develop new coaching guidelines to make the sport safer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012764"^"http://purl.org/au-research/grants/nhmrc/2012764"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Chromatin defects in histone mutated brain cancers: from basic mechanisms to novel therapeutic strategies,Ideas Grants"^"Paediatric glioblastoma (pGBM) is the most aggressive kind of brain cancer affecting children. To develop treatments for this disease, the underlying molecular mechanisms leading to disease formation must first be understood. This study will investigate how mutations in two key regulators of the genome change DNA integrity and gene activity, leading to the development of pGBM. It will thereby identify new targets for therapeutic intervention strategies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012769"^"http://purl.org/au-research/grants/nhmrc/2012769"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing the beneficial off-target effects of BCG vaccination to boost protection against SARS-CoV-2,Ideas Grants"^"Bacillus CalmetteâGuÃ©rin(BCG), the vaccine that protects against tuberculosis, also protects against other diseases. This is thought to be because BCG can boost immunity. We will investigate how BCG boosts immune responses to SARS-CoV-2 and if this improves protection against COVID-19 and the effectiveness of COVID-19 vaccines. We will combine use of mouse models with use of samples from BRACE, our 6800 participant trial testing if BCG vaccination protects against COVID-19 in healthcare workers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012772"^"http://purl.org/au-research/grants/nhmrc/2012772"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Inflammatory Cell Death, Circadian Rhythm &amp; Obesity: A Surprising Triad,Ideas Grants"^"Obesity rates continue to soar despite decades of efforts to promote lifestyle changes. Our work points to an important role for the RIPK1 gene in obesity through adipose tissue inflammation and circadian clock disruption. Using unique mouse models, nanoparticle therapies and novel technologies to map genetic reprogramming, we will explore how RIPK1 pathways drive these processes in obesity and provide proof-of-concept for novel anti-obesity therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012793"^"http://purl.org/au-research/grants/nhmrc/2012793"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Macrophage-driven lipid metabolism in health and disease â mechanisms and therapeutic opportunities,Ideas Grants"^"Macrophages are cells of the immune system that are abundant in every organ. We discovered that treating animals with a macrophage growth factor, Colony Stimulating Factor 1 (CSF1), reduces body fat mass and increases lean mass. This indicates that macrophages responding to CSF1 influence the cross-talk between metabolic tissues that controls energy metabolism and body composition. In this project we will investigate how this occurs and test CSF1 as a therapy for obesity-related complications."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012805"^"http://purl.org/au-research/grants/nhmrc/2012805"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel roles for NMDA receptors in cortical processing,Ideas Grants"^"Major psychiatric disorders, like schizophrenia and depression, are thought to arise from subtle changes in brain circuits. A key player in these changes is a protein called the NMDA receptor, which is important for electrical signalling in the brain. This project will study how NMDA receptors normally work in mouse brains to enable the animal to make sense of its environment. The findings will help guide the development of new NMDA receptor-targeting drugs with fewer side-effects."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012809"^"http://purl.org/au-research/grants/nhmrc/2012809"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"How the synergy between flavivirus protein and noncoding RNA defeats antiviral response,Ideas Grants"^"Flaviviruses represent a persistent threat with a devastating impact on human health. They have sophisticated mechanisms to subvert and control human antiviral response. One of them is by producing a noncoding RNA. In this project we will obtain an understanding of how these RNAs determine the ability of flaviviruses to evade immune response and establish infection in humans. The outcome will advance our understanding of flavivirus pathogenesis and inform future design of novel antivirals."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012828"^"http://purl.org/au-research/grants/nhmrc/2012828"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Circadian clock, sleep, and depression in adolescence: Modelling a novel pathway,Ideas Grants"^"Body clock and sleep undergo significant changes during adolescence, a critical phase for the development of depression. In a large sample of adolescents, we propose to test how later timing of the body clock, shorter sleep duration, and irregular sleep timing, are associated with increased depressive symptoms. We will also test how light exposure patterns affect the shift in timing of the body clock. The study will inform the development of evidence-based sleep interventions for adolescents."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012837"^"http://purl.org/au-research/grants/nhmrc/2012837"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Single-cell intravital imaging guides anti-fibrotic therapy to improve standard-of-care treatment in triple negative breast cancer,Ideas Grants"^"Tissue fibrosis is a well-known risk factor for breast cancer initiation, progression and prognosis. It is commonly found in aggressive cancers, such as triple negative breast cancer (TNBC). Fibrosis is also known to protect cancer cells from treatment including chemotherapy, which is the standard-of-care in TNBC. In this proposal we will test the hypothesis that reducing tissue fibrosis can improve standard-of-care performance and outcomes in pre-clinical models of TNBC."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012848"^"http://purl.org/au-research/grants/nhmrc/2012848"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Revolutionising immunotherapy response prediction in non-small cell lung cancer via longitudinal single-cell proteomic analysis of liquid biopsy derived cancer and immune cells,Ideas Grants"^"Lung cancer is leading personalised medicine (replacing âone medicine for allâ with drugs targeting unique cancer characteristics), but that only applies to a small subset of lung cancers with certain characteristics (biomarkers). This proposal uses innovative methods to apply and thourougly test novel biomarkers for lung cancer patients, predicting response to immunotherapy, improving treatment and preventing deadly side-effects. This will transform treatment of Australiaâs most deadly cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012860"^"http://purl.org/au-research/grants/nhmrc/2012860"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Restoring anti-tumour immunity in melanoma,Ideas Grants"^"Melanoma is a major Australian health problem and a common cause of cancer death in young adults. Two recent types of therapies have revolutionised the treatment of patients with melanoma, and although patient survival has improved, most patients will eventually become resistant to treatment. This research explores how cancer cells evade treatment and reveals cancer vulnerabilities that can be exploited to re-sensitize melanoma to current and new therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012863"^"http://purl.org/au-research/grants/nhmrc/2012863"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dissecting the healthy and immunosuppressed, primary and secondary immune responses within human lymph nodes following COVID-19 vaccination,Ideas Grants"^"The dynamics of the immune response to vaccines in human lymph nodes are important in determining eventual vaccine responses but are poorly characterised. We will investigate the critical components of the immune response in human lymph nodes that lead to an effective neutralising antibody response to novel COVID-19 vaccines. Our findings will provide insights into the critical responses required for a successful vaccine and will inform the rational design of future vaccines."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012882"^"http://purl.org/au-research/grants/nhmrc/2012882"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"MY Voice Library,Ideas Grants"^"For children with cerebral palsy and speech impairment access to a communication device is imperative. Today, accessing their communication device is often challenging, resulting in 15-20 times slower communication rates compared to those who can speak. This application seeks funding to support the development of a world-first data-driven MY Voice Library, a foundation for research and development of innovative engineering of real-time communication solutions for children with cerebral palsy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012883"^"http://purl.org/au-research/grants/nhmrc/2012883"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Predicting and preparing for the unfolding evolution of SARS-CoV-2,Ideas Grants"^"One year on from the emergence of the COVID-19 pandemic, variants of SARS-CoV-2 have evolved to be more transmissible, pathogenic and less susceptible to immune responses from infection or vaccination. We propose utilising the deep mutational scanning method to examine the molecular pathogenesis and vaccine escape of SARS-CoV-2 at a single amino acid residue resolution and towards developing a universal vaccine candidate to neutralise all potential future SARS-CoV-2 variants."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012895"^"http://purl.org/au-research/grants/nhmrc/2012895"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Exploiting the neuroprotective effects of the gut microbiome for the treatment of spinocerebellar ataxia-3 and related neurodegenerative diseases,Ideas Grants"^"Spinocerebellar ataxia-3 (SCA3, also known as Machado Joseph disease) is a fatal neurodegenerative disease that causes coordination and mobility problems, leading to paralysis. There is currently no treatment for SCA3. This project will investigate whether the gut microbiome, bacteria that inhabit the gut, and levels of chemicals produced by these microbes are altered in SCA3 patients. We will also investigate a therapeutic strategy to correct the gut microbiome and its products to treat SCA3."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012915"^"http://purl.org/au-research/grants/nhmrc/2012915"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Artificial Intelligence to Understand and Predict Chronic Subdural Haematoma Evolution,Ideas Grants"^"This project tackles chronic subdural haematoma, a disease caused by bleeding on the brainâs surface that is increasing in incidence due to our ageing population. Artificial intelligence and advanced brain imaging will be used to predict and identify earlier those patients who are likely to need and benefit from treatment. This will personalize patient care, allowing proactive treatment to prevent progression and decrease the burden of disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012929"^"http://purl.org/au-research/grants/nhmrc/2012929"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Why do women overeat? Understanding the neural circuits driving stress-related eating,Ideas Grants"^"For women negative emotions such as stress and loneliness are more likely to drive overeating compared to men. There is a dearth of literature detailing the brain circuits driving stress-induced binge eating, particularly in female subjects, as to date no suitable animal model exists. We have developed a highly translational model of stress-induced binge eating in female subjects, which enables us to determine for the first time the neurobiology underlying this specific form of eating behaviour."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012936"^"http://purl.org/au-research/grants/nhmrc/2012936"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Making a Niche: an in vitro human bone marrow organoid factory for blood,Ideas Grants"^"The bone marrow is the âfactoryâ where blood cells are made. The ability to recreate a human bone marrow organ from pluripotent stem cells in the laboratory would improve our ability to make blood stem cells for patients with leukaemia or bone marrow failure who cannot find a matched donor. We can now make all the individual componentsâ blood cells, bone, cartilage, blood vessels and stromal cells. In this project we will assemble these into a functioning human bone marrow organ."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012941"^"http://purl.org/au-research/grants/nhmrc/2012941"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"High-fidelity tumouroids: accelerating next generation personalised medicine,Ideas Grants"^"Anti-cancer drug testing using in vitro models are unable to recapitulate the complexity of human tumours, hindering the application of more effective therapeutic strategies. We have created ALTEN, a tissue-engineering system capable of preserving tumour biopsies maintaining their original environment. ALTEN allows parallel testing of different therapies on each patientâs biopsy, accurately identifying the most effective treatment for each patient, facilitating a personalised medicine approach."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012943"^"http://purl.org/au-research/grants/nhmrc/2012943"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Boosting cellular immunogenicity to combat metastatic cancer,Ideas Grants"^"Spread (metastasis) to bone in breast and prostate cancer is painful and very difficult to treat. We have discovered that cancers growing in bone have developed changes to allow them to go undetected and escape immune control. In this proposal, we will discover ways to reverse these changes and increase response to radiotherapy and immune therapies to target deadly metastatic cancers. This work will offer a new avenue of therapy for bone metastasis that is built on strong biological discoveries."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2012971"^"http://purl.org/au-research/grants/nhmrc/2012971"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A20 variants contribute to endemic kidney disease in Tiwi Islanders,Ideas Grants"^"Kidney disease is endemic amongst the Tiwi Islanders with the highest reported rates worldwide. It is thought that 60% of this risk comes from genetics. We have identified six gene variants in a gene likely to be important in controlling progression of kidney disease. These variants impair the ability of the gene to prevent kidney disease and offers a novel treatment target for the Tiwi Islanders."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013024"^"http://purl.org/au-research/grants/nhmrc/2013024"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Toward tailored excitation therapy for amyotrophic lateral sclerosis,Ideas Grants"^"Motor neuron disease and associated dementia are significantly debilitating Australians and we have no effective cures. Our work has discovered that the way brain cells communicate in these diseases is disrupted. We propose to develop a new way of treating these diseases, tailored to the part of the brain that is affected. With this knowledge we will investigate new targeted therapies that could prevent brain cells from tipping over from proper brain function to too much excitation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013027"^"http://purl.org/au-research/grants/nhmrc/2013027"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Revealing how junctional neural tube defects arise,Ideas Grants"^"The brain and spinal cord control are formed early in development from a common precursor called the neural tube. Each end of the neural tube forms by a different process and how these are united to form a single tube is unknown. Failures in this critical process cause severe birth defects in humans. We will use live imaging of transgenic quail embryos to understand how cells arrange into a continuous neural tube and what goes wrong when genes linked to human neural tube defects are mutated."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013058"^"http://purl.org/au-research/grants/nhmrc/2013058"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding latent fate programming in T cells.,Ideas Grants"^"Our immune response to infections and cancer involves amplification of T cells. Each of us has trillions of T cells, with only a handful specific for each infectious agent or cancer cell. What controls the effectiveness of their response is not yet known. In this project, we will use single cell approaches to describe what determines whether a T cell can yield an effective response. These studies will also provide a general framework to assess how fate is controlled in multicellular organisms."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013115"^"http://purl.org/au-research/grants/nhmrc/2013115"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Accelerating treatment for epilepsy in children with KIF1A-associated neurological disorders.,Ideas Grants"^"Epilepsies are life threatening, where approximately 40% patients do not respond to current medications. Mutations in the KIF1A gene lead to a devastating form of epilepsy where patients die within first 5 years of life. We will use extremely innovative and physiologically relevant models such as stem cells and bioinformatic algorithms to identify novel therapies for KIF1A-related epilepsies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013129"^"http://purl.org/au-research/grants/nhmrc/2013129"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A One Health/System Dynamics approach to reducing Clostridioides difficile infection,Ideas Grants"^"Clostridioides difficile infection is a major public health problem. While thought to be acquired in hospitals, evidence is growing that it can be acquired in the community. The bacteria have been found in food, households, farm animals and the environment, but we donât understand what role this plays in human infection. We will use a novel approach using systems modelling to understand how people become exposed to C. difficile and, most importantly, what we can do to control the infection."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013158"^"http://purl.org/au-research/grants/nhmrc/2013158"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Polygenic mitochondrial dysfunction in heart failure and neurodegeneration,Ideas Grants"^"Mitochondria are the energy producing components of our cells. Genetics influences mitochondrial function, which influences risk for diseases such as heart failure and neurodegeneration. We donât yet fully understand this genetic influence, however we propose that subtle, cumulative genetic (polygenic) differences may be liable. We will test this idea using unique mouse models, and use these findings to identify readily detectable measures for developing heart failure and neurodegeneration."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013180"^"http://purl.org/au-research/grants/nhmrc/2013180"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing artificial intelligence, spatial-omics and patient-derived organoids to cure glioblastoma.,Ideas Grants"^"This Proposal will investigate the mechanisms by which tumour cells reprogram healthy non-cancerous cells to support the tumour cellsâ energy demands. Our results will lay the foundations of new anti-cancer approaches that will not only inhibit tumour cell source of energy (metabolism) but also prevent their metabolic compensation via recruitment and reprogramming of surrounding healthy cells."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013189"^"http://purl.org/au-research/grants/nhmrc/2013189"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Bioengineered skeletal muscle to discover therapies for age-related muscle weakness,Ideas Grants"^"As we grow older the positive effects of exercise training in muscle are reduced. This project will use 1000s of lab made mini-muscles, which act and function like real human skeletal muscle to understand changes that occur when we get older and how muscle responds to training. By understanding these changes we aim to identify new therapies to treat age-related muscle weakness, so that every Australian can be active and healthy in their older years."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013215"^"http://purl.org/au-research/grants/nhmrc/2013215"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding how viruses overcome the nuclear pore complex, the gatekeeper of genomic access,Ideas Grants"^"HIV remains an incurable disease. New ways of treating HIV infection are needed if we are to be ready for emerging strains that are resistant to current treatments. The viral shell, the âcapsidâ, has proven to be a good target for new drugs. We aim to understand how the capsid tricks immune cells into allowing HIV to enter their nuclei where it establishes infection. Understanding how HIV enters the nucleus will not only inform HIV therapies but also virus-inspired gene therapy technologies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013237"^"http://purl.org/au-research/grants/nhmrc/2013237"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Overcoming chemoresistance in triple negative breast cancer,Ideas Grants"^"Triple negative breast cancer (TNBC) is the most challenging breast cancer to treat. There is no reliable targeted therapy available and chemotherapy is the standard of care. About 20-25% of patients will become chemoresistant. For these patients, there are few viable treatment options available and their median survival is about 12 months. In this study, we aim to better understand the pathways to chemoresistance and to use a novel paradigm to develop new drugs to circumvent chemoresistance."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013243"^"http://purl.org/au-research/grants/nhmrc/2013243"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Top down cortical control of hypothalamic feeding circuits,Ideas Grants"^"Obesity continues to be a significant burden to public health shows no sign of slowing. A central part of the problem is the overconsumption calorically dense, highly palatable and innately rewarding foods. Although genetic evidence shows this overconsumption is driven by our brain, the precise way this occurs remain unknown. In this proposal, we will assess how the brain cortex communicates with the hypothalamus in order to control food intake, food motivation and the development of obesity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013260"^"http://purl.org/au-research/grants/nhmrc/2013260"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel, dual-targeted therapeutic approach for reducing diabetes-accelerated atherosclerosis,Ideas Grants"^"Patients with diabetes are in a pro-inflammatory state and many of them develop an aggressive form of heart disease. Blood levels of the pro-inflammatory enzyme myeloperoxidase (MPO) are also elevated in these patients. This project will determine whether treatment with peptides that have anti-diabetic and anti-inflammatory properties plus an MPO inhibitor reduces heart disease in these patients more effectively than the peptides alone or an MPO inhibitor alone."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013278"^"http://purl.org/au-research/grants/nhmrc/2013278"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enhancing mitochondrial energetics to prevent age-associated muscle weakness,Ideas Grants"^"Sarcopenia is a recognized disease of ageing, describing the progressive decline in skeletal muscle mass and strength that occurs from midlife in humans. Recent research suggests that a decline in mitochondrial function, the energy producing cells in our body, precedes the development of sarcopenia. This project will test whether increasing mitochondrial energetics in skeletal muscle with the pharmacological compound BAM15 can prevent sarcopenia in mouse and human models of ageing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013281"^"http://purl.org/au-research/grants/nhmrc/2013281"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the pathophysiology of Parkinsonâs disease using cellular genomics,Ideas Grants"^"Parkinsonâs disease (PD) is a devastating neurodegenerative condition affecting 1% of Australians aged 60-years and over. Understanding the genetic basis of PD is critical to identifying new drug targets. We will apply powerful methods for measuring gene expression in single cells to identify specific genes that are altered in specific cell types in PD-related brain and gut regions. Our study will shed light on the cell type-specific molecular pathology of PD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013284"^"http://purl.org/au-research/grants/nhmrc/2013284"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming fertility treatment,Ideas Grants"^"It is estimated that worldwide 186 million individuals live with infertility. Depending on the cause of infertility, treatment ranges from medications to stimulate ovulation through to more complex procedures, such as in vitro fertilisation (IVF). These fertility treatments have been quite successful; however, they all rely on decades-old medications that promote or suppress hormone activity. We will develop a new set of drugs that target ovarian growth factors to treat or prevent infertility."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013285"^"http://purl.org/au-research/grants/nhmrc/2013285"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Bionic-array Directed Gene Electrotransfer for Treating Focal Brain Disorders,Ideas Grants"^"A platform for localized brain gene therapy, âBrain-BaDGEâ, will be developed from proprietary UNSW electric field-focusing technology. This translational program will produce a first-for-human âneedle-likeâ medical device for electrotransfer of therapeutic DNA encoding a neuromodulator targeted to groups of neurons in the brain to suppress epileptic seizures of focal origin. This Brain-BaDGE platform will establish a translational pathway for gene therapies treating localized brain disorders."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013305"^"http://purl.org/au-research/grants/nhmrc/2013305"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Precursor neurons on standby fast track neural repair,Ideas Grants"^"Brain and spinal cord injury are devastating events that has a life-long impact on the patientâs life with wide-reaching social and economic effects. This research program uses innovative regeneration models and screening approaches to identify how endogenous cells and molecules can be hoaxed to boost neural regeneration after injury or in disease. The work provides critical insight and hold keys to unlocking strategies for future restorative therapies in the brain or spinal cord."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013323"^"http://purl.org/au-research/grants/nhmrc/2013323"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Hospital trajectories for 15 million Australians,Ideas Grants"^"Patient segmentation, which divides a patient population into distinct groups with specific needs and characteristics, underpins a patient-centred approach to health care. We will use hospital records for the population of NSW and deep learning to identify clusters (segments) of patients who share patterns of hospital use, characterise and visualise these, and explore how they change over time. Our novel methods will have application in health service planning and delivery and research."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013349"^"http://purl.org/au-research/grants/nhmrc/2013349"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building the mind: interplay of transcriptional and electrical activities in the self-assembly of cortical circuits in vivo,Ideas Grants"^"The early impact of nature and nurture influences in human brain wiring remains poorly understood due to a lack of ways to study embryonic development in naturalistic live models. We have established advanced new methods in an Australian marsupial that allow, for the first time, mechanistic studies of how genes and electrical activity interact to form precise circuits in the cerebral cortex. These unique opportunities can revolutionise the way we understand brain wiring in health and disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013362"^"http://purl.org/au-research/grants/nhmrc/2013362"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Remodelling the ovary to extend female fertility and health,Ideas Grants"^"Female infertility is commonly caused by an inability to release an egg from the ovary, particularly in women who are middle-age or if they have obesity or PCOS. We discovered that these females also have fibrosis in the ovary; excess collagen deposited by cellular stress and inflammation that prevents the egg from being released. This project will identify strategies to combat the detrimental changes in the ovary that cause fibrosis in order to improve female health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013384"^"http://purl.org/au-research/grants/nhmrc/2013384"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Establishment of novel, neuronal-cell based, therapeutic screens for Alzheimerâs disease using patients stem cells,Ideas Grants"^"Alzheimerâs disease is the most common cause of dementia and a major cause of death in Australia. There is no effective treatment for this disease and there is an urgent need to develop treatments to target the cause of the Alzheimerâs disease. This project aims to use human neurons derived from patientâs stem cells to establish a powerful screening platform for the identification of targeted therapeutic drugs to rescue neuron defects to efficiently treat Alzheimerâs disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013404"^"http://purl.org/au-research/grants/nhmrc/2013404"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"aSPOC â Commercialisable Aptamer-based Diagnostics for Sepsis Point of Care,Ideas Grants"^"Sepsis - bacterial blood infection - is a common cause of disease in babies and adults. Current diagnostic tests are too slow and often miss the sepsis diagnosis. We have identified blood markers that can improve sepsis diagnosis. Our team have developed a powerful system for making the molecular tools needed to rapidly detect these blood markers. We are working with science and manufacturing experts to make new sepsis tests that can be used easily by frontline staff in hospitals and GP clinics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013421"^"http://purl.org/au-research/grants/nhmrc/2013421"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Inhibiting ASC with small molecules for treatment of inflammatory diseases,Ideas Grants"^"During flu infection inflammation causes significant morbidity there is therefore a need to reduce this inflammation while tackling the viral infection, we have special molecules that have this dual action. We will develop these molecules so they can become future drugs and explore their use in flu models combined with either asthma or obesity as these people are particularly vulnerable to the deadly effects of flu."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013427"^"http://purl.org/au-research/grants/nhmrc/2013427"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Do mitochondrial changes underlie insulin resistance induced by inadequate sleep, and can this be prevented by prescribed exercise?,Ideas Grants"^"More than 7.4 million Australians suffer from inadequate sleep. Sleep loss doesn't just make us tired; we have shown it also negatively affects mitochondria ("energy powerhouses") and glucose metabolism (increasing the risk of diabetes). Based on compelling data, this project will discover novel mechanisms responsible for the negative effects of sleep loss and test targeted exercise prescription as a cost-effective strategy to prevent metabolic problems arising from inadequate sleep."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013451"^"http://purl.org/au-research/grants/nhmrc/2013451"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"ALPK1 dysfunction: revealing a novel pathogenic pathway in retinal diseases,Ideas Grants"^"Genetic retinal diseases are caused by changes in many different genes and lack effective therapy. This proposal aims to characterise and modulate a newly identified disease pathway in the retina. This holds promise for development of novel approaches to preserve vision in genetic and other forms of blinding retinal degeneration."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013460"^"http://purl.org/au-research/grants/nhmrc/2013460"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Exploiting a novel cell surface biomarker to defeat multiple myeloma,Ideas Grants"^"Multiple myeloma is an incurable aggressive cancer of the bone marrow. In Australia, ~2,500 new cases are diagnosed every year with a 5 year survival rate of ~50% and treatment costs exceeding $700,000 per patient. We have identified a single cell surface protein to be upregulated by ~20% of myeloma patients who are then 3 times more likely to die within 6 years of diagnosis. This study examines a new prognostic tool to rapidly identify poor prognosis patients and new a target to treat them."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013468"^"http://purl.org/au-research/grants/nhmrc/2013468"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the asymptomatic carriage of pathogens and antimicrobial resistance (AMR) in the human gut microbiota,Ideas Grants"^"The rise of microbial antibiotic resistance (AMR) and the lack of novel antibiotic compounds could soon be cancelling the effectiveness of current infectious disease therapies. Understanding and controlling the spread of AMR is a major challenge for public health, but we currently do not understand well if and how healthy people can carry and spread AMR genes. Here, we propose to study AMR dynamics in the gut microbiome of &amp;gt;20,000 healthy people, linking it with health and prescription records."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013478"^"http://purl.org/au-research/grants/nhmrc/2013478"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying rational approaches to enhance the activity of BH3 mimetic drugs in blood cancers,Ideas Grants"^"It is now appreciated that normal cell death prevents cancers from developing; however, this could be undermined in blood cancers (e.g., leukemias). This is often due to overactivity of BCL2 which allows the cancer cells to persist. Treating patients with a drug blocking BCL2 - venetoclax - is proving highly effective for such blood cancers. However, the disease will often eventually recur: this project seeks to understand why this is and to discover ways by which this can be prevented."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013500"^"http://purl.org/au-research/grants/nhmrc/2013500"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"MicroRNA targeting to enhance haematopoietic stem cell function,Ideas Grants"^"The ability to transplant blood stem cells has dramatically improved outcomes for many blood diseases. However, there is a major limitation in the numbers of appropriate blood stem cells available for use. We have identified a gene family that represses the potential of blood stem cells to function after transplantation. Here, we aim to inhibit this gene family to enhance blood stem cell function."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013511"^"http://purl.org/au-research/grants/nhmrc/2013511"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The rogue germline: deciphering mechanisms of cancer testis antigen reactivation in cancer,Ideas Grants"^"Cancer testis antigens (CTAs) are proteins that are normally expressed in the germline of healthy individuals. During malignant transformation, CTAs become expressed in cancerous tissues, however their role in cancer formation is largely unknown. Given their tissue specificity, CTAs are being actively pursued as targets for cancer immunotherapy. This project aims to unravel the mechanisms of CTA reactivation and interrogate their contribution to cancer formation in vivo."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013538"^"http://purl.org/au-research/grants/nhmrc/2013538"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Increasing hematopoietic stem cell niches post transplantation through enhancing bone marrow macrophage resilience and regeneration mechanisms,Ideas Grants"^"Bone marrow transplantation, a potential cure for blood cancers and used to enable high dose therapy in treatment resistant cancers, has a high-risk profile preventing treatment progression and high mortality. We will investigate a novel treatment to alleviate transplantation risk by improving the recovery of the recipient's bone marrow environment. It is expected that the efficiency of donor stem cell engraftment will be increased, and reconstitution of blood and immune cells accelerated."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013563"^"http://purl.org/au-research/grants/nhmrc/2013563"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Evaluating Systems Change for Health Equity: A Case Study of Australiaâs COVID-19 Policy Response,Ideas Grants"^"This project will build new resources to evaluate the impact of policy reforms on changes to the underlying societal structures that shape health inequity. Using systems science we will study Australiaâs COVID-19 policy response and the impact it will have on the rules, norms, power dynamics, and resource flows that stratify society and shape peopleâs health. This new evidence will be used to advocate for policy reform that better targets the roots of health inequity in Australia and abroad."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013565"^"http://purl.org/au-research/grants/nhmrc/2013565"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"MACHINE LEARNING OF RANDOMISED CONTROLLED TRIALS: A major emerging opportunity to advance precision oncology,Ideas Grants"^"Individual patients can gain very different benefit from the same treatment. Immunotherapy for cancer is an important example of this - some patients have dramatic improvement in survival, whereas many others gain little or no benefit. Currently it is not possible to predict in advance who will benefit and who will not. We will evaluate of a new approach based on machine learning analysis of clinical trials to better distinguish patients who are unlikely to benefit from those who will benefit."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013574"^"http://purl.org/au-research/grants/nhmrc/2013574"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reinforcing the cell identity network to improve the function of aged cells,Ideas Grants"^"By 2055, one in four Australians will be aged over 65 and the frequency of age-related disorders will increase. In order to prevent unsustainable burdens for the health system and to reduce human suffering, innovative new therapies are needed to target the underlying causes of ageing. The proposal will provide the basis for new strategies to improve the function of aged cells by directly reinforcing youthful cell identity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013580"^"http://purl.org/au-research/grants/nhmrc/2013580"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A dual approach to activate a tumour suppressor for breast cancer therapy,Ideas Grants"^"Cancer is characterised by inactivation of proteins that inhibit cell growth and survival, called tumour suppressors. A rational way to treat cancer is to re-activate the tumour suppressors. Until recently this was not possible. However, we have developed drugs that can do this. Here, we will fully characterise how these drugs function in breast cancer, and use this knowledge to develop new anti-cancer therapies that could have wide reaching applicability for many cancer patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013615"^"http://purl.org/au-research/grants/nhmrc/2013615"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Interrogating the therapeutic potential of slow muscle programming in cancer,Ideas Grants"^"Physical activity can improve cancer prognosis, but many patients cannot exercise because of treatment complications. Slow muscle programming could confer exercise-like benefits but its therapeutic potential to improve muscle health in cancer has not been interrogated. These studies will determine whether this strategy can preserve and promote muscle health in different cancer settings. The outcomes will inform development of new therapies for cancer patients throughout the continuum of care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013620"^"http://purl.org/au-research/grants/nhmrc/2013620"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Do allergies start with the skin? A novel lipidomic analysis of early life skin to identify âhigh riskâ children and potential targets for preventive interventions,Ideas Grants"^"Eczema and food allergy are common conditions that cause a substantial burden for individuals and families. Impaired skin barrier in early life is believe to be critical in the development of these conditions, and skin lipids (fats) are the âmortarâ that holds the bricks of the skin barrier together. Using a non-invasive technique, we will test if the skin lipids can identify children who will develop eczema and food sensitisation, which may lead to novel preventive strategies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013621"^"http://purl.org/au-research/grants/nhmrc/2013621"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Treating Cardiometabolic Disease by Targeting Mitochondrial Defects,Ideas Grants"^"Cardiometabolic disease is the leading cause of death and disability in the world. We have discovered that depletion of Coenzyme Q10 (a molecule essential for energy production) occurs in people with pre-diabetes and that boosting CoQ10 is a potential treatment for cardiometabolic disease. Here we seek to understand the underlying cause of CoQ10 depletion and how depletion causes disease. Finally, we will use our newly acquired understanding of the disease process to develop new treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013629"^"http://purl.org/au-research/grants/nhmrc/2013629"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Positive allosteric modulation of anti-convulsant G protein-coupled receptor signalling to treat drug-resistant epilepsy.,Ideas Grants"^"Epilepsy remains a significant health burden, with current antiseizure medications (ASM) providing inadequate seizure control for &amp;gt;30% of patients. Activation of adenosine A1 receptors, a protein expressed on neurons, can effectively abolish seizures animal models. We will apply multidisciplinary, innovative approaches to develop novel drug leads that can modulate adenosine A1 receptor activity in a more selective and efficacious manner, developing a unique path for ASM discovery."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013631"^"http://purl.org/au-research/grants/nhmrc/2013631"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dominant classes of tumour specific antigens in Melanoma,Ideas Grants"^"We will explore new classes of antigens that can form targets of vaccines and immunotherapy in melanoma. In particular, we will compare the ability of small protein fragments that are generated via enzymatic modifications or through unusual proteolytic activities to stimulate patient immune responses to those protein fragments that contain cancer specific mutations. We anticipate that the inclusion of a broader variety of antigen classes will boost anti-cancer vaccines."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013641"^"http://purl.org/au-research/grants/nhmrc/2013641"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The development and potential of a malaria resistant mosquito for the Southwest Pacific,Ideas Grants"^"Malaria plagues the Southwest Pacific. With no vaccine, resistance to antimalarials growing, vector control is the mainstay in reducing malaria but mosquitoes are adapting to these tools. We are developing a malaria resistant mosquito in the lab with the capability to drive malaria resistant traits through populations. This project will permit the potential of this technology to be explored through population genomics and mathematical modelling to develop simulations of hypothetical releases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013650"^"http://purl.org/au-research/grants/nhmrc/2013650"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards optimizing diabetes therapies for cardioprotection: Precision approaches for women,Ideas Grants"^"Diabetes is an epidemic disease. A major cause of death in diabetic patients is due to heart damage &amp;amp; women are particularly vulnerable. No heart-specific therapies are available and current guidelines are not gender-targeted. The goal of this project is to understand why women have such high cardiac risk in diabetes, and to identify new treatment opportunities to maximise heart protection for diabetic women."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013757"^"http://purl.org/au-research/grants/nhmrc/2013757"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing a real-time machine learning rapid response and risk stratification system for in hospital patients,Ideas Grants"^"We intend to develop and implement a scalable and accurate patient-centred AI system based on the information derived during the whole patient journey for patients in a normal and pandemic setting so as to provide a clinical triage system for patients that match critical resources to patient needs and augment the current rapid response system (RRS) through more accurate and tailored risk predicting."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013783"^"http://purl.org/au-research/grants/nhmrc/2013783"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Promoting myelin repair in a refractory environment in vivo.,Ideas Grants"^"Many nerve cells in the brain are ensheathed in myelin. Myelin is critical for optimal brain function as it supports nerve cell function and survival. Damage to myelin, as occurs in multiple sclerosis and other neurodegenerative diseases leaves nerve cells vulnerable to degeneration. This proposal aims to identify whether a molecular target we have identified that promotes myelin repair can be optimised and promote myelin repair in a novel and more complex model of brain injury."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008644"^"http://purl.org/au-research/grants/nhmrc/2008644"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Communicate Study: partnership across the Top End to improve Aboriginal patientsâ experience and outcomes of healthcare,Partnership Projects"^"Effective communication in healthcare improves patient outcomes. Aboriginal language interpreters should be used for around 50% of Aboriginal patients in Northern Territory Top End, but only around 18% of those in need are currently getting access. The Communicate Study, partnering Menzies with health and interpreter services aims to improve cultural safety in healthcare, focusing on improved uptake of Aboriginal interpreters and integration of Aboriginal Heath Practitioners into tertiary care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010289"^"http://purl.org/au-research/grants/nhmrc/2010289"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"To Be Born Upon a Pandanus Mat (Yothuw gayatha dhÃ¤walâ guyaÅaânharaw),Partnership Projects"^"We will establish and evaluate, Australiaâs âBirthing on Countryâ very remote, demonstration site in Galiwinâku, Elcho Island, Northern Territory. We will redesign maternal and infant health services for YolÅu (Aboriginal) families who currently have one of the highest proportions of babies being born too soon (preterm) in Australia (22% versus 7% non-Indigenous Australians). DjÃ¤kamirrsâ (Indigenous doulas) will increase support for women to modify risk factors and reduce preterm birth by 50%."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010493"^"http://purl.org/au-research/grants/nhmrc/2010493"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development and evaluation of a Child and Family eHub to improve access, engagement and use of the existing community, social and mental health services system,Partnership Projects"^"Most Australian children with mental health concerns donât get the right care at the right time. With COVID-19 this will only get worse. This project aims to improve access and engagement of existing services to address problems early, especially for disadvantaged families. We will co-develop and test a Child and Family eHub, overlaying existing systems with an easily accessible digital entry point to seek information, connect with services, and provide a care navigator for those most in need."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2010866"^"http://purl.org/au-research/grants/nhmrc/2010866"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising the implementation of an evidence-based school program to engage adolescents in muscle-strengthening activities consistent with national guidelines,Partnership Projects"^"School-based physical activity interventions need to be âscaled-upâ to improve population health. The aim of this project is to study the effects of different implementation support models on the scale-up of an evidence-based physical activity program in NSW secondary schools. Expected outcomes include an optimal support model for scaling up school-based health promotion interventions, and population health benefits from participation in resistance training."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011157"^"http://purl.org/au-research/grants/nhmrc/2011157"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Promotion of evidence-based physical activity for older adults and people with disabilities by health professionals,Partnership Projects"^"Promotion of physical activity by health services is part of the solution to global inactivity proposed in the WHO Global Action Plan on Physical Activity. Health professionals are an underutilised resource in the global fight against inactivity. This project aims to mobilise and empower Health professionals to encourage and support physical activity among patients by targeting implementation barriers identified at our Partnership health services."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/GNT1078523"^"http://purl.org/au-research/grants/nhmrc/GNT1078523"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Psychosocial impact of genetic counselling and testing,Research Fellowship"^"Not applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008937"^"http://purl.org/au-research/grants/nhmrc/2008937"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Healthy Environments And Lives (HEAL) - National Research Network on Human Health and Environmental Change,Special Initiative"^"HEAL aims to strengthen the Australian community and health systemâs resilience to changing environmental conditions, climate change and extreme weather events. This will be achieved by stimulating collaborative research that will improve the current understanding of the interactions between the climate, the natural and built environment and our health. HEAL will lead to more effective policies and measures that will protect and improve the health of the community and reduce inequalities."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2011289"^"http://purl.org/au-research/grants/nhmrc/2011289"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identification of metabolic alterations in cancer cachexia,Ideas Grants"^"Cachexia is a metabolic disease where tumours cause muscle and fat to waste away. We established a Drosophila (fruit fly) model of cachexia-like wasting, opening up a novel opportunity to use its powerful genetic tools to better understand the genetic basis of cachexia-like wasting. This grant proposes to look at how organs can communicate with each other, and our findings will allow us to find potential new avenues for the development of treatment strategies for cachexia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013881"^"http://purl.org/au-research/grants/nhmrc/2013881"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A First-In-Class Tumour Matrix Targeting Approach to Enhance Chemotherapy in Pancreatic Cancer,Development Grants"^"Chemotherapy is the standard-of-care for pancreatic cancer patients. Whilst chemotherapy initially works, it quickly becomes ineffective and patients go on to relapse. One reason for this failure is chemotherapy-induced scarring (fibrosis) in and around the tumour. This scarring blunts the effectiveness of subsequent rounds of treatment. Our preliminary data show that our novel compound can block this scar formation offering a novel stromal targeting approach to improve chemotherapy efficacy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013899"^"http://purl.org/au-research/grants/nhmrc/2013899"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a Novel Photo-Angioplasty Device for the Treatment of Occlusive Peripheral Vascular Disease,Development Grants"^"We have designed and developed a new light-activated drug eluting balloon (DEB) angioplasty device termed Lumi-Solve, which targets drug delivery and activation specifically to the surface of a re-narrowed blood vessel, at the time of angioplasty balloon deployment, for the safer and more effective treatment of vascular disease. Our project aims to evaluate Lumi-Solve, in a large animal model with a view to commencing human trials shortly after completion of these studies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013973"^"http://purl.org/au-research/grants/nhmrc/2013973"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preventing reperfusion injury in stroke with an acutely dosed NK1R antagonist prodrug,Development Grants"^"Stroke represents a major clinical and societal burden (on individuals and society) and is the primary cause of adult disability, second-most common cause of dementia, and third-leading cause of death. We will develop a novel and effective intravenous form of a compound known to act beneficially in these clinical settings. This form of administration will act quickly and more effectively with beneficial stroke victim outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014002"^"http://purl.org/au-research/grants/nhmrc/2014002"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building Synthetic DNA Controls for Oxford Nanopore Sequencing.,Development Grants"^"The mutations that cause many cancers are often missed using current sequencing technologies because they are too large and complex. Our partner, Oxford Nanopore Technologies, developed a long-read sequencing method that can detect these complex mutations, but is too inaccurate and unreliable for use in clinical laboratories. We will build synthetic controls that improve the accuracy of long-read sequencing, and enable its use to diagnose mutations that are otherwise missed in cancer patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014063"^"http://purl.org/au-research/grants/nhmrc/2014063"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing HCK inhibitor drugs to improve immunotherapy,Development Grants"^"Anti-tumour immune responses are modulated by a cell type called macrophages, which suppress the effects of immunotherapy. We identified a molecule called HCK, which induces macrophages to inhibit the anti-tumour immune response. In collaboration with SYNthesis and the Cancer Therapeutics CRC we will develop inhibitors for HCK. We will test these compounds in preclinical cancer models to identify the most effective combination with immunotherapies to provide the greatest patient benefits."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014079"^"http://purl.org/au-research/grants/nhmrc/2014079"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting metabolism to correct fatty liver disease,Development Grants"^"The severe form of fatty liver disease steatohepatitis affects ~40 million people worldwide and has no approved treatment. This project aims to identify new drugs and test them in mouse models to establish proof-of-concept that they safely reverse steatohepatitis. Success of this project will generate new drug candidates for human clinical testing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014095"^"http://purl.org/au-research/grants/nhmrc/2014095"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Lung Ventilation Imaging: A new device to protect the lungs for cancer treatment,Development Grants"^"We will develop a device that gives clinicians insight into how their patients lungs are functioning. The information our technology will provide will allow radiotherapy plans to be shaped to minimise side effects for each individual patient, and allow surgeons to assess suitability for surgery in marginal patients with greater confidence. We will leverage the proven track record of our industry partner in complementary technologies to develop our device into a commercially ready product."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014168"^"http://purl.org/au-research/grants/nhmrc/2014168"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a non-invasive mucosal integrity diagnostic and ingestible capsule sampling tool targeting IBD gut health.,Development Grants"^"Inflammatory Bowel Disease (IBD) affects many Australians and is a chronic condition requiring life-long management and intervention. Current technologies to manage the disease include invasive colonoscopy or non-specific lab tests. There is a need for non-invasive methods to improve the health and well-being of people suffering from IBD. We wish to develop a non-invasive diagnostic and ingestible sampling capsule that can determine gut-health and guide treatment for the long-term patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014250"^"http://purl.org/au-research/grants/nhmrc/2014250"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing a first-in-class therapeutic for chronic visceral pain using venom derived peptides,Development Grants"^"Irritable Bowel Syndrome (IBS) is a leading cause of chronic pain, both world-wide and in Australia, but is without treatment. Chronic pain arises from nerve fibres in the colon which fail to "reset" back to normal following inflammation. Targeting these nerve endings with drugs is a key advance in IBS treatment. This project will identify specific voltage-gated sodium channel analogues that act at the level of the colon to numb pain sensing nerve fibres, providing efficacious pain relief in IBS"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014380"^"http://purl.org/au-research/grants/nhmrc/2014380"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Retinal Implant with Closed-loop, Multichannel Stimulation to Improve Visual Acuity,Development Grants"^"Previously we developed a retinal implant capable of restoring some vision to a group of patients blinded by the retinal disease, retinitis pigmentosa. However, the level of vision is relatively low. This project will develop a prototype retinal implant that aims to dramatically improve the level of vision provided. This would significantly increase the market of patients that could benefit from the implant."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014388"^"http://purl.org/au-research/grants/nhmrc/2014388"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting the Achilleâs heel of multi-drug resistant Neisseria gonorrhoeae with drugs that disrupt metal homeostasis,Development Grants"^"Neisseria gonorrhoeae causes sexually transmitted disease gonorrhea. Most gonococcal infections are asymptomatic and can lead to pelvic disease, infertility and increasing risk of HIV co-transmission. Due to the recent emergence of multidrug resistant superbugs, N. gonorrhoeae is now classified as an immediate public-health threat. No vaccine is available. This ideas grant will generate new antibiotics to treat multidrug resistant gonorrhea infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014395"^"http://purl.org/au-research/grants/nhmrc/2014395"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel RNA-based therapeutic for liver cancer,Development Grants"^"The outlook for patients with liver cancer is poor. A new form of RNA-based treatment offers promise. An exciting development is the addition of a molecular hook to the RNA, which specifically targets the RNA-drug to the liver. We have modified our drug, miR-7, to make it more effective in the body and also to specifically target the liver. In this project we will evaluate how effective the new drug is and develop some of the essential data needed to progress it to a clinical trial."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014398"^"http://purl.org/au-research/grants/nhmrc/2014398"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"RESCUING CONE PHOTORECEPTORS IN RETINITIS PIGMENTOSA WITH LASER-DELIVERED PHOTOBIOMODULATION,Development Grants"^"This proposal develops a new laser to treat the blinding eye condition, retinitis pigmentosa. The low energy laser rescues the light-sensitive film at the back of the eye and preserves central vision preventing complete blindness."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014416"^"http://purl.org/au-research/grants/nhmrc/2014416"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a novel topical serine protease inhibitor for tissue repair and inflammatory skin disease,Development Grants"^"Slow tissue repair, excessive scarring and many skin diseases are driven by the bodyâs inappropriate or excessive immune response to the injury or environmental trigger. A key enzyme that causes this excessive response is Granzyme B. We will develop a new drug that can target Granzyme B. We will generate the data to support the first in human trials of the drug at the end of this study to support translation to better treat patients with scarring, fibrosis and inflammatory skin disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014427"^"http://purl.org/au-research/grants/nhmrc/2014427"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a potent and fast acting antimalarial that is orally efficacious in vivo,Development Grants"^"Malaria is a devastating disease that causes 420,000 deaths worldwide annually. Critically malaria parasites have become resistant to nearly all currently used drug classes, and therefore there is an urgent need to develop new therapies. We have identified a highly active antimalarial class with a known mechanism of action and all the prerequisites required to advance this antimalarial class into human clinic trials in partnership with Medicines for Malaria Venture and Janssen Pharmaceuticals."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014512"^"http://purl.org/au-research/grants/nhmrc/2014512"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing FXIIa inhibitors as next-generation anticoagulants,Development Grants"^"We have designed a new potential drug to inhibit disease-related blood clotting without interfering with normal clotting processes. The new molecule is promising because it is effective at stopping clotting, but to develop it into a drug we need to generate additional data confirming its safety and stability, then test it in animal models of thrombosis as a precursor to human trials. This project aims to generate these data and to optimise the lead molecule to make it suitable for such trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014538"^"http://purl.org/au-research/grants/nhmrc/2014538"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a novel blood test that accurately predicts response to checkpoint therapy in cancer patients,Development Grants"^"New cancer therapies that target the patientâs immune system can cure patients whose cancers are resistant to all other therapies. However these new immune targeting treatments are effective in only a minority of patients, can cause significant toxicity and are very expensive. This application will meet the urgent need for a blood test that can accurately predict which patients will respond before therapy is started."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014544"^"http://purl.org/au-research/grants/nhmrc/2014544"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel long-acting and orally delivered conotoxin-based peptides with both analgesic efficacy and disease modifying potential.,Development Grants"^"Chronic pain is a common and debilitating condition and there is a significant need for new analgesics to treat this pain. We have designed conotoxin (small peptides from marine cone snail venom) analogues with potent analgesic effects and the objective of this project is the preclinical development of these molecules as novel long-acting treatments of chronic pain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014584"^"http://purl.org/au-research/grants/nhmrc/2014584"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"c-FIND: Diagnosis of infections in minutes,Development Grants"^"Diagnostic tests dictate treatment algorithms for infectious diseases which has become incredibly complex due antibiotic resistance. The inability to diagnose infections or lengthy delays in diagnosis result in patients being unable to access appropriate, timely or effective treatment. WEHI has been using a gene technology called CRISPR for over a decade and we have adapted this to accurately detect infections in patients within minutes to inform management at the point of care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013798"^"http://purl.org/au-research/grants/nhmrc/2013798"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding response and resistance to immunotherapy in immunocompromised patients with cutaneous squamous cell carcinomas,Postgraduate Scholarships"^"Cutaneous squamous cell carcinoma (CSCC) is common in those with impaired immune systems and these patients have been excluded from the major immunotherapy trials. This research looks at CSCC that has improved or worsened on immunotherapy so we can better understand why some tumours respond and others do not. This will help assess who will benefit from immunotherapy, how we can fight resistance and improve treatment outcomes for vulnerable immunosuppressed patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013800"^"http://purl.org/au-research/grants/nhmrc/2013800"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using twin studies to investigate epilepsy aetiology and antiepileptic drug-induced birth defects,Postgraduate Scholarships"^"By measuring and comparing the degree of similarity in a trait or disease between identical and non-identical twins, we can understand how much of the difference in a trait or disease between people is attributable to genes. This project will use twins to study the genetic contributions to epilepsy and to birth defects seen in babies born to mothers taking antiepileptic medications in pregnancy. The results will improve patient management and lead to the development of better treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013809"^"http://purl.org/au-research/grants/nhmrc/2013809"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the genetics and mechanisms of spontaneous coronary artery dissection,Postgraduate Scholarships"^"SCAD occurs in young women as a bleed into the wall of an artery of the heart, resulting in a heart attack. Cause(s) are not known but there is a genetic link in some cases. I plan to: (1) use advanced heart imaging to define differences between heart arteries of affected and unaffected people; (2) use animal models to correlate the observed characteristics (phenotype) and genetics (genotype) of SCAD; (3) sequence DNA from people with SCAD and selected relatives to identify causative genes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013816"^"http://purl.org/au-research/grants/nhmrc/2013816"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Pregnancy in Crohn's and Colitis - Observations, Levels and Outcomes Extension (PICCOLO - X) study,Postgraduate Scholarships"^"Poorly controlled IBD has been shown to negatively affect outcomes for mother and baby. As newer medications become available to treat IBD, it is increasingly important to determine: 1. How disease activity can be accurately and non-invasively monitored in pregnancy. 2. To what degree medications cross the placenta into the baby. 3. For how long medications remain detectable in the baby after delivery. 4. The effect on the babyâs brain and immune system development. PICCOLO-X will address these."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013817"^"http://purl.org/au-research/grants/nhmrc/2013817"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing the power of Patient Reported Outcomes (PROs): demonstrating novel applications of PROs in the care of oncology patients,Postgraduate Scholarships"^"Patient-reported outcomes (PROs) empower patients to communicate their symptoms and needs to clinicians. Understanding the impact of treatment from a patientâs perspective is vital to ensure their concerns are addressed and to inform improvements to cancer care. This study will examine new ways of using PROs to understand the patient experience, enable treatment side effects to be captured and communicated with patients, and promote the collection of PROs in clinical registries."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013821"^"http://purl.org/au-research/grants/nhmrc/2013821"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Long-term Outcomes of Surgery for Diseases of the Aortic Valve in Children,Postgraduate Scholarships"^"Over 2400 children in Australia are born with a heart defect annually. Up to 7% will have an abnormal aortic heart valve and need open-heart surgery in order to survive. Although surgery is often successful, affected children will need multiple heart operations throughout their life and face heart complications and premature death. This study will investigate the long-term outcomes of aortic valve surgery in children and aim to identify strategies to minimise complications and maximise survival."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013829"^"http://purl.org/au-research/grants/nhmrc/2013829"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Negative Symptoms of Psychosis,Postgraduate Scholarships"^"Impairments in facial expressivity, motivation, and sociality â the ânegative symptomsâ - are the most debilitating features of psychotic disorders, yet they are inadequately treated. In this study, I will use facial emotion detection algorithms, functional brain imaging, and novel tasks including real-time facial feedback and heart rate feedback, to discover the changes in the brainâs emotional circuits that underlie negative symptoms."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013831"^"http://purl.org/au-research/grants/nhmrc/2013831"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Evolution of Streptococcal pathovars,Postgraduate Scholarships"^"Streptococcus dysgalactiae subspecies equisimilis (group C/G Streptococcus) is a bacterium that is increasingly recognised as a cause of serious human disease. It shares genes and disease manifestations with the closely related bacteria, Streptococcus pyogenes (group A Streptococcus). We aim to analyse a global streptococcal genetic database to identify common drivers of disease and potential shared vaccine targets to inform public health and vaccine approaches to combat streptococcal disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013839"^"http://purl.org/au-research/grants/nhmrc/2013839"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards the understanding of the immunopathogenesis of autoantibody-mediated systemic diseases: new approaches to old problems,Postgraduate Scholarships"^"Autoantibodies and white cells called B cells are found in systemic autoimmune diseases such as lupus. These are normally present in healthy individuals but a series of failed checkpoints enable them to go ârogueâ, damage host tissue and cause debilitating symptoms. Understanding their molecular signatures will allow me to understand the processes that occur that lead to autoimmunity. This will help create personalised therapies for patients to âeliminateâ these rogue populations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013842"^"http://purl.org/au-research/grants/nhmrc/2013842"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Meeting an unmet need in systemic sclerosis: defining the burden of arrhythmia and sudden cardiac death,Postgraduate Scholarships"^"Scleroderma is an autoimmune condition which damages multiple organs. Scleroderma patients are at risk of heart rhythm abnormalities which can result in sudden death. We do not understand why some people develop heart problems, or how to identify patients at greatest risk of rhythm abnormalities. We aim to determine how often heart rhythm problems occur in scleroderma, to understand how to predict risk of heart rhythm disturbances and potentially prevent them from occurring."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013844"^"http://purl.org/au-research/grants/nhmrc/2013844"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Randomised Evaluation of the Impact of Catheter Ablation versus Medical Therapy on Psychological Distress and Neurocognitive Function in Atrial Fibrillation,Postgraduate Scholarships"^"Atrial fibrillation (AF), a type of arrhythmia, is a risk factor for both psychological distress and cognitive decline. This study aims to determine if potentially curative catheter ablation procedures result in a greater improvement in markers of psychological distress and neurocognitive function compared to ongoing anti-arrhythmic drugs. We will also assess if catheter ablation procedures lead to reduced AF burden and hospitalisations as well as improved quality of life and cardiac function."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013845"^"http://purl.org/au-research/grants/nhmrc/2013845"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advancing the prevention and early intervention for co-occurring anxiety and alcohol use disorders,Postgraduate Scholarships"^"Alcohol use disorders often occur together with anxiety disorders, especially among youth. When these two occur together, individuals can have worse symptoms and treatment outcomes. This study will enhance the prevention and early intervention between anxiety and hazardous alcohol use by identifying key underlying mechanisms driving their relationship, and optimising interventions which address both conditions simultaneously."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013862"^"http://purl.org/au-research/grants/nhmrc/2013862"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting immune resistance mechanisms to enhance anti-tumour immunity in Non-Small Cell Lung Cancer,Postgraduate Scholarships"^"Lung cancer remains the leading cause of cancer related death globally. Treatments designed to unleash the immune systemâs brakes (âimmunotherapyâ) have resulted in significantly improved long-term survival in only a minority of patients. Tumour cells evolve to escape the immune system by silencing signals that allow their recognition by immune cells. We will identify means to reactivating these signals could enable immunotherapy to work in these otherwise resistant tumours."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013877"^"http://purl.org/au-research/grants/nhmrc/2013877"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Risk factors for and burden of low back pain in elite athletes.,Postgraduate Scholarships"^"Despite being in peak physical condition, athletes experience low back pain (LBP) at a higher rate than other members of our community. The reasons for this are not well understood and the advice to "keep active" that is given to non-athletic patients is less appropriate for athletes. This project will recruit and follow 300 elite athletes for one year to identify risk factors for athlete LBP. The project will also measure the cost of LBP in terms of episodes of pain and training time lost."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013894"^"http://purl.org/au-research/grants/nhmrc/2013894"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Young people with old knees: The role of matrix metalloproteinase 3 and type 2 collagen C-telopeptide fragments in predicting post traumatic osteoarthritis after anterior cruciate ligament reconstruction,Postgraduate Scholarships"^"Anterior cruciate ligament (ACL) injuries are common in young and active people. The development of knee arthritis after ACL injury and ACL surgery is a concern because it can lead to a situation were a young patient has an "old knee". This scenario is a major cause of disability and is very challenging to treat. This research is important in identifying patients at risk of premature arthritis and to facilitate prevention, treatment and better outcomes for this young patient group."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013908"^"http://purl.org/au-research/grants/nhmrc/2013908"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Validation and implementation of smartphone-based digital biomarkers in multiple sclerosis to define subclinical progression and treatment failure: the ACTIVE MS study,Postgraduate Scholarships"^"Multiple sclerosis (MS) is a leading cause of disability amongst young Australian adults. To date, only 2 effective treatments for progressive MS has been found. Current treatment is limited by the lack of accurate tools to detect disease progression, which leads to inefficient clinical trials for progressive MS. This project aims to establish smartphone-based apps as a tool to monitor disease activity and detect subtle clinical progression, thereby empowering patients in their own care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013928"^"http://purl.org/au-research/grants/nhmrc/2013928"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Comorbid Mental Health and Drug and Alcohol Use Among Sexuality and Gender Diverse Young People in Australia,Postgraduate Scholarships"^"This study aims to fill a gap in current literature around existing rates of comorbid mental ill-health and drug and alcohol use among young sexuality and gender diverse people (aged 14-25). Existing literature has demonstrated that this population have higher rates of mental ill-health and drug and alcohol use compared to their heterosexual and cisgender peers. I will examine the rates and risk and protective factors of comorbidity among this group, using nationally representative datasets."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013946"^"http://purl.org/au-research/grants/nhmrc/2013946"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Hypertension with low renin - new insights into prevalence, pathophysiology and management,Postgraduate Scholarships"^"High blood pressure is a major cause of death affecting over 6 million Australians, yet two-thirds of patients have poor control. Many of these patients may have a type of hypertension that will respond well to a cheap and widely available medicine called an aldosterone blocker. We will test this drug against currently recommended hypertension treatments to find out if our approach will improve blood pressure control and the overall health of patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013949"^"http://purl.org/au-research/grants/nhmrc/2013949"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Maternal and Child Health Nursing: A golden opportunity to integrate screening for reproductive coercion and increase effective contraception use?,Postgraduate Scholarships"^"This research will create and test a short set of questions about behaviours used to control the pregnancy choices of another person. We aim to help health care workers talk to clients about making a safety plan and planning a pregnancy. The questions will be tested in the Victorian Maternal Child Health Service where nurses currently ask about domestic and family violence. Researchers will also review research papers and talk to nurses, their clients and experts to learn about their opinions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013951"^"http://purl.org/au-research/grants/nhmrc/2013951"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preventing infectious disease and reducing associated harms among people who inject drugs,Postgraduate Scholarships"^"People who inject drugs (PWID) are an understudied population and there are gaps in our understanding of their experience with infectious disease. This project will produce crucial evidence on: 1) vaccination rates and barriers; 2) rates of infection; 3) service utilisation after infection; and 4) effect of drug dependence treatment on infectious disease-related outcomes. These data will inform interventions to prevent and treat infectious disease, improving health outcomes of PWID."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013953"^"http://purl.org/au-research/grants/nhmrc/2013953"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The impact of COVID-19 and associated health policies on access to allied healthcare, care quality, and health outcomes in Australian residential aged care facilities,Postgraduate Scholarships"^"This PhD seeks to explore care quality, health outcomes, and allied healthcare delivery in residential aged care facilities pre and during COVID-19. This PhD uses electronic medical record data from a large aged care provider. Findings will be used to inform care practices and policy during future RACF lockdowns which occur regularly for conditions like influenza. The results also address key policy areas in care quality, e.g., falls, restraint use, and access to allied healthcare."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013961"^"http://purl.org/au-research/grants/nhmrc/2013961"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Genomic architecture of skin in the vicinity of previous melanoma in photodamaged and non-photodamaged areas,Postgraduate Scholarships"^"UV damage is a cause of melanoma-associated mutations, but recent work shows that even normal skin is awash with mutations. Why do some sites become melanoma, but not in nearby, equally UV-damaged sites? I will identify genomic aberrations, that are markers of melanoma-prone sites, by assessing skin from UV-damaged sites near melanomas, UV-damaged sites away from melanomas, and sun-protected sites with spatial profiling technology that will enable a molecular map of aberrations across the skin."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013970"^"http://purl.org/au-research/grants/nhmrc/2013970"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"High-risk lymphoproliferative malignancies in the era of novel therapies: Infection risk, surveillance and prophylaxis,Postgraduate Scholarships"^"Opportunistic infection risk in lymphoma patients is incompletely understood, especially amongst heavily pre-treated patients receiving novel cellular therapies. This project will explore infection epidemiology, prediction and prophylaxis strategies amongst lymphoma patients. Retrospective cohort analysis, immune-profiling, multivariate analysis of infection risk and national audit of prophylaxis strategies will be conducted, informing future infection prevention and treatment strategies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013981"^"http://purl.org/au-research/grants/nhmrc/2013981"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing and evaluating an evidence-based training program for improving labour and childbirth care in India.,Postgraduate Scholarships"^"Prolonged labour is a major cause of stillbirth and maternal haemorrhage. The WHO Labour Care Guide (LCG) is a labour-monitoring tool which assists nurses, midwives and doctors provide early and effective interventions to prevent these complications. In my PhD, I will develop a LCG training program and evaluate its effects on LCG use within four hospitals in India. By optimizing LCG use, we expect the quality of maternity care and women's childbirth experiences to improve."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013987"^"http://purl.org/au-research/grants/nhmrc/2013987"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Responsible pre-operative Opioid use for Hip and knee ArthropLasTy (OpioidHALT) study,Postgraduate Scholarships"^"Opioids are medicines used to manage strong pain, but are associated with significant side effects. Opioids are often prescribed inappropriately for osteoarthritis and, when used before surgery, lead to worse pain and longer hospital stay. We propose an intervention where pharmacists educate patients on pain self-management and help with lowering opioid doses before surgery. This research is projected to save $5 million from safer opioid use and reduced hospital costs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014022"^"http://purl.org/au-research/grants/nhmrc/2014022"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Revolutionising System Reform in Mental Health: Addressing Gaps in the System through Big Data and Data Linkage,Postgraduate Scholarships"^"The current mental health system in Australia is not providing the care to those that need it the most. This program of research aims to understand how the mental health system is failing these individuals though an internationally unique approach of analysing population-level ambulance and healthcare records to provide insights into how to improve and re-develop the system."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014024"^"http://purl.org/au-research/grants/nhmrc/2014024"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying and addressing the needs and priorities of patients with genetic kidney disease and their families,Postgraduate Scholarships"^"Chronic kidney disease has a genetic cause in 10% of affected adults and up to 70% of children. A diagnosis of genetic kidney disease (GKD) can bring about a complex emotional response, this psychological burden if not addressed leads to frustration, and distress. I aim to describe patient and clinician experiences of genetic testing, and of GKD, determine patient priorities for genetic testing and models of care in GKD, and develop and implement patient resources to improve care in GKD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014035"^"http://purl.org/au-research/grants/nhmrc/2014035"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Personalising Pain Relief for People With Cancer: The Right Opioid For the Right Person at the Right Time,Postgraduate Scholarships"^"Cancer pain is common and distressing. There is no scientific method to predict which opioid will work for which person. The same opioid may treat one personâs pain well, but cause confusion, or be ineffective for another. This multi-phase project aims to transform pain management.It will consolidate the evidence, and evaluate the impact and feasibility of using gene testing to personalise opioid prescribing for cancer, so that the right opioid is prescribed to the right person at the right time"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014036"^"http://purl.org/au-research/grants/nhmrc/2014036"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Biomarker profiles in Indigenous Australians with systemic lupus erythematosus,Postgraduate Scholarships"^"Lupus is a serious, incurable illness which reduces quality of life and life expectancy. Indigenous Australians have more frequent and severe lupus than the general population, although the reasons for this are unclear. I aim to analyse proteins in the blood of Indigenous and non-Indigenous lupus patients, to determine if there are biochemical differences which explain these disparities. This may help us select better treatments for Indigenous lupus patients in the future."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014037"^"http://purl.org/au-research/grants/nhmrc/2014037"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Treatments to expand regulatory T cells and/or deplete autoantibody production in primary membranous nephropathy,Postgraduate Scholarships"^"Primary membranous nephropathy (pMN) is a kidney disease caused by antibodies that attack the kidney (autoantibody) and is often difficult to treat. We propose research into treatments in a rat model of pMN that target autoantibody-producing immune cells or promote regulatory immune cells, using manufactured immune cells and protein vaccination. We will also compare the immune cells in humans with pMN and healthy individuals to identify specific immune cells targetable using our new treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014038"^"http://purl.org/au-research/grants/nhmrc/2014038"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards vaginal microbiota stability: new treatment paradigm for bacterial vaginosis,Postgraduate Scholarships"^"Bacterial vaginosis (BV) is very common in reproductive aged women. Current therapies are not very effective. However bacterial vaginosis is linked with poor reproductive health outcomes in women. New therapies are needed. Phages are viruses that attack bacteria, and CPR bacteria are a group of little-known bacteria that parasitise other bacteria. This research will investiage how phages and CPR bacteria affect vaginal health and develop new BV therapies based on phages and CPR bacteria."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014056"^"http://purl.org/au-research/grants/nhmrc/2014056"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using mathematical models to generate evidence to support Australiaâs COVID-19 responses and prepare for future pandemics,Postgraduate Scholarships"^"My PhD will utilise mathematical modelling to generate evidence to support COVID-19 responses in Australia and prepare for future epidemics/pandemics. The main objectives are to address current COVID-19 policy questions (e.g. vaccination strategies), learn lessons from deep analysis of previous COVID-19 outbreaks in Australia, and produce generalisable and impactful guidelines for future pandemic responses."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014074"^"http://purl.org/au-research/grants/nhmrc/2014074"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Economic evaluation of strategies to increase kidney donation and transplantation,Postgraduate Scholarships"^"I will investigate value and harm of changing the way organ donation is managed in Australia using health economic approaches. I will use data from a large trial to look at how quality of life changes over time as people wait for a transplant. By linking health datasets together I will look at whether the transplant program in Australia treats everyone fairly."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014086"^"http://purl.org/au-research/grants/nhmrc/2014086"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Syphilis diagnosis and management in the community,Postgraduate Scholarships"^"Syphilis is an important global health problem. Rates of syphilis have climbed dramatically in Australia, with heterosexual populations increasingly affected and rises in congenital syphilis. This research project has three objectives: i) to optimize diagnosis of syphilis in general practice using new testing methods; ii) to design and evaluate clinic systems to improve screening for syphilis; and iii) to improve partner notification using internet based contact tracing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014100"^"http://purl.org/au-research/grants/nhmrc/2014100"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding Cirrhotic Cardiomyopathy,Postgraduate Scholarships"^"Liver transplant is the only life-saving option for people with end-stage liver disease. People with liver disease can also have a type of heart failure that can be problematic with liver transplant because of the major stress on the body. This project aims to enrich our understanding of how often, and why this disease happens. We will use a new technique called "metabolomics" to look for specific bloods markers and also follow patients and the changes in their hearts before and after transplant"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014110"^"http://purl.org/au-research/grants/nhmrc/2014110"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Radial artery conduits in coronary artery bypass surgery: the impact of prior instrumentation with a focus on the vascular biology and clinical outcomes.,Postgraduate Scholarships"^"Certain patients with severely narrowed coronary arteries may require bypass (open heart) surgery, with the radial artery in the forearm frequently used as a bypass graft. Prior to surgery, this artery is also used to insert wires and plastic tubes which are fed up the arm to the heart to perform a coronary angiogram. This research aims to assess what damage a coronary angiogram does to the radial artery, and whether this impacts on its ability to be used as a coronary artery bypass graft."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014111"^"http://purl.org/au-research/grants/nhmrc/2014111"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"An integration of multi-omics and machine learning to stratify patients with lupus nephritis for precision medicine,Postgraduate Scholarships"^"This project will investigate genetic and metabolic changes associated with Lupus Nephritis (LN). I will undertake transitional, genomic and metabolic profiling of patients to assess alterations associated with disease activity in LN. I will then analyse this data using machine learning to stratify patient disease class and generate non- invasive disease markers to predict LN activity and uncover new drug targets. This approach will provide personalised medicine for patients with LN."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014112"^"http://purl.org/au-research/grants/nhmrc/2014112"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Cardiovascular Screening in Cancer Patients Treated with Immune Checkpoint Inhibitors,Postgraduate Scholarships"^"Patients with cancer treated with immunotherapy are at higher risk of cardiovascular disease. As cancer survival with immunotherapy is improving, it is important to address cardiovascular risk and screening in cancer patients to reduce the burden of cardiovascular disease and improve overall survivorship. We aim to evaluate cardiovascular risk and guide screening policies that could help prevent cardiovascular disease in cancer patients receiving immunotherapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014114"^"http://purl.org/au-research/grants/nhmrc/2014114"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The role of cytochrome polymorphisms in primaquine metabolism and effects on its activity in radical cure of Plasmodium vivax infection,Postgraduate Scholarships"^"Malaria is a mosquito-borne infection that can be life threatening. Globally there were 228 million cases and 405,000 deaths in 2018. One species, vivax malaria, can cause recurrent infection due to a dormant stage in the liver. The drug primaquine kills this dormant stage. However, recent studies have shown that genetic variations may limit primaquine effectiveness. This research will investigate how genetic variations affect primaquine metabolism and the prevention of recurrent vivax malaria."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014122"^"http://purl.org/au-research/grants/nhmrc/2014122"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Informing future recommendations for prevention and treatment of ovarian cancer using population data,Postgraduate Scholarships"^"Ovarian cancer is the eighth most commonly diagnosed cancer in females worldwide. Five-year survival remains below 50% and physical and psychological symptoms are common amongst survivors. I aim to assess: 1. Factors associated with ovarian cancer risk to inform prevention strategies 2. Survival, symptom and wellbeing outcomes associated with current care pathways to optimise future treatment 3. Lifestyle and genetic factors associated with survival, symptoms and wellbeing to improve outcomes"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014140"^"http://purl.org/au-research/grants/nhmrc/2014140"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Cardiometabolic, Genetic and Lifestyle Risk Factors for Arrhythmias,Postgraduate Scholarships"^"Abnormal heart rhythms are common conditions that cause debilitating symptoms and lead to poorer health outcomes. We have recently begun to appreciate the importance of managing lifestyle and other risk factors in these disorders; however, we still have an incomplete understanding of the role of alcohol consumption, healthy diet, and iron deficiency. This project will inform us of the optimal management of these risk factors, to provide the best care for patients with heart rhythm disorders."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014142"^"http://purl.org/au-research/grants/nhmrc/2014142"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Perinatal and early childhood risk and protective factors for paediatric infection,Postgraduate Scholarships"^"Infection is the most common reason for children needing healthcare. All children are exposed to viruses and bacteria that can cause them to become ill. However, some children are more likely to become ill or get a more severe illness than other children, and the reasons why are not known. This project looks at whether events or conditions during pregnancy, birth and the early years of life could change how likely children are to get sick, or how severe their illness is."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014147"^"http://purl.org/au-research/grants/nhmrc/2014147"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing a community-based psychosocial intervention for young people with mental illness,Postgraduate Scholarships"^"The overall aim is to design, develop, deliver, and evaluate a community-based program for youth with serious mental illness. The tangible outcome of this research will be the development of a trauma-informed, community-based mental health program that has been designed by youth, for youth, to effectively meet their unique psychosocial needs. It is intended that the program improves psychosocial functioning, reduces symptom severity, and enhances the life trajectory of these vulnerable youth."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014148"^"http://purl.org/au-research/grants/nhmrc/2014148"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Decolonising approaches for Aboriginal and Torres Strait Islander children with complex health needs exposed to the youth justice system in Australia: Reducing incarceration and recidivism rates,Postgraduate Scholarships"^"Urgent research is required to reduce lifelong harm and the over-representation of Aboriginal and Torres Strait Islander youth who are exposed to police custody and youth detention. A co-designed culturally appropriate diversionary model of care is imperative to identify complex health needs and create alternative pathways, away from detention. Scoping literature reviews and yarning circles with Aboriginal and Torres Strait Islander youth and their communities will inform this process."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014162"^"http://purl.org/au-research/grants/nhmrc/2014162"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Determining health system and public policy elements for successful implementation and sustainability of cervical cancer elimination strategies at a country and regional level,Postgraduate Scholarships"^"The global burden of cervical cancer is significant, however elimination is possible. This PhD aims to support global cervical cancer elimination by determining a best practice approach for member states to achieve optimum implementation of WHO strategies and concurrent health system strengthening. Policy analysis, stakeholder consultation and expert consensus will be used to develop a planning tool for governments to optimise implementation of cervical cancer elimination strategies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014163"^"http://purl.org/au-research/grants/nhmrc/2014163"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising trial processes and generating translational gains: Studies Within A Trial (SWATs) for the MELSELF randomised controlled trial of patient-led melanoma surveillance.,Postgraduate Scholarships"^"With increasing concerns about research waste in clinical trials, there is recognition of the need to improve the design and operation of trials. With that in mind the Studies Within a Trial (SWAT) methodology has been developed to generate evidence to inform the conduct of future trials. My research will evaluate strategies to improve participant recruitment, retention, and intervention adherence within a series of SWATs embedded within a melanoma surveillance host trial."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014165"^"http://purl.org/au-research/grants/nhmrc/2014165"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Application of advanced manufacturing technologies to offload diabetes-related foot ulceration,Postgraduate Scholarships"^"People with diabetes can develop wounds on their feet due to high pressures. These wounds cause significant health and personal impacts for those affected and present a high cost to the health system. Current treatments are not always provided and are often not used by patients. This project explores how 3D scanning, computer aided design, and 3D printing could be used to make a more affordable, accessible and personalised treatment that clinicians are more likely to provide and patients use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014166"^"http://purl.org/au-research/grants/nhmrc/2014166"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development and evaluation of strategies to improve syphilis screening of pregnant women to prevent congenital syphilis,Postgraduate Scholarships"^"This project aims to improve screening for syphilis at a time when increasing numbers of babies are being infected with syphilis. It will have three main aims: to assess the current situation regarding syphilis screening during pregnancy, to implement a new screening policy in pregnancy and to assess the efficacy of the new policy and techniques."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014180"^"http://purl.org/au-research/grants/nhmrc/2014180"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving evidence-based practice for comorbid alcohol and other drug and mental health conditions: the role of implementation science and quality improvement toolkits,Postgraduate Scholarships"^"Alcohol and other drug (AOD) and mental disorders frequently co-occur, yet there is a lack of evidence-based treatment in AOD services and a lack of studies focusing on reducing this evidence-to-practice gap. This thesis seeks to improve evidence-based practice in AOD services by developing, implementing and evaluating the effectiveness of a quality improvement toolkit that assists services to implement evidence-based guidelines for managing comorbid mental health conditions in AOD settings."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014206"^"http://purl.org/au-research/grants/nhmrc/2014206"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating epigenetic regulators of disease and novel epigenetic treatment approaches for imprinting disorders,Postgraduate Scholarships"^"Prader-Willi Syndrome (PWS) and Schaaf-Yang syndrome (SYS) are incurable disorders caused by a lack of expression of the paternal copy of particular genes. Patients have normal maternal copies but these are switched off. A potential treatment is to activate the silenced copies by removing the function of proteins that normally repress their expression. Here we will investigate a new potential treatment for PWS/SYS targeting the protein called SMCHD1 that normally switches off these genes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014208"^"http://purl.org/au-research/grants/nhmrc/2014208"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Koolungar Urban Moorditj Healthy Skin: Determining the burden of skin disease in urban Aboriginal children and adolescents.,Postgraduate Scholarships"^"Skin infections and their complications are very common in remote-living Australian-Aboriginal children, but we do not know if urban Aboriginal children have this same risk. This is despite almost 80% of Australia's Aboriginal and Torres Strait Islander population living in regional and metropolitan areas. Working with Aboriginal Elders, we have designed a project to determine how common skin diseases are in urban Aboriginal youth, in order to improve prevention and treatment of skin infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014210"^"http://purl.org/au-research/grants/nhmrc/2014210"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining host immune response and prevention strategies for viral respiratory tract infections in patients with haematological malignancy,Postgraduate Scholarships"^"Viruses such as COVID-19 and influenza can lead to severe chest infections in patients with blood cancers. This research project aims to study the immune response to infection by these viruses in patients receiving treatment for blood cancers. This information will help us to improve treatment and vaccination against these viruses. A major aim is to prevent further infection. Results from this project may change current vaccination practice in Australia and lead to further research projects."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014215"^"http://purl.org/au-research/grants/nhmrc/2014215"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enhancing venetoclax and other pro-apoptotic agents to improve outcomes for patients with haematological malignancies,Postgraduate Scholarships"^"Blood cancers kill &amp;gt;4,500 Australians per year. A new drug, venetoclax, has significantly improved outcomes for these patients, but relapses frequently occur. This PhD will analyse cancer cells at the single cell level to identify and specifically target the resistant populations that cause relapse. We will study how to undermine the energy metabolism of cancer cells, which may synergise with venetoclax. These projects strive to develop new treatments to improve patient care and achieve cures."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014234"^"http://purl.org/au-research/grants/nhmrc/2014234"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dissecting the challenge of AML,Postgraduate Scholarships"^"Acute myeloid leukaemia (AML) is a life-threatening blood cancer that is difficult to treat. Recently, several new âtargeted therapyâ drugs have been developed, which work by blocking specific changes in cancer cells that help them survive and grow. Unfortunately, resistance to treatment commonly emerges. This project aims to understand how resistance can arise and how they affect responsiveness to different drugs. This information will help us develop better treatments for patients with AML."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014244"^"http://purl.org/au-research/grants/nhmrc/2014244"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Ventricular arrhythmia mechanisms and therapies,Postgraduate Scholarships"^"Heart disease is the leading cause of death in Australia, with heart rhythm disorders being a major cause for debilitating symptoms and sudden cardiac death. Our understanding of heart rhythm disorders is incomplete. My aim is to study the mechanisms and therapies of heart rhythm disorders, including medications and procedural technologies, using advanced techniques and diagnostic tools to treat and potentially cure heart rhythm disorders, improve quality of life &amp;amp; prevent sudden cardiac death."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014245"^"http://purl.org/au-research/grants/nhmrc/2014245"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Untangling Neuroinflammation's Role in Alzheimer's Disease Development (UNRAVEL),Postgraduate Scholarships"^"My PhD will lead to new understandings around the associations between tau homeostasis, neuroinflammation, and neurodegeneration, as well as identifying clinically useful biomarkers to support the diagnosis, prognosis and monitoring of patients with AD. My work will also shed light on the effects of SAMe on neuroinflammatory pathways, providing further information on the activity of this potential therapeutic, as well as identifying novel potential neuroinflammatory therapeutic targets."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014256"^"http://purl.org/au-research/grants/nhmrc/2014256"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A randomised controlled human challenge trial to evaluate Strep A vaccine efficacy, safety, and immunogenicity,Postgraduate Scholarships"^"In human challenge models, healthy volunteers are given a carefully monitored infection to learn how diseases work and how to stop them. In this project, a new Australian strep throat human model will be used to test a vaccine against Strep A, which affects &amp;gt;750 million and kills &amp;gt;500,000 annually."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014258"^"http://purl.org/au-research/grants/nhmrc/2014258"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving care and outcomes for vulnerable patients with chronic kidney disease â the young and the elderly,Postgraduate Scholarships"^"This study aims to examine patient-centered interventions for vulnerable populations with chronic kidney disease that assist with managing their condition, accessing care to ultimately improve healthcare outcomes. Specifically the study will assess the impact of personalised care plans that integrates patient priorities to improve the quality of life and reduce the burden of disease among children and older frail people with CKD and their families; and engaging patients in translatable research."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014261"^"http://purl.org/au-research/grants/nhmrc/2014261"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel technologies and strategies to identify arrhythmogenic substrate and triggers for sudden cardiac death,Postgraduate Scholarships"^"The most common cause of sudden cardiac death is ventricular arrhythmias (VAs) - rapid heart rhythms can cause the heart to stop beating. Catheter ablation (CA), where regions of the heart from which these rhythms arise (scar) are burned can treat VA however requires accurate identification scar with invasive maps. Novel technologies including machine learning, 3D echocardiography and ECG imaging allow for non-invasive characterisation. This project aims to further validate these technologies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014262"^"http://purl.org/au-research/grants/nhmrc/2014262"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Exceptional cognition in old age and interactions with other aspects of successful ageing,Postgraduate Scholarships"^"Research on adults who function successfully at older ages could provide insights into what determines wellbeing in old age, how dementia could be prevented and what services might be required for older adults. This research will examine not just memory and other cognitive processes but also physical function and social connectedness to see how these aspects of functioning interact in successful ageing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014266"^"http://purl.org/au-research/grants/nhmrc/2014266"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Evaluating the use of an open access self-collection cervical screening pathway: The solution to declining participation and to long standing inequities?,Postgraduate Scholarships"^"Australiaâs renewed National Cervical Screening Program enabled an alternative self-collection pathway for women who were under-screened. Data collected from early adopters indicates it is highly acceptable, however, significant implementation issues with the strict eligibility criteria and limited promotion have led to a low uptake of the pathway. This research will evaluate the use of open access to self-collection as a solution to addressing longstanding inequities in Australiaâs program."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014285"^"http://purl.org/au-research/grants/nhmrc/2014285"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Cognitive Ageing Risk Evaluation (CARE) Tool to Support Clinical Diagnosis of Dementia for Aboriginal and Torres Strait Islander Peoples,Postgraduate Scholarships"^"Dementia among Aboriginal and Torres Strait Islander peoples is much greater than the general Australian population. There is need to better understand the risk factors that account for this and the role of brain imaging and blood tests in assessment of Aboriginal and Torres Strait Islander peoples vulnerable to cognitive decline. This research will look at the risk factors and blood markers to improve diagnosis, management and support for patients and families affected."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014292"^"http://purl.org/au-research/grants/nhmrc/2014292"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Science of Cold Snare Polypectomy,Postgraduate Scholarships"^"Colorectal cancer (CRC) was the third most commonly diagnosed cancer in Australia in 2017 with an estimated incidence rate of 67 per 100,000. Screening by colonoscopy can lead to a reduced cancer incidence as well as mortality through early detection of cancer and pre-cancerous lesions. Endoscopy training is heuristic and imperfect. Identifying risk factors for incomplete polypectomy and quantifying adequate resection margin will help frame world polypectomy guidelines."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014294"^"http://purl.org/au-research/grants/nhmrc/2014294"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"How does methamphetamine use, mental health and treatment interventions affect one another?,Postgraduate Scholarships"^"Within Australia, an increasing proportion of people are using crystalline methamphetamine, or ice. Using amphetamines has been linked to various harms and an increased risk of comorbid mental health disorders. However, exploring the link between comorbid mental health and treatment outcomes has been limited. The proposed PhD aims to explore this link further through linking multiple cohorts of people dependent on methamphetamine as well as methamphetamine-related hospital presentations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014320"^"http://purl.org/au-research/grants/nhmrc/2014320"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Modulation of the gut microbiome and mucosal immune response in IBD,Postgraduate Scholarships"^"Inflammatory bowel disease (IBD) is an incurable condition with significant morbidity and mortality. Australia has one of the highest prevalence rates in the world, costing $3.1 billion dollars annually. The gut microbiome appears to be a key player in the onset and trajectory of IBD. Over the course of a 4 year PhD, we aim to evaluate how the gut microbiome affects the gut immune system and how this can be utilised to develop and target drug therapy to better control and potentially cure IBD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2008433"^"http://purl.org/au-research/grants/nhmrc/2008433"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovative point-of-care diagnostics and environmental surveillance tools for the elimination of Asian schistosomiasis,International Collaborations"^"Accurate and rapid diagnostics are one of the key cornerstones for control and elimination of schistosomiasis in Asia. This cooperative research project aims to develop and trial rapid, cost-effective, field-friendly point-of-care (POC) diagnostics and environmental DNA (eDNA) detection tests for Asian schistosomiasis. Integrating the POCs and eDNA detection to the current schistosomiasis control programs within Asia and beyond can lead control policy and assess elimination goals.&lt;/field&gt;&lt;field id="e-Asia Project Title"&gt;Innovative point-of-care diagnostics and environmental surveillance tools for the elimination of Asian schistosomiasis"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009545"^"http://purl.org/au-research/grants/nhmrc/2009545"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Ending HIV transmission by Optimizing Pre-exposure prophylaxis in East Asia (HOPE),International Collaborations"^"This cooperative research project aims to bring together regional experts to co-design strategies with affected communities in Australia, Thailand and Philippines to optimize adherence to pre-exposure prophylaxis (PrEP) for HIV. Activities include networking and capacity building through cross-country, multidisciplinary workshops and conferences; and implementing interventions informed by innovative methods (crowdsourcing, discrete choice experiments) to optimize adherence among PrEP users.&lt;/field&gt;&lt;field id="e-Asia Project Title"&gt;Ending HIV transmission by Optimizing Pre-exposure prophylaxis in East Asia (HOPE)"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009656"^"http://purl.org/au-research/grants/nhmrc/2009656"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Vector sero-surveillance tools to accelerate malaria elimination,International Collaborations"^"Measuring antibody responses to mosquito salivary proteins in human sera may be a practical, highly sensitive alternative approach to estimate human biting rates and exposure to vector-borne diseases such as malaria. We will measure these salivary antibodies in a human biting challenge trial where volunteers are repeatedly bitten by mosquitoes to define antibody thresholds which predict biting rates. Furthermore, we will validate this sero-surveillance tool in field trials of vector control."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2009816"^"http://purl.org/au-research/grants/nhmrc/2009816"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting MYCN/NCYM for cancer therapy,International Collaborations"^"Primary liver cancer is a common cause of death from cancer in adults. Hepatocellular carcinoma represents approximately 90% of all cases of primary liver cancer. Cancer is the most common cause of death from diseases in children. Neuroblastoma is the most common solid tumour in early childhood. In this project, we will identify a novel therapeutic strategy targeting hepatocellular carcinoma and neuroblastoma for clinical translation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014513"^"http://purl.org/au-research/grants/nhmrc/2014513"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"COgNiTive propagation in pRodrOmaL Parkinsonâs disease: CONTROL-PD,International Collaborations"^"It has long been felt that not all patients with Parkinsonâs disease are affected by the same pattern of cell death, which results in differences in their presentation, progression and response to treatment. This program will link international research teams who have can perform detailed assessments not only patients with the condition but also in the prodromal phases of disease to help better understand these differences and improve outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014629"^"http://purl.org/au-research/grants/nhmrc/2014629"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Effects of early-Stress On Lipid mediators and Inflammation for early Detection of neurodegeneration (SOLID),International Collaborations"^"The next frontier in Alzheimerâs Disease (AD) research is to find easily measurable biomarkers for neurodegeneration and cognitive dysfunction. Our translational project will leverage data and samples from 4 established human cohorts and 10+ rodent models. We will identify i) early biomarkers predictive of neurodegeneration and cognitive dysfunction ii) the causal role of early-life adversity on predisposition to AD and iii) an intervention strategy for alleviating these effects."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014651"^"http://purl.org/au-research/grants/nhmrc/2014651"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Leveraging medical records to identify patients at risk of neurodegenerative disease,International Collaborations"^"Neurodegenerative diseases represent one of the main public health issues in our western societies and one of the greatest challenges in drug development. Therapeutic intervention for these disease works best with early intervention, ideally at pre-symptomatic stages. LeMeReND proposes to use electronic health records (EHR) to identify biomedical risk factors through studying previous diagnoses (pre-clinical comorbidities), drug prescription, clinical care usage, and biological test results."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014745"^"http://purl.org/au-research/grants/nhmrc/2014745"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A randomised CONtrolled trial of Tailored Acceptance and Commitment Therapy for older people with treatment resistant Generalised Anxiety Disorder (CONTACT-GAD),International Collaborations"^"Generalised anxiety disorder (GAD) is one of the most common mental disorders in later life. It is characterised by excessive and uncontrollable worry that is often chronic and associated with poorer quality of life, increased disability and greater use of medication and health services. Current treatments for GAD are not always well tolerated in this population. Acceptance and Commitment therapy (ACT) is a promising psychological therapy. This clinical trial will compare ACT to usual care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014792"^"http://purl.org/au-research/grants/nhmrc/2014792"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The neoGASTRIC trial: Avoiding routine gastric residual volume measurement in neonatal critical care, a multi-centre, randomised controlled trial,International Collaborations"^"Before feeding preterm babies, nurses aspirate the contents of the stomach from the feeding tube to assess the âresidual volumeâ of feed, to determine the feeding plan. It is not clear if this is helpful (by detecting gut issues early), or harmful (by unnecessarily delaying feeding). In this trial, half of included infants will have gastric residual volumes routinely measured, and half will not. This will show which approach is best, for establishing feeding and avoiding any harm."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015634"^"http://purl.org/au-research/grants/nhmrc/2015634"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015635"^"http://purl.org/au-research/grants/nhmrc/2015635"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015636"^"http://purl.org/au-research/grants/nhmrc/2015636"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015637"^"http://purl.org/au-research/grants/nhmrc/2015637"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015638"^"http://purl.org/au-research/grants/nhmrc/2015638"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015639"^"http://purl.org/au-research/grants/nhmrc/2015639"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015640"^"http://purl.org/au-research/grants/nhmrc/2015640"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015641"^"http://purl.org/au-research/grants/nhmrc/2015641"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015642"^"http://purl.org/au-research/grants/nhmrc/2015642"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015643"^"http://purl.org/au-research/grants/nhmrc/2015643"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015644"^"http://purl.org/au-research/grants/nhmrc/2015644"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015645"^"http://purl.org/au-research/grants/nhmrc/2015645"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015646"^"http://purl.org/au-research/grants/nhmrc/2015646"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015647"^"http://purl.org/au-research/grants/nhmrc/2015647"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015648"^"http://purl.org/au-research/grants/nhmrc/2015648"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015649"^"http://purl.org/au-research/grants/nhmrc/2015649"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015650"^"http://purl.org/au-research/grants/nhmrc/2015650"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015651"^"http://purl.org/au-research/grants/nhmrc/2015651"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015652"^"http://purl.org/au-research/grants/nhmrc/2015652"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015653"^"http://purl.org/au-research/grants/nhmrc/2015653"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015654"^"http://purl.org/au-research/grants/nhmrc/2015654"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015655"^"http://purl.org/au-research/grants/nhmrc/2015655"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015656"^"http://purl.org/au-research/grants/nhmrc/2015656"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015657"^"http://purl.org/au-research/grants/nhmrc/2015657"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015658"^"http://purl.org/au-research/grants/nhmrc/2015658"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015659"^"http://purl.org/au-research/grants/nhmrc/2015659"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015660"^"http://purl.org/au-research/grants/nhmrc/2015660"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015661"^"http://purl.org/au-research/grants/nhmrc/2015661"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015662"^"http://purl.org/au-research/grants/nhmrc/2015662"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015663"^"http://purl.org/au-research/grants/nhmrc/2015663"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015664"^"http://purl.org/au-research/grants/nhmrc/2015664"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015665"^"http://purl.org/au-research/grants/nhmrc/2015665"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015666"^"http://purl.org/au-research/grants/nhmrc/2015666"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015667"^"http://purl.org/au-research/grants/nhmrc/2015667"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015668"^"http://purl.org/au-research/grants/nhmrc/2015668"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015669"^"http://purl.org/au-research/grants/nhmrc/2015669"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015670"^"http://purl.org/au-research/grants/nhmrc/2015670"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015671"^"http://purl.org/au-research/grants/nhmrc/2015671"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015672"^"http://purl.org/au-research/grants/nhmrc/2015672"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015673"^"http://purl.org/au-research/grants/nhmrc/2015673"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015674"^"http://purl.org/au-research/grants/nhmrc/2015674"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015675"^"http://purl.org/au-research/grants/nhmrc/2015675"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015676"^"http://purl.org/au-research/grants/nhmrc/2015676"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015677"^"http://purl.org/au-research/grants/nhmrc/2015677"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015678"^"http://purl.org/au-research/grants/nhmrc/2015678"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2021 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000699"^"http://purl.org/au-research/grants/nhmrc/9000699"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000700"^"http://purl.org/au-research/grants/nhmrc/9000700"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000714"^"http://purl.org/au-research/grants/nhmrc/9000714"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000701"^"http://purl.org/au-research/grants/nhmrc/9000701"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000702"^"http://purl.org/au-research/grants/nhmrc/9000702"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000703"^"http://purl.org/au-research/grants/nhmrc/9000703"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000704"^"http://purl.org/au-research/grants/nhmrc/9000704"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000705"^"http://purl.org/au-research/grants/nhmrc/9000705"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000706"^"http://purl.org/au-research/grants/nhmrc/9000706"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000707"^"http://purl.org/au-research/grants/nhmrc/9000707"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000716"^"http://purl.org/au-research/grants/nhmrc/9000716"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000717"^"http://purl.org/au-research/grants/nhmrc/9000717"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000708"^"http://purl.org/au-research/grants/nhmrc/9000708"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000709"^"http://purl.org/au-research/grants/nhmrc/9000709"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000710"^"http://purl.org/au-research/grants/nhmrc/9000710"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000715"^"http://purl.org/au-research/grants/nhmrc/9000715"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000711"^"http://purl.org/au-research/grants/nhmrc/9000711"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000718"^"http://purl.org/au-research/grants/nhmrc/9000718"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000712"^"http://purl.org/au-research/grants/nhmrc/9000712"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000713"^"http://purl.org/au-research/grants/nhmrc/9000713"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/9000719"^"http://purl.org/au-research/grants/nhmrc/9000719"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2021,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^